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Introduction 
DNA stores all genetic information that is required for a cell to manufacture the molecules it needs 
to function. Although most somatic cells in a human body contain identical DNA sequences, the 
vast variety of cellular phenotypes implies that the information stored in the DNA sequence on its 
own is not sufficient to explain cell diversity and function. Cells depend on the acquisition and the 
maintenance of epigenetic traits to acquire and maintain a specific phenotype. An epigenetic trait is 
formally defined as “a stably heritable phenotype resulting from changes in a chromosome without 
alterations in the DNA sequence” 1. Genomic DNA is a major constituent of chromatin, a complex 
structure consisting of DNA, and all associated proteins and RNA. The nucleosome is the 
fundamental unit of chromatin, consisting of two copies of the 4 core histones (H2A, H2B, H3 and 
H4) with 147 base pairs of DNA wrapped around it. N-terminal histone ‘tails’ protrude from 
chromatin and are subject to a wide variety of posttranslational modifications. Over recent years, 
many enzymes and chromatin associated proteins have been identified that can write, erase 
and/or read these modifications, providing an epigenetic register of, for instance, transcriptional 
activity. Increasing evidence suggests that epigenetic processes dynamically regulate partitioning 
of the genome in ‘active’ and ‘inactive’ chromatin. Chromatin can undergo dynamic changes in 
structure, resulting in various states of compaction, which either facilitate or block accessibility of 
the DNA template. Chromatin structure modification is an important regulatory aspect of all DNA 
templated processes, including e.g. transcription, replication and repair 2.  
 
Epigenetics 
Increasing insights into the molecular mechanisms underlying epigenetic regulation reveals an 
incredibly complex apparatus that has major implications for development and disease. Although 
epigenetic regulation controls several processes, regulation of transcription is understood best, 
and this occurs at the level of RNA, DNA and proteins. 
At the DNA level, cytosines in CpG dinucleotides were found to be methylated by DNA 
methyltransferases (DNMTs) and promoter DNA methylation by and large correlates with 
transcriptional silencing 3.  
At the RNA level, non-coding RNAs were identified as transcriptional repressors 4.  Perhaps the 
best known non-coding RNA is Xist: Xist covers the outside of the inactive X-chromosome and 
thereby maintains the transcriptionally inactive state 5. Another mechanism by which non-coding 
RNAs silence gene expression is RNA interference (RNAi): microRNA’s and small interfering 
RNA’s (siRNAs) bind RNA through (sometimes imperfect) sequence homology thereby regulate 
gene expression through  blocking gene transcription, regulating RNA translation, RNA processing 
or RNA stability 4. For example, non-coding RNA can bind messenger RNA (mRNA) to prevent 
translation or to activate the RNAi pathway to degrade mRNAs by recruiting the Risc complex to 
mRNAs. Interestingly, binding of non-coding RNAs to specific mRNAS was also shown to enhance 
translation.  
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At the protein level, N-terminal histone tails in nucleosomes are subject to numerous 
posttranslational modifications (i.a. (mono-, di-, or tri-) methylation, phosphorylation, acetylation, 
ubiquitylation) by a diversity of enzymes, such as histone methyltransferases (HMTs), kinases, 
histone acyltransferases (HATs) and ubiquitylases 2. Other enzymes are specialized in removing 
histone modifications, e.g. histone demethylases (HDMs), phosphatases, histone deacetylases 
(HDACs) and deubiquitylases 2. Proteins can recognize and bind to specific modifications through 
specialized domains, forming chromatin-associated multi-protein complexes with relevant 
epigenetic activity. In addition to the various types of modifications that can occur, histones can be 
modified at multiple sites and may be recognized in combination. In the context of transcription, 
these collective histone modifications constitute an epigenetic index of gene activity. How 
epigenetics precisely regulates gene activity is incompletely understood. Certain modifications 
strongly correlate to transcriptional activity, or inactivity, although no perfect correlation has been 
found to date. Together, this array of writers, erasers and binders of epigenetic modifications 
suggests complex and dynamic epigenetic regulation of gene activity. 
 
Polycomb Group proteins 
Polycomb Group (PcG) proteins are best known as transcriptional repressors. First identified in 
Drosophila melanogaster as important regulators of segmentation, PcG complexes maintain 
expression boundaries of homeobox (Hox) genes within the Homeotic gene clusters (HOM-C) 
along the antero-posterior (AP) axis. Hox genes are important regulators of segment identity in the 
fly. It is clear that PcG proteins exert a repressive function and that PcG proteins and their targets 
are conserved throughout evolution. Also in mammals PcG control segmentation: Hox genes 
determine vertebral identity along the AP-axis. PcG-mutations in the mouse cause vertebral 
identity changes and other skeletal defects 6. PcG proteins form large multiprotein complexes that 
combine intrinsic with associated epigenetic activities. PcG repressive complex 2 (PRC2) for 
instance harbors Eed, SUZ12 and the HMT EZH2, which harbors a SET domain with HMT activity 
for lysine 27 on histone 3 (Figure 1). This PcG associated posttranslational modification is 
recognized and bound by specific chromobox proteins (CBX) in the PRC1 complex that also 
contains PHC, BMI1, RING1 and RNF2 (Figure 1). In addition the PRC1 complex harbors E3 
ligase activity for lysine 119 of H2A. Both PRCs are associated with many other factors relevant for 
regulation of transcription. In the fruit fly larvae PRC2 is believed to initiate PcG-based gene 
silencing, whereas PRC1 takes over as a maintenance complex. Although PcG are known as 
transcriptional repressors, how PRCs control repression of promoter activity is mechanistically far 
from understood.  
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Enchondral ossification 
Enchondral ossification is a multistep process in which the ossified skeleton is formed from a 
cartilaginous matrix. The local microenvironment plays an important role in regulation of the 
different steps of Enchondral ossification. Locally produced soluble factors, such as insulin-like 
growth factors, bone morphogenetic proteins, fibroblast growth factors and many others 7 regulate 
the different stages of chondrocyte and osteocytes maturation.   
Cartilage is a dense connective tissue, consisting of collagen, proteoglycan and elastin fibres, 
excreted by chondrocytes. Cartilage is characterized by the absence of blood vessels, and thus 
the hypoxic environment. Therefore chondrocytes receive nutrients and oxygen by diffusion from 
synovial fluids, and depend heavily on hypoxia-inducible factor 1 (HIF-1) and anaerobic 
metabolism to function and survive 7. 
Longitudinal growth of bones is accomplished by two growth plates (epiphysary regions) that move 
away from each other as condensations of mesenchymal (stem/progenitor) cells differentiate into 
chondrocytes. The growth plates are arranged in distinct regions that reflect the different stages of 
chondrocyte differentiation. The first phase of chondrocyte differentiation is characterized by 
activation of the proliferative capacity of resting chondrocytes and longitudinal growth occurs. Next, 
the proliferating chondrocytes become flattened and packed in condensed clusters. Through a 
phase of pre-hypertrophy, the chondrocytes terminally differentiate into hypertrophic chondrocytes. 
In addition to excretion of the cartilage matrix, hypertrophic chondrocytes secrete i.a. VEGF to 
induce the formation of blood vessels, and TGFβ to attract mesenchymal cells and to differentiate 
these cells into osteocytes. As blood vessels and osteocytes enter the cartilage matrix, 
chondrocytes undergo programmed cell death and osteocytes calcify the extracellular matrix to 
form bone. 
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Figure 1 Schematic overview PRC1 and PRC2 complexes
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Aim and outline of this thesis 
Mechanisms underlying PcG mediated transcriptional repression are beginning to unravel. In 
addition, although poorly understood, PcG proteins have been associated with replication and DNA 
repair. However, many questions about Polycomb group biology remain: how are PcG proteins 
regulated themselves? How are PcG proteins involved in mediating gene-environment 
interactions? How are PcG proteins targeted to cell-type specific targets? What is the mechanism 
behind PcG mediated transcriptional repression? What is the role of PcG in replication and DNA 
repair? What is the role of PcG in enchondral ossification? 
We here specifically focus on the role of PcG proteins in chondrogenesis. PcG mutant mice display 
skeletal malformations along the AP-axis, associated with deregulation of Hox gene expression 
boundaries. However, very little is known about the direct involvement of PcG proteins in 
enchondral ossification. The working hypothesis of the research described in this thesis is that PcG 
proteins mediate gene-environment interactions, thereby allowing the epigenomic landscape to 
change and to facilitate chondrogenic differentiation. The research described in this research 
aimed to elucidate the role of PcG proteins and underlying molecular mechanisms in chondrogenic 
differentiation. 
In chapter 2, a detailed review of our current understanding of epigenetic regulation of transcription 
and replication, with a particular focus on PcG proteins, is presented. Chapter 3 describes a novel 
in vivo model to study enchondral ossification in relation to gene-environment interactions, with 
important relevance to alternative tissue repair strategies in regenerative medicine. In chapter 4, 
Egr1 was identified as an important immediate early transcription factor, rapidly induced upon 
chondrogenic differentiation. We find that Egr1 directly controls epigenetic remodelling required for 
chondrogenesis, and present evidence for interaction with PcG function at several levels. Chapter 
5 describes the role for Bmi1 in regulating transcription and replication during transit amplification 
of differentiating chondrocytes. In chapter 6, we show that the epigenetic drug valproic acid 
induces replication stress during transit amplifying chondrocytes, leaving the cells incapable of 
fulfilling the differentiation program. Finally, in chapter 7 the results obtained in these studies are 
discussed. 
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Abstract  
Polycomb Group proteins have been associated with numerous cellular processes that use 
chromatin as a template, including transcription, replication and DNA repair. The link between 
Polycomb function and DNA replication is a long-standing one, yet poorly understood. Recent 
observations position Polycomb proteins at the cross road of transcription and replication and 
begin to offer explanations for cellular and morphological phenotypes. Here we review this 
emerging role for Polycomb in the context of development and cancer. 
 
Introduction  
Lineage commitment and terminal differentiation in the context of development are dependent on 
acquisition and maintenance of heritable epigenetic traits. An epigenetic trait is formally defined as 
“a stably heritable phenotype resulting from changes in a chromosome without alterations in the 
DNA sequence” 2. Although gradually unfolding, the epigenetic mechanisms underlying stable 
inheritance of cell fate decisions (i.e. in mitosis and meiosis) are still far from being completely 
understood. Chromatin remodeling underlies all DNA-templated cellular processes such as 
replication, transcription and repair. Continuous redefinition of chromatin states by covalent 
modification of DNA (i.e. CpG methylation) and/or chromatin associated proteins (e.g. post-
translational modifications of core histones), allows a cell to undergo cell fate determination and to 
function in its micro-environment, i.e. to respond to constantly changing physiological or metabolic 
conditions. Lineage commitment and early differentiation are likely to inflict massive strain on the 
genome, which, under these conditions, is simultaneously transcriptionally redefined and 
replicated. Both the transcriptome and the genome are subject to dynamic changes throughout 
differentiation. Within the context of differentiation, however, the underlying epigenetic mechanisms 
that help tuning replication to transcription and vice versa remain poorly understood. It is 
conceivable that differential epigenomic states functionally partition the genome and help guide 
cells through differentiation, establish and maintain novel physiological states, while allowing 
genome duplication without compromising genetic integrity and genome stability. Thus DNA 
transcription, DNA replication and DNA repair require coordination if they are to occur from one 
and the same template. Perhaps, predictably, transcription, replication and repair ‘machineries’ 
share basal components. It is likely that such proteins and the regulatory pathways they control 
evolved to tune these processes in the context of differentiation in multi-cellular organisms. 
Polycomb Group proteins are connected to many processes that require chromatin structure 
remodeling, among which transcription, replication and repair 3,4. Although biochemical processes 
relevant to epigenetic regulation of transcriptional repression by PcG complexes are becoming 
increasingly clear, how exactly cellular memory is installed and whether and how this connects to 
DNA replication remain enigmatic. We here review how specialized pathways and chromatin 
structure control help cells cope with several important chromatin–based processes (like 
Replicating DNA at Top Speed – Chromatin at Risk 
 
 15
transcription and replication) that, although seemingly in conflict with each other, often occur 
simultaneously in the context of differentiation and development. Specific focus will be on the 
potential role of Polycomb Group (PcG) proteins in these control mechanism.  
 
Epigenetics in transcription 
Perhaps the most studied and mechanistically relatively best understood example of epigenetic 
control of a DNA-templated process is that of transcription. Transcription, production of RNA from 
DNA, is a process highly coordinated by a variety of proteins surrounding the key factor in 
transcription: RNA polymerase. Polyadenylated RNA synthesis requires formation of a preinitiation 
complex (PIC) by RNA polymerase II (RPOL II) with the general transcription factors (GTF) TFIID, 
TFIIA and TFIIB 5. GTF direct RPOLII to these core elements and transcription is initiated by ATP-
dependent TFIIH helicase activity, which uncoils and denatures the DNA allowing RPOLII to bind 
single stranded DNA. To date, in eukaryotes seven core promoter elements have been identified 
(e.g. TATA box), which comprise specific DNA sequences required for promoter function and for 
proper assembly of the PIC 6. Both initiation of transcription and elongation of RNA by RPOLII are 
phosphorylation dependent events 7,8. Access to DNA by local chromatin structure remodelling 
events is essential for initiation and elongation. This is controlled at the epigenetic level and 
includes both covalent histone modifications and nucleosome remodeling machineries 9. Although 
the order of these events is currently under debate, they essentially recruit transcriptional 
activators and expose DNA binding elements.   
Select post-translational modifications (PTM) of histone proteins are linked to specific biological 
processes. Examples include histone variant H2AX phosphorylation in the context of DNA damage 
responses and specific histone H3 acetylation and methylation events that are often associated 
with activation and repression of transcription, respectively 3,7,10. Histone modifications often occur 
and function in conjunction, for example, histone acetylation and methylation events are 
collectively responsible for nucleosome displacement and transcriptional activation 11. Overall, the 
epigenome is defined by a combination of molecular mechanisms at all three macromolecular 
levels, DNA, RNA and protein, which are thought to collectively constitute a highly complex register 
of gene status 4. Some modifications occur in correlation with higher-order chromatin structures. 
For example, as opposed to euchromatin, condensed constitutive heterochromatin is often 
associated with H3K9me3. Compared to euchromatin, heterochromatin often displays distinct 
subnuclear localisation, is replicated later during S-phase and heterochromatic DNA repair requires 
additional components 12. Although a putative inductive role for H3K9me3 in chromatin 
condensation is neither proven nor clear, the correlation does illustrate an important concept: the 
eukaryotic genome is functionally partitioned by the epigenome.  
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Polycomb in Transcription 
Polycomb Group (PcG) proteins are best known as transcriptional repressors. First described in 
Drosophila melanogaster as important regulators of segmentation, it is clear that PcG genes, and 
hence protein structure, their repressive function and their targets are conserved throughout 
evolution. PcG proteins form large macromolecular complexes that combine intrinsic with 
associated epigenetic activities. PcG repressive complex 2 (PRC2) for instance harbors EZH, a 
SET domain protein with histone H3K27-directed methyltransferase (HMT) activity. This PcG 
associated PTM is recognized and engaged by specific chromobox proteins (CBX) in the PRC1 
complex. Both PRCs comprise many other factors relevant for regulation of transcription (see table 
1). In the fruit fly larvae PRC2 is believed to initiate PcG-based gene silencing, whereas PRC1 
takes over as a maintenance complex 13. Although experimental models, seemingly with very few 
exceptions, define PcG as transcriptional repressors, how PRCs control repression of promoter 
activity is mechanistically far from completely understood. The now somewhat antiquated notion 
that PcG silencing is based on chromatin compaction (i.e. higher order structures) and 
consequently reduced accessibility for transcription factors is based on steric principle, finds limited 
experimental support 14. Recent studies identifying PcG association with the general transcription 
factory machinery provide new insights into PcG silencing mechanisms. In the fruit fly, PcG act by 
assembling on Polycomb Responsive Elements (PREs), DNA sequences that can regulate 
silencing of a nearby promoter in a PcG-dependent fashion 15. PcG silencing only slightly reduces 
accessibility of restriction enzymes to the promoter and binding of TATA-binding-protein (TBP) and 
Rpol2 to the HSP26 promoter was not lost, arguing against chromatin compaction as a major 
feature in PcG-mediated repression. Drosophila PRC1 proteins interact with several TBP-
associated factors (TAFs), that complex with the general transcription factor TFIID 16,17. 
Furthermore, the Xenopus eed homologue, a PRC2 member, interacts with TAFII32, a key 
component of the TFIID complex in Xenopus 18. Relevantly, Rpol2 still associates with PcG-
silenced promoters but is inhibited in its ability to initiate transcription16. Trithorax group proteins 
are epigenetic activators known to contain histone methyl transferase activity for H3K4, which is 
correlated with active transcription. Interestingly, trithorax proteins activate transcription by 
counteracting PcG function and by promoting the early phase of transcription elongation 19. 
Although this points to PcG silencing taking place at primary chromatin fibers, the seemingly 
paradoxical co-occurrence of PcG proteins and RPOLII at repressed promoters, and conversely, 
the finding that numerous H3K27me3-associated promoter are transcriptionally active 20,21 indicate 
there is more to PRC-mediated repression than meets the eye. An overview of PcG-associated 
proteins involved in regulation of transcription is presented in table 1. 
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Epigenetics in replication  
DNA replication serves to duplicate DNA in cells in preparation of mitosis. DNA replication is 
controlled by mechanisms highly conserved throughout evolution. The first step in replication 
initiation is licensing of replication by recruitment of multiprotein complexes to discrete foci within 
the nucleus, called replication origins. Replication origins acquire replication competence during 
G1 phase in eukaryotes. Binding of the origin recognition complex (ORC) functionally defines DNA 
replication origins by formation of a pre-replication complex (pre-RC) through complexation with 
Cdc6 and Cdt1, a replication licensing factor that recruits the MCM2-7 helicase complex. 
Subsequently, additional proteins including Cdc45 and DNA polymerases join the pre-RC to form 
the replication fork. The assembly of these multiprotein complexes at replication origins signals the 
beginning of S-phase. The helicase activity of the complex unzips the DNA, and next the ssDNA is 
bound by the heterotrimeric protein RPA preventing the DNA from winding back on itself. The ring-
structured replication factor PCNA is loaded onto DNA and associates with topoisomerases and 
replicative DNA polymerases. By sliding along the DNA ahead of the replication fork PCNA 
enhances the processivity of enzymes in the replication fork 22,23.  
Termination of replication involves Geminin (Gmnn). Gmnn binds free Cdt1, and prevents access 
of the MCM complex to Cdt1, thereby preventing the initiation of novel pre-RC’s. As such Gmnn 
prevents inappropriate reinitiation of replication, and thus ensures that DNA is replicated only once. 
Gmnn expression commences at the onset of S-phase and its expression is maintained until the 
end of mitosis; subsequent inactivation of Gmnn then allows the cell to prepare for a new round of 
replication 23,24.  
Several lines of evidence implicate chromatin structure in spatial and temporal regulation of DNA 
replication. As for transcription, chromatin needs to be made accessible for DNA replication. 
(Hetero)chromatin needs to be decompacted and DNA needs to unwind for replication to occur. 
Although very little is known about chromatin states around ORCs and pre-RC complexes, this is 
likely to involve some form of epigenetic regulation. Cell cycle dependent chromatin remodelling is 
most dramatically visible at the G2/M transition, when chromosomes condense. Although relatively 
little is known about epigenetic changes that accompany this condensation, some well-known 
histone-PTMs precede chromosome condensation, e.g. H3S10, H3S28 and H2AX 
phosphorylation. Many chromatin associated proteins are also phosphorylated in mid/late S and 
released from chromatin. Combined phosphorylation may be required for ensuring chromosome 
condensation and/or new transcriptional states are epigenetically defined at this time point in the 
cell cycle when chromatin is assembled. Not only DNA is replicated faithfully, epigenetic 
information is also transferred from one cell to the other. Chromatin-proteins, like histones, are 
believed to play a crucial role in this cross-generational transcriptional memory. DNA replication 
commences at the onset of S-phase and is subject to dynamic programming. Classic nucleotide 
analogue pulse-labelling experiments have established that DNA replication is differentially 
regulated throughout the nucleus, defining characteristic S-phase replication patterns in space and 
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time. In 1963 Hay and Revel showed that euchromatin is replicated early, whereas 
heterochromatin is replicated late in S-phase 25. In line with this, DNA replication occurs early in S-
phase within genomic regions which are transcriptional active, whereas late replicating DNA is 
found in transcriptionally inactive regions 26. Goldman showed that housekeeping genes, active in 
all cells are replicated during the first half of S-phase 27. Also, tissue-specific genes are replicated 
early in tissues in which their transcriptional activity is high, whereas non-tissue specific genes are 
replicated late 27. As this differential replication is maintained over subsequent rounds of replication 
and cell division 28, it seemed reasonable to assume that structural organization of chromatin 
defines both transcriptional status and replication timing. Hence replication timing profiling may 
provide information about the developmental status and lineage potential of a cell. Indeed, recent 
comparisons of replication timing of lineage specific and non-specific genes between pluripotent 
embryonal stem cells (ESCs) and uni-potent T lymphocytes or neural cells revealed that replication 
timing is closely linked to lineage restriction and developmental status 20,29.  
The most direct evidence for coordinate tuning of transcription and replication comes from 3D-
fluorescence imaging studies in mouse and human diploid fibroblasts. Euchromatic DNA 
replication and transcription are constrained to defined nuclear areas, indicating that an underlying 
genomic architecture, likely involving epigenomic marking, segregates the two processes in time 
and place 30. Combined the data shows that replication timing is not a static process but that it 
dynamically shifts across the genome in the contexts of commitment and terminal differentiation 
20,29. Thus, replication timing is an intrinsic cellular feature and is closely linked to transcription. A 
perhaps logical consequence of this is the notion that transcription and replication need to be tuned 
to each other during replication. This raises a number of questions: 1) is replication timing a 
consequence of chromatin structure regulation in the context of transcription? or 2) vice versa does 
replication timing provide a cellular mechanism to transmit epigenetic information to the next 
generation, with transcriptional regulation as a consequence? 3) What epigenetic mechanisms are 
responsible for definition and proper coordinated regulation of both transcription and replication 
throughout S-phase?   
The first cause-or-consequence issues have been studied extensively in the mammalian β-globin 
locus. The β-globin locus is replicated form a single bidirectional origin, firing early in S-phase in 
erythroid cells, and late in all other cell types 31. Transcriptional activity of the β-globin locus is 
controlled by a locus control region (LCR). Although loss of the LCR at the β-globin locus 
significantly reduces transcription of the β-globin genes chromatin structure, measured by DnaseI 
sensitivity, and replication timing are unaffected 32. This suggests that at least for the β-globin 
locus, replication timing is not defined by transcriptional status. However, whether specific histone 
modifications at the LCR are involved in transcriptional regulation of the β-globin locus, and 
whether those participate in replication timing is currently unknown.   
To begin to probe causal and consequential relationships between transcription and replication 
timing, it was proposed that chromatin structure is (re)established by virtue of differential 
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expression of chromatin modifiers (epigenators; 2) at specific time points during S-phase  26,33. 
Proteins involved in assembly of euchromatin would be expressed early in S-phase where proteins 
involved in heterochromatin formation would be expressed late in S-phase. In support of this, the 
de novo DNA methyltransferase DNMT1, a transcriptional repressor implicated in heterochromatin 
formation, targets DMAP1, a transcriptional co-repressor, to replication foci during the entire S-
phase. Also HDAC2 associates with DNMT1 and DMAP1, although this interaction was restricted 
to late S-phase 34. Thus, factors involved in the formation of transcriptionally repressed epigenetic 
state are recruited to chromatin during the period in S-phase when heterochromatin is duplicated. It 
is conceivable that e.g. micro-environmental cues (i.e. morphogens, growth/differentiation factors, 
cell-cell contacts) may provide the signalling required for (re)activation of epigenators and tissue 
specific transcription factors to lineage relevant genes and networks 2. At the bases of coordinated 
regulation of DNA-templated processes, the assumption that euchromatin is readily available and 
accessible for replication, and is consequently replicated early, whereas the heterochromatin 
fraction is less accessible and needs to be remodeled before replication can take place may be a 
workable starting point. X-chromosome inactivation provides a model to study epigenetic 
mechanisms in replication timing and transcriptional inactivation. Differentiating female embryonic 
stem cells inactivate one of two X chromosomes through mechanisms involving a non-coding RNA, 
called Xist. Xist covers the entire inactive X (Xi) chromosome 35. The Xi is hypoacetylated on 
histone 3 and 4, shows increased H3K9 and DNA methylation, and relevantly, Xi is replicated late 
in S phase 36. Interestingly, mutations in the DNA methyltransferase dnmt3b in female 
lymphoblasts are associated with DNA hypomethylation and shift Xi-linked gene replication to 
earlier time points in S-phase 37. In keeping with this, inhibition of DNA methylation results in both 
reactivation of gene expression of Xi genes and advanced replication timing 38. Although epigenetic 
mechanisms are clearly involved, not one chromatin modification perfectly correlates with 
replication timing, hence there must be some degree of flexibility to replication timing and/or 
additional mechanisms must be responsible for regulation of replication timing in relation to 
transcription. 
 
Polycomb in replication 
During development expression patterns have to be maintained through several rounds of cell 
divisions. Histone modifiers and modifications provide a mechanism by which cellular memory of 
gene expression can be inherited to next cell generations. Polycomb proteins and their 
counterparts Trithorax proteins are known to be involved in transmitting epigenetic information to 
next generations during replication 39. During every cell cycle, when DNA is replicated in S-phase, 
chromatin-associated proteins and histone modifications are diluted, and need to be re-established 
on the newly formed daughter strands. Current models imply that modified parental histones are 
randomly distributed across the two replicating daughter strands 40. Interestingly, besides for 
PRC1, H3K27me3 acts as a recognition mark for the PRC2 complex; this suggests a possible 
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mechanism for transmission of H3K27me3 marks by PRC2 to newly assembled nucleosomes 41. 
Recent studies also suggest a more direct role for PcG proteins in DNA replication. Drosophila  
mutants for PRC1 members Ph, Pc and Psc, and the Enhancer of Trithorax and Polycomb (ETP) 
gene Asx  show severe chromatin segregation defects in syncytial embryos 42. Although poorly 
understood, these and other earlier observations provided an association between PRC-function 
and DNA replication 42. Importantly, Drosophila Grp/Chk1 and Chk2 (DmChk2) mutants also 
accumulate segregation defects, as a result of failure to activate checkpoint (metaphase to 
anaphase delay) in response to DNA damage or incompletely replicated DNA 43. These raises the 
question whether the accumulation of segregation defects in PcG mutant Drosophila is the direct 
consequence of problems in DNA replication and whether a DNA damage response is involved 
(please see discussion below).  
Direct and genetic interactions exist between PcG proteins and proteins involved in regulating DNA 
replication. Topoisomerase II (Topo2), well-known for its role in replication, and Barren (BARR), a 
potential activator of Topo2 44, both associate with genomic PcG target sequences in Drosophila  
45. In line with the finding that Topo2 and Barren bind PREs, they directly bind to the PcG protein 
Polyhomeotic (Ph). In addition, Cramped (CRM), a Drosophila PcG protein, localizes to the 
nucleus during S-phase and CRM expression disappears at mitosis. The cell cycle-dependent 
localization resembles that of PCNA and suggested a functional relationship. Indeed, CRM and 
PCNA colocalize on salivary gland polytene chromosomes and a double mutant for crm and pcna 
(Drosophila mus209 allelle), displays an exaggerated phenotype in anteroposterior and distal-
proximal transformations. Besides shared function, more importantly, this illustrates that defective 
replication is a determining factor in abnormal segmentation 46. In further support of functional 
kinship, a transient association of Gmnn with the mammalian PRC1 members Scmh1 and 
Phc1/Mphc/Rae28 was recently discovered 47. And finally, the mammalian PcG protein Bmi1 was 
identified as a direct interactor of the replication licensing factor CDC6: the transition of late to early 
replication of the INK4A/ARF locus in senescing embryonic fibroblasts underscores the functional 
association between PcG and replication timing 48. Overall, whilst experimental proof in this area 
will undoubtedly expand, the collective data suggests that PcG function is directly implicated in 
regulation of replication. An overview of PcG-associated proteins involved in regulation of 
replication and repair is presented in table 1. 
 
Coordinated regulation replication and transcription by PcG 
Although PcG proteins are classically associated with transcriptional repression, mounting 
evidence supports a broader role for PcG in other DNA templated processes besides 
transcriptional regulation. In Drosophila , regulatory elements of Iab-4 and mcp are enriched for 
both Polycomb (PC) and Trithorax (TRX) early in embryogenesis, while seemingly in conflict with 
the classic view that PRC alter chromatin for transcriptional repression, both genes are 
transcriptionally active 49. Analogously, bivalently marked promoters in murine embryonic stem 
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cells, carrying both repressing (H3K27me3) and activating (H3K4me3) marks, were found to be 
transcriptionally active, albeit at low levels 21. We recently found evidence for significant 
transcriptional induction of putative PcG-target genes in vitro and in vivo, despite persistence of 
H3K27me3 marks; in vitro phospho-dependent release of PRC1-complex members correlated with 
activation of expression (50+ in preparation). These findings begin to show that the role of H3 
trimethylation, and possibly PRC1 function, exceeds that of transcriptional silencing only.  
Cells undergo replication stress under conditions that affect replication fork progression during S-
phase. As stalled replication can be mutagenic and induce cell death, several pathways have 
evolved to repair damaged DNA and to get collapsed replication forks back on track 51,52. Activation 
of sophisticated intraS-phase checkpoints allows cells to resolve replication stress and DNA 
damage, and to complete S phase to allow cells to proceed to mitosis 53. The majority of DNA 
damage in replicating cells, even under normal conditions, probably comes from highly frequent 
collision between replication forks and transcription machineries, as both processes move along 
the same template 51,54. Hence, these processes need to be tightly regulated to prevent DNA 
damage. Under conditions of rapid proliferation, e.g. in response to enhanced mitogenic signalling 
by, among others, oncogenic E2Fs, cMyc, Ras, Braf, and RUNX, the increased replication rate 
puts a tremendous strain on chromatin. Upon initial oncogene-induced hyperproliferation, 
sustained expression of oncogenes in fibroblasts activates a senescence response termed 
oncogene-induced senescence (OIS) 55,56. In support of the notion  that under hyperproliferative 
conditions, cells are unable to cope with the stress that the increased demand for DNA replication 
puts on chromatin, cells expressing oncogenic RasV12, for example, amass replication-dependent 
double strand DNA breaks (DSB) and accumulate stalled replication forks; senescent cells harbour 
senescence-associated DNA-damage foci (SDF), containing ATM, NBS1, ATR, ATRIP and RPA 
56. Activation of a DNA damage response (DDR) is instrumental in the induction of OIS, as knock-
down of various DDR proteins (ATM, ATR, Chk1, Chk2 and p53) rescues proliferation 56. 
Intriguingly, co-expression of Bmi1 in RasV12 expressing cells bypasses senescence to a large 
extent 57. Although mechanistically not worked out in detail, analogy with oncogenic cooperation 
between c-Myc and Bmi1 points to a possible involvement of INK4A/ARF suppression by Bmi1 58.  
Recent data from our group support a role for PRC1 in replicative control and begins to shed some 
light on underlying mechanisms.  In analogy to expression of oncogenes in fibroblasts, activation of 
differentiation in vitro often sets off a transient hyperproliferative phase commonly referred to as 
transit amplification TA: transit amplifying cells (TAC) provide the necessary expansion of 
progenitor populations to provide for adequate tissue repair/replacement from limited numbers of 
mobilized stem cells (SC). Although hard to pinpoint in vivo, TA has been suggested to underlie the 
rapid regeneration of tissues, among which intestinal villi from SCs located in the crypts of 
Lieberkühn  59. One of the few places in the body where TAC are readily identifiable is the 
proliferative zone in the developing skeleton: during endochondral ossification (the formation of 
bony skeletal elements from cartilage scaffolds) histologically distinctive tracts of rapidly 
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proliferating cells are readily visible 60. TA can be mimicked in vitro, in chondrogenic models: the 
mesenchymal stem cell ATDC5 will undergo a proliferative burst upon induction of differentiation 61. 
Despite the characteristic effect of many PRC1 null-mutations on antero-posterior skeletal 
morphogenesis in mice 62, a direct role for PRC1 in chondrogenesis was never established. 
Unexpectedly, PRC1-deficient ATDC5 cells fail to undergo TA, and activate an intraS-phase block 
in response to massive accumulation of DNA damage. PRC1-KD cells are very sensitive to 
replication poisons; accumulate DSB at sites of de novo DNA synthesis and ultimately senesce, 
exposing a causal relationship between defective PRC1-fuction and replication induced DNA 
damage (this thesis).  
An obvious question is: how does PRC1 prevent replication stress? A number of observations 
points in the direction of coordinated regulation of transcription and replication during TA. Whereas 
G1 nuclei typically stain brightly for Ser5-phosphorylated Rpol2 (pRpol2), cells progressing through 
S-phase normally undergo a transition from genome-wide transcriptional activity to complete shut-
down of transcription initiation at mid/late S-phase. Co-staining for BrdU and pRpol2 revealed 
enhanced BrdU incorporation at sites where transcription initiation was low, or put differently, low 
transcriptional activity at site of DNA replication (30, this thesis). Remarkably, this functional 
genome partitioning is completely lost in S-phase arrested Bmi1-deficient cells. In addition, cells 
carrying DSB display a generally deregulated transcription, which is also reflected in comparative 
expression array analysis in the context of differentiation: transcription levels of many genes were 
consistently upset throughout differentiation; in addition, genes irrelevant to chondrogenesis were 
induced, whereas other genes that should have been induced were not. Although deregulation of 
specific pathways awaits further analysis, it is clear that redefinition of transcription and replication 
activity are closely coupled during chondrogenesis and that somehow PRC1 is required to facilitate 
differentiation under hyperproliferative conditions.  
Recently, PRC1 was identified as an E3 ligase for Gmnn: Rnf2/Bmi1-mediated ubiquitylation of 
Gmnn targets it for proteasomal degradation. In vivo, loss of the PRC1 protein Phc1, through which 
Gmnn is associated to PRC1 and a direct interactor of Bmi1 and Rnf2, results in stabilization of 
Gmnn and blocks haematopoietic stem cell proliferation 63.  Stabilization of Gmnn indeed prevents 
cell from completing their cell cycle 64. To explain the leukopenia in Phc1-null mice, PRC1-
mediated control of Gmnn expression was suggested to affect the proliferative potential and/or 
differentiation capacity of HSC 65. The earlier described physical interaction between PcG 
complexes with elements of transcription factories as well as replication machineries, in addition to 
the physical and biochemical interactions between PRC1 and Gmnn, suggest a mechanism for 
PRC1-mediated orchestration of transcription in respect to replication and/or vice versa. We here 
propose a model in which PCR1/Gmnn acts as a molecular switch between transcriptional and 
replicative choices in mid-S phase (figure 1): H3K27me3-mediated recruitment of the core complex 
CBX/Rnf2/Bmi1 installs repressive H2AK119ub1 marks, which interfere with transcription initiation, 
possibly through recruitment of additional PRC (associated) proteins 1. Local presence of 
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Rnf2/Bmi1 E3 ligase activity would target Gmnn for degradation, relieving a potential replication 
block. Conversely, loss of Bmi1/Rnf2 stabilizes GMNN, hence blocking replication, yet permitting 
transcription. Chromatin dissociation of Bmi1/Rnf2 is likely controlled by post-translational 
modification (PTM). In line with this idea, we recently observed a positive correlation between 
PRC-phosphorylation, PRC1/chromatin dissociation and Gmnn stabilization under various 
conditions of cell stress (JWV, YT unpublished observations). Stress signaling induces chromatin 
dissociation of PRC1 members (Bmi1, Ring and CBX proteins; 50). In contrast, Phc1/Rae28 50 
undergoes a nuclear redistribution under these conditions and may provide a docking point for 
Gmnn stabilization.  
As indicated before, Gmnn levels gradually increase toward late S-phase and chromatin–bound 
Gmnn blocks rereplication of DNA at the in G2/M. Increased Gmnn-chromatin association 
correlates with PRC1 dissociation from chromatin during mid S-phase 66. Relevantly, Bmi1-
deficient chondrogenic progenitors arrest in midS-phase and display significantly increased Gmnn 
chromatin association (this thesis). The inverse correlation between Gmnn and Bmi1/Rnf2 
chromatin association during mid-S is in perfect agreement with the ubiquitin-mediated induction of 
Gmnn proteolysis by Bmi1/Rnf2 65. Relevantly, the most dramatic replication-retiming happens at 
mid-S-phase in the context of differentiation, when replication origins are spatially redefined and 
replication timing and transcription are re-tuned 26. The dynamic relocation of PRC1 and Gmnn 
during this phase suggests a functional connection with replication timing in the context lineage 
commitment and differentiation from a pluri- or multipotent stem cell.   
Of note, the primary task of H3K27me3 (and possibly H3K4me3) in the proposed model would not 
be to mediate transcriptional repression (or activation, respectively) per se. Rather global (and 
local) histone trimethyl (and possibly additional) marking may provide the required epigenomic 
context for tuning transcription and replication. Our observation that cell stress consistently co-
induces global H3 trimethylation at K4, K27 and K9, supports the idea that these marks regulate 
more than transcription. Hence, PcG and trxG-associated epigenetic marks may functionally 
partition the genome and help coordinate DNA-templated processes, for example in the context of 
development.  
 
Concluding remarks 
Early observations in Drosophila melanogaster, although incompletely understood, provided an 
early indication of a link between PRC-LOF phenotypes and DNA replication 42. We here provide a 
tentative explanation for the replication defects in PRC-mutants: PRC1 orchestrates chromatin-
based processes, such as increased transcriptional reprofiling and enhanced DNA replication 
during transit amplification in the context of differentiation. The consequence of this observation in 
relation to the etiology of PRC1 phenotypes in vivo is as of yet unclear. PRC1 proteins classically 
maintain HOX gene expression boundaries set by segmentation and pair-rule genes, and skeletal 
phenotypes correlate with defective maintenance of HOX gene expression boundaries 67. In line 
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with published data on regulation of proliferation by HOX-genes, in addition to long-standing 
speculations about contribution of a proliferative component to axial and appendicular phenotypes 
in HOX mutants, it is possible that proliferation and HOX gene expression both contribute to 
abnormal replication 68. However, since no two single PRC1 mutants affect the same HOX genes; 
although by and large, most PCR1-null mutants display relatively similar posterior transformations, 
this automatically begs the question whether HOX deregulation may be consequential rather than 
causal in this context. Multiple additional interesting questions arise: What is the exact molecular 
nature of functional genome partitioning? Does replication timing determine transcriptional activity, 
or vice versa? Is coordination of transcription and replication subject to clustered regulation, i.e. 
groups of genes or networks in the context of lineage commitment, and how exactly are PRCs 
implicated in these matters? What post-translational modifications and protein interactions help 
direct PRC activity toward transcriptional repression or replication? Can the findings reported 
herein be readily projected onto embryonal stem cells, i.e. does failure to properly coordinate 
simultaneous DNA templated processes contribute to self-renewal defects? And, in the context of 
OIS, is PRC1 inactivation involved in OIS or, conversely could Polycomb overexpression in cancer 
be required for protection during hyperreplication? Chromatin has been called the most relevant 
physiological substrate in a cells’ life. Coordinated regulation of processes like transcription, 
replication and DNA repair is important to prevent DNA damage and help maintain genome 
integrity, cell identity and provide regenerative capacity. As all these processes use one and the 
same template, DNA, it should come to no surprise that many regulatory components are shared, 
including Polycomb group proteins and geminin. An important future challenge will be to determine 
the exact molecular mechanisms and contributions of Polycomb Group proteins at the cross road 
of chromatin templated processes, like transcription and replication.  
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Table 1 Overview PcG binding proteins 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drosophila  Mammals Associated proteins Process 
E(z) Ezh1/Ezh2 Xnp 69 DNA repair 
Esc Eeed TAFIID (Xenopus) 18 Transcription 
Su(z)12 Suz12   
Pc Cbx4, Cbx6, Cbx7, Cbx8 TBP 17 Transcription 
Pcl Phf1 Rad50, Smc1, Dhx9 and 
p53 70 
DNA repair 
Ph Phc1/Phc2/Phc3 Tbp 17, Gmnn 47 
Topo2, Barr 44 
Transcription/Replication 
Sce/dRing Ring1A/Rnf2 Tbp 17 Transcription 
Psc Bmi1/ Mel18 Tbp 17, Gmnn 47, Cdc6 48 Transcription/ 
Replication 
Pho YY1 Tbp 16 Transcription 
Smc Smch1 Gmnn 47 Replication 
Crm  Pcna 46 Replication 
 Rybp Mdm2 71 DNA repair 
replication
transcripion 
Phc
gene target
Rnf2
Cbx
Bmi1
Scmh
gene targetRnf2
Cbx
PhcBmi1
Figure 1
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Figure 1. Proposed model for segregation of transcription and replication by PcG proteins. 
H3K27me3-mediated recruitment of the core complex CBX/Rnf2/Bmi1 installs repressive H2AK119ub1 
marks, which interfere with transcription initiation, possibly through recruitment of additional PRC 
(associated) proteins 1. Local presence of Rnf2/Bmi1 E3 ligase activity would target Gmnn for 
degradation, relieving a potential replication block. Conversely, loss of Bmi1/Rnf2 stabilizes GMNN, 
hence blocking replication, yet permitting transcription. 
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Abstract 
Numerous growth and transcription factors have been implicated in endochondral bone formation 
of the growth plate. Many of these factors are up-regulated during hypoxia and downstream of 
Hypoxia-Inducible Factor (HIF)-1α activation. However, the specific function of these factors, in the 
context of oxygenation and metabolic adaptation during adult periosteal endochondral bone 
formation, is largely unknown. Here, we studied HIF-1α and the possible roles of (HIF-1α related) 
growth and transcription factors in a recently developed in vivo model for adult periosteal 
endochondral bone formation. 
At different phases of periosteal endochondral bone formation, mRNA levels of Transforming 
Growth Factor (TGF)-β1, Bone Morphogenetic Proteins (BMP)-2, -4, and -7, Indian Hedgehog 
(Ihh), Parathyroid Hormone-related Protein (PTHrP), Sox9, Runx2, HIF-1α, Vascular Endothelial 
Growth Factor (VEGF), periostin (POSTN), and Glyceraldehyde-3-Phophate Dehydrogenase 
(GAPDH) were evaluated with RT-real time-PCR. Also protein levels of TGF-β1, BMP-2, -4, and -7, 
HIF-1α, and POSTN were examined. During the chondrogenic phase, the expression of Sox9, Ihh, 
and HIF-1α was significantly up-regulated. TGF-β1 mRNA levels were rather constant, and the 
mRNA levels of BMPs were significantly lower. Immunohistochemical detection of corresponding 
gene products, however, revealed the presence of the proteins of TGF-β1, BMP-2, -4, and -7, HIF-
1α, and POSTN within the chondrocytes during chondrogenesis. This discrepancy in gene 
expression between mRNA and protein level for TGF-β1 and the different BMPs is indicative of 
post-transcriptional regulation of protein synthesis. HIF-1α activation and up-regulation of GAPDH 
support a hypoxia-induced metabolic shift during periosteal chondrogenesis. Our model 
recapitulates essential steps in osteochondrogenesis and provides a new experimental system to 
study and ultimately control tissue regeneration in the adult organism. 
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Introduction 
Endochondral bone formation is a multistage process; early commitment of mesenchymal stem 
cells (MSC) to a chondrogenic cell fate is accompanied by morphological changes and activation of 
a cartilage specific gene program. At progressive differentiation stages toward osteogenesis, 
chondrocytes resume proliferation, mature into hypertrophic chondrocytes, and then calcify their 
surrounding matrix and undergo programmed cell death1. Simultaneously, angiogenesis is 
stimulated and the calcified cartilage is replaced by bone. Transforming Growth Factor (TGF)-β1 
and members of its superfamily, among which are the Bone Morphogenetic Proteins (BMPs), play 
an important role in endochondral bone formation and fracture healing2. BMPs are known to 
interact with the Indian Hedgehog (Ihh)/Parathyroid Hormone related Protein (PTHrP) pathway and 
exert their function, at least in part, via expressional regulation of Sox9, an essential transcription 
factor in chondrogenesis 1-7. In addition, hypoxia, as a micro-environmental determinant, is thought 
to promote differentiation of mesenchymal cells along a chondrocyte pathway, in part by activating 
Sox-9 via an HIF-1α-dependent mechanism 8. Although conditions are hypoxic within the 
endochondral growth plate 9, not much information is available on oxygenation and metabolic 
adaptation during periosteal callus formation. Several observations directly link oxygen tension to 
osteochondrogenic differentiation. The transcription factor Runx2 (Aml3, Osf2/Cbfa1) is required 
for differentiation of osteoblast progenitors during the final stages of endochondral bone formation 
and is also downstream of BMP signalling 10,11 . Runx2 mRNA is subject to IRES-dependent 
translational control, which is thought to permit continued translation under conditions suboptimal 
for cap-dependent translation (e.g. under low oxygen concentration) 12. The cell adhesion protein 
periostin (POSTN, Osf2—not to be confused with Osf2/Cbfa1) is highly homologous with βigH3/ 
βigH3 and is induced by TGF-β1 and hypoxia 13-16. POSTN may play a role in the recruitment and 
attachment of osteoblast precursors and is specifically found in periosteum and the periodontal 
ligament 14. The mRNA expression for this protein is highly up-regulated during fracture healing 
and also increases with mechanical stress in periodontal ligament tissues 17-19. Most of these 
findings stem from in vitro models. A possible connection between oxygenation and expression of 
these growth and transcription factors during periosteal endochondral bone formation in vivo has 
so far not been studied. Studies on endochondral bone formation in vivo often use whole embryos 
or growth plates as paradigms 5,6,20. In addition, fracture healing models in adult rodents are used 
in which the bone marrow is penetrated 21,22. To date, experimental models for endochondral bone 
formation in adult organisms have, to our knowledge, not been described, whereas such models 
are likely relevant in respect to clinical situations. We have recently established a novel in vivo 
model for osteochondrogenesis, in which periosteum is damaged without breaking the bone and 
accessing the bone marrow23. Periosteum contains pluripotent progenitor cells that harbor MSC 
characteristics 24,25 and can differentiate to chondrocytes and osteoblasts during normal bone 
growth and fracture healing 26,27. We demonstrated the chondro-regenerative capacity of periosteal 
MSC 23. This novel model can be used to study the function of periosteum during cartilage and 
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endochondral bone formation. In addition, the model is expected to provide important mechanistic 
insight for tissue engineering of cartilage and/or bone and for fracture healing 23. The aim of this 
study was to evaluate expression of essential factors, among which is the hypoxia-responsive 
factor HIF-1α, during the in vivo generation of adult periosteum derived cartilage and bone. 
 
Materials and methods 
Surgical procedures 
Six-month-old female New Zealand White rabbits were used for this study. European and Dutch 
laws on animal experimentation were strictly followed throughout the study, and the animal 
experimental protocol was approved by the Maastricht University committee for animal 
experiments. Surgical procedures were performed under general anesthesia and with the use of 
sterile techniques. Anesthetic induction was obtained with 35 mg/kg ketamine hydrochloride and 5 
mg/kg xylazine hydrochloride administered by intramuscular injection. Anesthesia was maintained 
by means of a mixture of 2% halothane and oxygen/nitrous oxide delivered by an automatic 
ventilator using an especially designed mask. All rabbits received a preoperative intramuscular 
injection with antibiotics (10 mg/kg ceftiofur sodium, Pharmacia and Upjohn, Woerden, The 
Netherlands). Postoperative analgesia provided by administering 0.05 mg/kg buphenomorfine 
intramuscular once a day for 2 days. Bilaterally, the skin and the overlying fascia were opened over 
the upper medial tibia. A piece of approximately 7×15 mm of the periosteum was dissected. The 
harvested tissue of five rabbits was used to assess expression levels of the genes of interest in 
undifferentiated periosteum (t=0 day). The overlying fascia was closed with Polysorb 2.0 sutures 
(Tyco Healthcare, USA). Special care was taken that the tendon of the semitendinosus muscle 
was sutured on top of the lower, short side of the rectangular periosteum defect. Hereafter the skin 
was closed with Polysorb 4.0 (Tyco Healthcare, USA). At days 10, 20, and 40 postoperative, the 
reactive tissue of five rabbits per time point was harvested. For this purpose, the rabbits were 
anesthetized as described above. The reactive tissue was dissected with a scalpel or osteotome 
(40 days). Again the overlying fascia and skin were closed with Polysorb (Tyco Healthcare, USA). 
Specimens were cut in two halves, one part was used for RNA isolation, and the other was fixed in 
4% paraformaldehyde, dehydrated and embedded in paraffin. 
 
RNA isolation 
Immediately after harvest, the tissue was frozen in liquid nitrogen and stored at −80°C. The frozen 
tissue was cooled further in liquid nitrogen and pulverized using a microdismembrator S (Bauer, 
Goettingen, Germany). The resulting powder was collected in TriZol reagent, and RNAwas 
extracted according to the protocol of the manufacturer (Invitrogen, Breda, The Netherlands). 
Quantity and purity of the RNAwere determined 260/280 nm absorbance measurements. The RNA 
samples were subjected to RNase-free DNase digestion to remove any genomic DNA and to 
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agarose gel electrophoresis to assess the intactness of RNA. Complete removal of genomic DNA 
was verified by PCR. 
 
Rabbit primer design 
Since sequence information on the rabbit genome is limited, conserved human and murine gene 
sequences were determined to design primer sets for Ihh, Runx2, Sox9, Collagen Type II and Type 
X and POSTN by using Blast2 software (www.ncbi.nlm.nih.gov). PCR primer sets were designed 
for homologous gene sequences and tested on rabbit cDNA samples (Supplemental table 1). The 
identities of the PCR products were confirmed by direct sequencing and comparison with known 
human and mouse genes and then submitted to GenBank (AY633663, AY598932, AY598933, 
AY598934, AY598935, AY598936, AY598937). 
 
Semi-quantitative reverse transcription-polymerase chain reaction 
Although multiple real time primer sets were tested, the expression of Collagen Type (COL) X, 
TGF-β1 and Ihh could only be determined with a semiquantitative RT-PCR. To this end, we 
performed PCR reactions on serially diluted cDNAs using primer sets for Ihh, TGF-β1, COLX, 
either alone or in combination with a primer set for 28S. 28S cDNA amplification was also 
performed separately. Ethidiumbromide signals were quantified using a GELDoc 1000 system with 
Multi-Analyst imaging analysis (Bio-Rad, CA, USA). Marker mRNA levels are expressed relative to 
28S rRNA. Two hundred nanograms of heat denatured RNA was reverse transcribed with 100 U 
MMLV reverse transcriptase (Promega, WI, USA) in 50 mM Tris–HCl (pH 8.3), 75 mM KCl, and 3 
mM MgCl2 and 10 U RNAsin (Promega, WI, USA). Two microliters c-DNA from each sample was 
amplified in 10 μL PCR reaction mixture. For semi-quantitative expression measurements, 200 ng 
cDNA was diluted in five-fold increments (i.e. undiluted, 5×, 25×, 125×, 625× diluted). Eight 
microliters of each PCR sample was run on a 2% agarose gel containing 0.5 mg/mL 
ethidiumbromide (Invitrogen, Breda, The Netherlands). Positive bands were visualized and 
quantified with a Geldoc 1000 system using Multi-Analyst software (Bio-Rad, CA, USA). Values 
were normalized to 28S rRNA expression. 
 
Real time PCR assays 
Real time PCR assays were performed in triplicates with qPCR mastermix for SYBR® Green I 
(Eurogentec, Seraing, Belgium) in 96-well optical plates with primer concentrations of 300 nM. 
Oligonucleotide sequences for Collagen Type I and II, aggrecan, BMP-2, -4, and -7, periostin, 
PTHrP, VEGF, 28S rRNA, GAPDH, Sox9, and HIF-1α (Supplemental table 2) were based on the 
gene sequences which were submitted to or obtained from GenBank (Supplemental table 1) using 
Primer Express 2.0 software (Applied Biosystems, Foster City, CA, USA). cDNA was used for the 
real time quantitative PCR reactions using an ABI PRISM® 7700 Sequence Detection System 
(Applied Biosystems, Foster City, CA, USA, user bulletin #2). Serially diluted standard curves were 
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included to quantify the samples. PCR conditions were: 2 min at 50°C, 10 min at 95°C, 40 cycles 
for 15 s at 95°C, and 1 min at 60°C followed by a melt curve 15 s at 95°C ramp to 60°C for 1 min, 
followed by 20 s at 95°C. Data were analyzed using Sequence Detection Software version 1.7 
(Applied Biosystems, Foster City, CA, USA). Values were normalized to 28S rRNA. 
 
Staining protocols 
Paraffin sections were deparaffinated, hydrated and stained with thionine for 10 min. After washing 
and drying, coverslips were mounted using Entellan (Merck-Europe, Darmstad, Germany). For 
immunostaining, (paraffin-embedded) sections were deparaffinated and hydrated. Primary 
antibodies were diluted in PBS as follows: goat-polyclonal anti-BMP-2 (Santa Cruz, CA, USA, sc-
6895) 1:25; goat-polyclonal anti-BMP-4 (Santa Cruz, CA, USA, sc-6896) 1:12.5; goat-polyclonal 
anti BMP-7 (Santa Cruz, CA, USA, sc-9305) 1:800; goat-polyclonal anti-TGF-β1 (R&D Systems 
Inc, MN, USA) 1:30; mouse-monoclonal anti-periostin (5H8) 1:600 [28,29]; mouse monoclonal anti-
HIF-1α (Abcam Limited, Cambridge, UK, ab463) 1:50; and mouse monoclonal anti-Collagen Type 
II (II-II6B3, diluted 1:50; Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, 
IA). Prior to the incubation with the goat-polyclonal anti-TGF-β1, sections were placed in 250 mL 
Antigen Retrieval buffer (Dako Cytomation BV, Glostrup, Denmark) supplemented with 4.5 mL 
0.1Mcitric acid+0.5 mL 0.1MNa citrate and incubated for 5 min in a microwave at 750 W. After 
incubation with the primary antibody, sections were washed with PBS and incubated with an 
appropriate biotin-labeled secondary antibody. Subsequently, sections were washed with PBS and 
incubated with the avidin–biotin binding complex with horseradish peroxidase (HRP) or alkaline 
phosphatase (ALP) (Dako Cytomation BV, Glostrup, Denmark). Diaminobenzidine (DAB) (Merck-
Europe, Darmstad, Germany) was used as a substrate for HRP and Vectastain (Vector 
Laboratories, Burlingame, USA) for ALP. The sections were counterstained with hematoxylin dried 
and coverslipped. 
 
Statistical analysis 
Differences in mRNA levels were analyzed using the Mann–Whitney U test with a Hochberg post 
hoc correction test. Statistical significance was assigned for p<0.05. 
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Results 
Dissection of periosteum induced reactive tissue (periosteal callus—PC) which demonstrated 
cartilaginous characteristics at 10 and 20 days postoperative (PO) and osteogenic at 40 days (PO) 
as previously published 23. To validate the new osteo/ chondrogenic model, we mapped gene 
expression profiles during PC formation and differentiation and compared these to published data.  
 
 
 
Fig. 1. Gene expression profiles throughout periosteal callus formation and differentiation (n=5 per time point). mRNA 
expression level of Collagen Type II (COL2;A), aggrecan/AGC (B), Sox9 (F), COLX and Ihh (G), and HIF-1α (I) are 
significantly up-regulated during periosteal chondrogenesis (t=10). No significant mRNAup- or down-regulation is 
observed for COLI (B), TGF-β1 (C), Runx2 (F), and periostin/POSTN (H) during follow-up. BMP-2, -4, and -7 are 
significantly downregulatedduring chondrogenesis (D, E). VEGF expression is up-regulated 20 days post-surgery (J). 
Quantitative RT-PCR expression measurements are normalized to 28S ribosomal RNA. Relative COLX, Ihh, and TGF-β1 
mRNA levels were measured by semi-quantitative RT-PCR (see Materials and methods for details). Briefly,relevant 
marker gene cDNAs were either separately amplified or in combination with 28S rRNA. SD is indicated by error bars. 
 
 
Chapter 3 
 36 
 
Matrix and adhesion molecules in PC  
As expected, in undamaged periosteum (t=0), Collagen Type II (COL2) expression was not 
detected. At 10 days PO, a significant up regulation of this marker for chondrogenesis was clearly 
detectable (Fig. 1A). Forty days post-surgery, COL2 expression had almost returned to basal level 
(Fig. 1A). A comparable expression profile was seen for aggrecan (AGC). Collagen Type I (COLI) 
was not significantly up- or downregulated (Fig. 1B). Thionine staining and immunohistochemical 
detection of COL2 correlated nicely with mRNA expression levels: no AGC and COL2 expression 
was detectable in control periosteum (t=0; not shown). Ten and twenty days PO, thionine staining 
indicated the presence of Glycosaminoglycans (GAG, i.a. AGC) and immunohistochemical 
detectable COL2 confirmed the expression of these proteins (Fig. 2A). Twenty days PO, 
ossification of the PC was first observed at the site attached to the tibial cortex (Fig. 2B). Forty 
days PO, full ossification was observed and only remnants of cartilaginous matrix molecules were 
detected (Fig. 2C). mRNA levels of the adhesion molecule periostin (POSTN) were not significantly 
up- or down-regulated during follow-up (Fig. 1C). In good agreement with this, a positive 
immunohistochemical staining for POSTN was observed in periosteum. This adhesion molecule 
was found intra- and peri-cellular in both the cambium layer and the fibrous layer of periosteum 
(t=0) (Fig. 3A). The matrix of the overlying fibrous layer remained positive during follow-up. At 10 
days PO, POSTN was predominantly found in both hypertrophic and immature chondrocytes. The 
intensity of staining and number of POSTN positive cells were higher in chondrocytes located at 
then outside of the newly formed cartilage (Fig. 3C). Twenty days PO, only a few of the 
chondrocytes stained positive for POSTN. At 40 days PO, the adhesion molecule could only be 
detected in some of the bone marrow cells (Fig. 3D). 
 
 
Growth factors in PC 
Throughout PC formation and differentiation, relative expression of TGF-β1 did not significantly 
change (Fig. 1D). BMP-2, -4, and -7 mRNA were down-regulated (2.4; 8.9; 3.7 decrease 
respectively) during the chondrogenic phase (Figs. 1E,F). Immunohistochemical staining of TGF-
β1 confirmed protein presence in periosteum. TGF-β1 was found predominantly peri-cellular in 
both the cambium layer and the fibrous layer of periosteum (not shown). BMP-2, -4, and -7 
proteins were not detected in normal periosteum. Ten days PO, BMP-2, -4, and -7 were clearly 
detectable in the chondrocytes in the newly formed cartilaginous tissue; intense staining for all 
BMPs was specifically seen in the pre-hypertrophic chondrocytes. Fig. 4D only shows BMP-2 
staining, a similar staining was observed for BMP-2, -4, and -7; however, BMP-4 positive cells 
were detected less frequent and appeared to be more restricted to the hypertrophic zone (Figs. 4A, 
B). Ten days PO, TGF-β1 was also found in both hypertrophic and mature chondrocytes and the 
overlying fibrous layer (not shown). Twenty days PO, BMP-2 and -4 could no longer be detected by 
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immunohistochemical staining (Fig. 4C). The intensity of BMP-7 staining was lower; a positive 
staining was only found in some hypertrophic chondrocytes and some osteoblasts in the newly 
formed trabecular bone (not shown). At this follow-up, the staining intensity for TGF-β1 also 
decreased and was only found in the newly formed trabecular bone. Forty days post-surgery, the 
newly formed bone marrow was positive for TGF-β1 and BMP-2, -4, and -7 (Fig. 4E, only BMP-2 is 
shown as example). Newly formed trabecular bone and bone marrow stained intensely for BMP-7; 
only a few cells were positive for BMP-2.   
 
 
Fig. 2. Immunohistochemical detection of Collagen Type II in periosteal reactive tissue (callus); (A) 10 days post-surgery, 
this collagen is present in the newly formed cartilage (a thionine stained section is enlarged). (B) At 20 days post-
surgery, the presence of Collagen Type II decreases at the zone of calcification (ZC and bone formation. (C) 40 days 
post-surgery, remnants of Collagen Type II are still visible (brown). Sections counterstained with hematoxylin. Original 
magnification (A) ×16; (B) ×16; (C) ×16; insert in (A) ×100. 
 
 
 
Fig. 3. Immunohistochemical detection of periostin/POSTN in periosteum. (A) POSTN is detected (brown color) 
especially in the cambium layer (CL) but is also found in the fibrous layer (FL) of periosteum. (C) 10 days post-surgery, 
the number of POSTN-positive cells is higher in the peripheral chondrocytes (PCh) compared to the chondrocytes 
localized centrally (CCh). (D) 40 days post-surgery, POSTN is present in the newly formed bone marrow (BM). (B) 
Immunohistochemical staining of HIF-1α shows its presence (red) in chondrocytes, 10 days post-surgery, no HIF-1α 
staining is found in hypertrophic chondrocytes (arrows). Original magnification (A) ×200; (B) ×200; (C) ×200; (D) ×200. 
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Fig. 4. Immunohistochemical detection of BMP-4 in periosteal callus; (A) 10 days post surgery, chondrocytes stain 
positive (red) for BMP-4. (B) is an enlargement of the box in (A). (C) 20 days post-surgery, BMP-4 is neither detected in 
chondrocytes nor in the zone of calcification (ZC). Sections counterstained with hematoxylin. Immunohistochemical 
detection of BMP-2 in periosteal callus; (D) 10 days post-surgery, chondrocytes stain positive (red) for BMP-2. (E) 40 
days post-surgery, BMP-2 is detected in the newly formed bone marrow (arrows), the overlying fibrous layer is indicated 
with FL. Original magnification (A) ×200; (B) ×400; (C) ×200; (D) ×400; (E) ×100. 
 
Key lineage specific signaling and programming molecules in PC.  
The expression of the transcription factor Sox9 was significantly up-regulated (14 increase) at 10 
days PO compared to t=0 (Fig. 1G). At 20 and 40 days PO, the expression level of Sox9 gradually 
decreased. No significant up- or down-regulation was observed for Runx2 (Fig. 1G). At 40 days 
post-surgery, then mRNA expression level of this transcription factor returned to the same level as 
detected in periosteum (t=0; Fig. 1G). In contrast to Parathyroid Hormone-related Protein (PTHrP) 
(Fig. 1G), Indian Hedgehog (Ihh) was not expressed in periosteum (Fig. 1H). During the 
chondrogenic phase (t=10) a significant up-regulation was seen for Ihh. At all later stages during 
osteogenesis, mRNA levels decreased for both these genes (Figs. 1G, H).  
 
Oxygenation and angiogenic marker genes  
A simultaneous increase in the mRNA expression level of GAPDH (2.6-fold increase) and a 
significant increase in expression level of HIF-1α (3.4-fold increase) were detected at 10 days PO 
(Fig. 1I). Immunohistochemical detection of HIF-1α protein was reflected in the mRNA expression 
profile; HIF-1α was only detectable in the chondrocytes present at 10 days post-surgery. Mature 
chondrocytes and early hypertrophic chondrocytes stained positive for HIF-1α (Fig. 3B). The 
protein was not detected in late hypertrophic chondrocytes (Fig. 3B). At 20 days PO, a few 
chondrocytes in the outer layer stained positive for HIF-1α. In periosteum and at 40 days PO, HIF-
1α protein could not be detected by immunohistochemical staining. VEGF mRNA levels expression 
increased 20 days post-surgery (2.7-fold increase) (Fig. 1J). 
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Discussion 
We here report on a first analysis of lineage specific marker gene expression in a novel in vivo 
model for osteo/chondrogenesis in full-grown animals. The model makes use of experimentally 
induced local damage to the periosteum. The damaged periosteum responds by callus formation; 
within this periosteal callus (PC), MSC-like activity is mobilized, which subsequently supports and 
recapitulates several well-described stages of chondrogenesis and osteogenesis. During the 
chondrogenic phase of PC formation, we find that cells of the cambium layer first commit to a 
chondrogenic cell fate; mRNA of the transcription factors Sox9, Ihh, is up-regulated and cartilage 
matrix molecules like aggrecan and Collagen Types II and X are produced. This stage is followed 
by chondrocyte hypertrophy and osteogenesis as indicated by extensive calcification of 
surrounding matrix (to independently verify these results, we partially repeated expression analysis 
of matrix molecules throughout differentiation, as reported in one of our earlier studies 23). Thus far, 
whole embryos or the growth plate are the models of choice for study of endochondral bone 
formation in vivo 5,6,20. This novel concept represents a relevant pre-clinical animal model, which 
thus enables us to study periosteum derived endochondral bone formation in vivo in the context of 
physiologically relevant signaling. Cartilage is known to lack vascularization, and oxygenation 
probably decreases during this first step of PC formation 9. In addition, because of metabolic 
activity and concomitant oxygen consumption, oxygen tension is expected to be low in the direct 
vicinity of cells 30. These factors combined most likely contribute to reduced oxygen tension in our 
model system. The increase in mRNA expression levels of GAPDH and HIF-1α and the presence 
of HIF-1α protein are indicative of a response to a change in oxygenation, and a metabolic shift 
indicative of adaptation to hypoxia. Under normoxia, the HIF-1α subunit is rapidly degraded via a 
concerted action of prolyl hydroxylases, which hydroxylate HIF-1α, and the von Hippel-Lindau 
tumor suppressor gene product VHL, which ubiquitylates HIF-1α and thereby targets it for 
proteasomal degradation. Oxygen deprivation blocks hydroxylation and thereby stabilizes HIF-1α. 
These processes play an important role in chondrocyte growth arrest and survival under hypoxia 
31,31. During the chondrogenic phase, many essential factors are activated by HIF-1α-dependent 
mechanisms 8,14,33-35. HIF-1α plays an important role in the “Pasteur effect” which includes 
decreased oxidative phosphorylation and an increase in glycolysis 36. Since glycolytic ATP 
production is significantly less efficient per molecule of glucose compared to that by oxidative 
phosphorylation, glycolytic metabolism is up-regulated to sustain free ATP levels in the hypoxic 
cell. In good agreement with published data in other model systems, our PC formation model 
shows a concomitant increase of HIF-1α and GAPDH mRNA levels, one of the key enzymes in 
glycolysis and a known HIF-1α target 36. Interestingly, while the mRNA expression levels of BMP-2, 
-4, and -7 were significantly decreased during chondrogenesis, these growth factors were readily 
detectable by immunohistochemical staining at 10 and 40 days PO. Reports on BMP expression 
levels during chondrogenesis are inconsistent: Yaoita et al. report an unaffected expression of 
BMPs after inducing a fracture, while Kloen et al. report a positive staining of BMPs in human 
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callus 37-38. Others report a rapid upregulation of BMP-2, only 24 h after surgical release of the 
periosteum 39. Uusitalo et al. reported an inducing effect on periosteal endochondral callus 
formation in mice upon adenovirus-mediated gene delivery of BMP-2 7. The downregulation of 
BMP-2 at the RNA level we observe is part of a genetic reprogramming controlled by autologous 
regulatory sequences, which may be absent in adenoviral vectors. Factors like these most likely 
contribute to fine-tuning of the in vivo response and further substantiate the complexity of BMP-2 
regulation during chondrogenesis. The results of the study presented herein indicate that, 
throughout periosteal callus formation and osteochondrogenic differentiation, BMP expression is 
regulated both by transcriptional and post-transcriptional mechanisms. Increased association with 
polysomes during conditions of cell stress (e.g. hypoxia) has recently been shown to result in 
preferential translation of select mRNAs 40. It is tempting to speculate that such mechanisms act on 
BMP and other mRNAs. The exact mechanism of translational regulation of cartilage matrix 
molecules, BMPs, Sox9, Ihh, PTHrP, and periostin during chondrogenesis under conditions of 
lowered oxygen availability remains unknown and is subject of further study in our laboratories. 
PTHrP expression was found in periosteum. In the growth plate, this molecule diffuses to sites of 
hypertrophic differentiation of chondrocytes to inhibit this process 2,41. Ihh was not expressed in 
periosteum, but its expression was markedly increased during chondrogenesis at 10 days, which is 
an indicator of hypertrophic chondrocyte differentiation 41. Combined, the presence of both Ihh and 
PTHrP, the sites at which they are co-expressed, and the timing of their expression are highly 
indicative of a function for the Ihh/PTHrP interplay in periosteal callus formation equivalent to their 
proposed role in growth plate models 41. In contrast to other reports 14,19, in which POSTN mRNA 
was not detected in chondrocytes, the present study shows that POSTN protein was detectable in 
mature chondrocytes. POSTN is an extracellular matrix/adhesion molecule 16, however, its exact 
function during osteo- and chondrogenesis is unclear. Our immunolocalization studies confirmed 
this notion, in that POSTN is also detected in the cartilaginous matrix around POSTN-positive 
chondrocytes. POSTN expression, both at the mRNA and protein level, is increased during fracture 
healing possibly to enhance the recruitment and adhesion of chondro- and osteo-progenitors from 
essential sources such as bone marrow and blood 19. The higher number of peripherally located 
POSTN-positive cells in the newly formed cartilage is consistent with this idea. In line with our 
observation that both TGF-β and POSTN have similar mRNA expression profile, several studies 
report a TGF-β dependency of POSTN regulation 42. POSTN expression is regulated downstream 
of cellular stress responses, including hypoxia, i.e. during vascular remodeling in different systems 
13,42,43. Ectopic POSTN expression in several models increases adhesion, migration, and 
invasiveness 44,45. These properties may relate to its proposed role in epithelial–mesenchymal 
transition 44. As a ligand for alpha-V/beta-3 and alpha-V/beta-5, POSTN mediates that growth 
promoting and angiogenic signaling in experimental cancers 46,47. We do not find significant up-
regulation of POSTN at the mRNA level, yet protein detection suggests that POSTN may be 
regulated in a cell type specific manner during chondrogenesis in our model. The combined above 
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data suggest that POSTN may mediate comparable processes during chondrogenesis and 
endochondral bone formation. Whether regulation of POSTN includes a selective translational 
component, for instance in PC, awaits further analysis. In conclusion, in our periosteal callus 
formation model, the sequential steps of endochondral bone development are recapitulated and we 
were able to describe these processes in some cellular and molecular detail: presumptive 
chondrocytes undergo well-ordered and controlled phases of proliferation, hypertrophic 
differentiation, mineralization of the surrounding matrix, and finally the cartilaginous tissue is 
replaced by bone. We have provided evidence that HIF-1α is activated during the chondrogenic 
phase of periosteal callus formation, which suggests that conditions during callus formation and 
differentiation are, at least transiently, hypoxic. Interestingly, expression of BMPs appears to be 
regulated at a posttranscriptionallevel during these processes. 
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Abstract 
Initiation of and progression through chondrogenesis is driven by changes in the cellular 
microenvironment. For instance, Insulin Receptor signaling is known to mobilize resting 
mesenchymal stem cells and to initiate a complex, step-wise chondrogenic differentiation program 
in vivo and in vitro. Differentiation requires coordinated transcriptomic reprofiling and increased 
progenitor proliferation, both processes require chromatin remodeling. The nature of early 
molecular responses that relay differentiation signals to chromatin is poorly understood. We here 
show that immediate early genes are rapidly and transiently induced in response to a changed 
cellular microenvironment. Functional ablation of Egr1 severely affects induction of genes required 
for proper differentiation. In addition, differentiating cells accumulate DNA damage, activate a DNA 
damage response and induce a senescence-like response, which terminates in global histone 
hypermethylation. Novel molecular connections with Polycomb Group function identified in this 
report begin to explain the replicative arrest. We here for the first time describe an important role 
for Egr1 in early epigenomic reprogramming, exceeding its classical role as transcription factor, to 
accommodate early gene-environment interactions in chondrogenesis.  
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Introduction 
Differentiation requires orchestration of numerous parallel cellular responses, processes and 
altered physiological states associated with the novel cell fate. Such changes are often induced by 
environmental cues (i.a. soluble factors, cell-cell contacts), which are signaled to the nucleus and 
translated into spatio-temporal re-profiling of gene expression. As coding and non-coding genes 
are ‘packed’ in chromatin, access to and activation of genes during differentiation is subject to 
important epigenetic regulation, including covalent modifications to histone proteins and chromatin 
structure remodeling. Post-translational modifications on histone tails serve to recruit either 
transcriptional activators or repressors and nucleosome remodeling machineries, and as such 
constitute an epigenetic register of expression potential 1-3. Recent studies have provided 
important insights in epigenomic changes that accompany lineage commitment of ES cells. ES 
cells respond rapidly to changes in the micro environment: as ES cells are induced to differentiate, 
their epigenome is remodeled such that lineage-related genetic programs are selectively activated, 
whereas non-lineage relevant genes are progressively inactivated. Part of these epigenetic 
alterations includes post-translational modifications at amino-terminal tails of histones, which are 
closely associated with DNA, i.e. genes, as they are the major constituents of nucleosomes. 
Interestingly, many key developmental regulator genes in pluripotent ES cells appear bivalently 
marked: they carry both ‘activating’ (e.g. H3K4me3; histone H3, lysine 4, trimethyl) as well as 
‘inactivating’ (e.g. H3K27me3) epigenetic marks in the chromatin surrounding transcription start 
sites. This bivalent marking switches to monovalency as the differentiation program proceeds 4. 
These observations suggest that although common epigenetic principles exist to initiate cell fate 
decisions, specific cellular cues are integrated that eventually allow successful lineage 
demarcation.  
Microenvironmental factors play an important role in chondrogenesis. As chondrogenic progenitors 
move away from the growth plate, their microenvironment changes constantly. These changes 
include soluble growth and differentiation factors, hormones, oxygen tension, cell-cell and cell 
ECM contacts 5-8. Cells respond to these changes in the microenvironment by altering their gene 
expression profiles, which in turn are accompanied by locally changing in the epigenome. An 
important open question concerning the most primary choices that are made by undifferentiated 
cells is: What connects these environmental cues to chromatin? Which signaling factors are 
involved in early epigenomic remodeling and, hence, in differentiation? The Polycomb repressive 
Complex (PRC) proteins Ezh2 and Bmi1 are important factors in cell fate determination in that they 
provide cells with an epigenetic memory function: Ezh2 is a histone lysine methyl transferase 
(HKMT) in Polycomb repressive complex 2 (PRC2), which writes the H3K27me3 mark 9. Bmi1 is 
part of Polycomb repressive complex 1 (PRC1), which is recruited to H3K27me3 marks and 
maintains transcriptionally repressed states 10-12. As such, PRCs are recognized to sustain lineage 
commitment in the context of development. We and others have recently shown that Polycomb 
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function is regulated by post-translational modifications (reviewed by HN JWV; in press), 
suggesting a link between cell signaling and epigenetic re-programming involving PRC. The 
observation that PRC LOF mutant mice often display abnormal skeletogenesis indicates a 
potential link to endochondral ossification (i.e. formation of an ossified skeleton from a 
cartilagenous scaffold) 13-16. 
 
We here study chondrogenesis as a function of environmental changes. On their way to becoming 
terminally differentiated chondrocytes, chondrogenic progenitor cells in vivo undergo a well-
described sequential series of events at the cell biology level: initially resting growth plate stem 
cells undergo a transit replicative burst. In vivo, this rapid progenitor expansion in the so called 
proliferative zone is a distinctive feature of developing cartilage. During endochondral ossification, 
as cells move away from the growth plate, they differentiate, become hypertrophic and are 
replaced by bone tissue 17, 18. Chondrogenesis is controlled by numerous well-described 
environmental and endocrinoid factors 6-8, 17-19. Per example, signaling through the insulin receptor 
has been intensively studied because of its mobilizing effect on resting stem cells and stimulatory 
effects on cells in the proliferative zone 20. ATDC5 cells were originally identified as stem cells of 
mesenchymal origin that harbor chondrogenic potential 21. The ATDC5 model uniquely combines a 
number of relevant elements. Chondrogenic differentiation of ATDC5 cells reiterates numerous 
micro-environmental changes that accompany dynamic and strictly timed transcriptomic re-profiling 
observed during embryogenesis 21-23. In addition, proliferation is rapidly upregulated early in 
differentiation 21. Hence ATDC5 cells represent an excellent model to study gene-environment 
interaction at the epigenetic level.  
The rapid activation of immediate early genes (IEG) denotes the first line of cellular responses to 
environmental stimuli. Expression of IEG encoded proteins precedes de novo synthesis of other 
proteins; as such IEGs represent an important gateway to genomic responses and physiological 
adaptation. For instance, FOS, JUN and EGR1 (KROX24/NGFR1) induction is a well-described 
feature of neurotransmission 24, 25. In the context of cancer, EGR1 acts either oncogenic or 
tumorsuppressive 26, hence, in some cancers it is overexpressed, in others egr1 is deleted.  
Not much is known about the role of EGR1 in chondrogenesis. We here report that IEG family 
members (i.a. cFos, cJun, EGR) are rapidly induced in response to insulin signaling. We show that 
egr1 mRNA induction in chondrogenesis is transient and precedes transcriptional upregulation of 
SOX9, a known key regulator of chondrogenesis. Acute loss of Egr1 prevents SOX9 induction, 
supporting a role for Egr1 in transcription of SOX9. In addition, loss of Egr1 leads to replication 
arrest in culture, which correlates with increased TRP53 and P21CIPWAF expression. In line with the 
above, loss of Egr1 has long-lasting effects on epigenomic reprogramming. Finally, we here 
describe a novel biological association between Egr1 and Polycomb Group function, providing at 
least a partial explanation for the observed defective differentiation in the Egr1-deficient model. 
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Materials and methods 
Cell culture 
ATDC5 cells were cultured at 37 °C, 5% CO2, 100% humidity in DMEM/ F-12 supplemented with 
5% fetal calf serum (FCS), antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin), 200 mM 
L-glutamine on tissue culture plates (Greiner Bio-One). For differentiation experiments cells were 
seeded at 6400 cells/cm2 and were allowed to attach overnight. Growth medium was changed for 
differentiation medium, which includes ITS (10 μg/ml insulin, 10 μg/ml transferrin and 3 x10-8M 
sodium selenite). Differentiation medium was replaced every two days. 
 
Retroviral infections 
Ecotropic retroviral supernatants were produced by transfection of phoenix cells with calcium-
phosphate precipitation; 24-48 hours post-transfection, the supernatant was harvested, filtered and 
used for infection of ATDC5 cells in presence of 4µg/ml polybrene. Cells were incubated for 12 
hours and then allowed to recover for 24 hours on fresh medium before selection pressure was 
applied. Infected cells were selected with puromycin (8 µg/ml) for 72 hours, before experiments 
were initiated. Short-hairpin (sh)RNA target sequence for Egr1: 5’- ACAAAGTAACCTGTTTGGC-
3’. Short hairpin sequence targeting shGFP was used as reference sh sequence [44]. 
 
Chrystal violet  
ATDC5 cells were plated in 12-multiwell plates (Greiner Bio-one). At each time point cells were 
washed twice with phosphate-buffered saline, and fixed for 10 minutes with 3.7% formaldehyde at 
room temperature. Next, cells were rinsed 5 times with demiwater. Cells were stained with 0.1% X-
tal violet for 30 minutes or overnight, respectively, and washed 5 times with demiwater. X-tal was 
extracted with 10% acetic acid and absorbance was measured spectrophotometrically at 590 nm 
(Benchmark, Biorad).  
 
RNA isolation and cDNA synthesis 
Cells were suspended in Tri-reagent, and RNA was extracted according to the protocol of the 
manufacturer (Sigma). Quantity and purity of the RNA were determined by 260/280 nm 
absorbance measurements. cDNA was synthesized using iScriptTM cDNA synthesis kit (Biorad). 
Primers used are listed in supplemental Table 1. 
 
Western analysis 
Cells were lysed in RIPA buffer containing 5 mM Benzamidine, 5 μg/ml Antipain, 5 μg/ml 
Leupeptin, 5 μg/ml Aprotinin, 1 mM Sodium Vanadate, 10 mM Sodium Fluoride, 10 mM 
Pyrophosphate, 10 mM β-glycerophosphate, 0.5 mM DTT and 1mM PMSF. Lysates were 
subjected to 3 freeze-thaw cycles in liquid nitrogen, and to 3 cycles of sonication. After 
centrifugation for 10 minutes at 13.2 krpm, protein concentration was determined using a BCA 
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protein assay kit (Pierce). Equal amounts of protein were boiled in Laemmli buffer and loaded on 
9-15% polyacrylamide gels. Proteins were transferred to polyvinylidene fluoride (PVDF) 
membranes. After blocking with 5% non-fat dry milk in PBS containing 0.1% Tween-20, 
membranes were incubated o/n at 4ºC with the following antibodies:  anti β-actin Mab (C4, 
691001, MP Biomedicals), anti Gapdh, anti Ezh2 Mab (BD43; coutesy D. Pasin Copenhagen, 
Denmark), anti Bmi1 Mab (F6; Courtesy M. van Lohuizen; Amsterdam, The Netherlands), anti 
Egr1 Poab sc-110 (Santa Cruz Biotechnology), anti Chk1-DCS-310 (Abcam Ab22610), anti p-Chk2 
(Thr68) #2661 (Cell signaling), anti H2A.X (Ser139) Poab #2577 (Cell signaling), anti TRP53 Mab, 
anti geminin (FL-209) Poab (Santa Cruz Biotechnology), anti H3K4me3 Poab (ab8580) (Abcam), 
anti H3K27me3 Poab, #07-449 (Upstate), anti Kap1 Poab A300-275A (Bethyl Laboratories, anti 
H3K9/14Ac Poab (#06-599, Upstate Biotechnology). After extensive washing, membranes were 
incubated with corresponding horseradish peroxidase conjugated secondary antibodies for 1h at 
room temperature. Signals were detected using enhanced chemoluminescence. 
 
Immunofluorescence 
Briefly, cells were washed and fixed for 10-15 minutes in 100% methanol at -20°C and stored at 
4°C in 70% ethanol or used directly for immuno-histochemistry. Cells were permeabilized for 5-10 
minutes in 0.2& triton-X in PBS. To prevent epitope loss in combination with acid treatment for 
BrdU detection, primary antisera were incubated for 1.5 hours at 37°C, 4-5x washed in 0.02% 
triton-X/PBS and fixed in 2% formaldehyde/PBS for 10 minutes at room temperature. Cells were 
washed with PBS and incubated for 20 minutes in 2.0N HCl at 37°C, followed by two rinses of 0.1 
M sodium tetraborate solution, pH 8.5 for in total 2 minutes. Cells were than incubated with the 
primary antisera against BrdU, washed at indicated before and incubated with secondary 
fluorescently labeled antibodies. All Antisera were diluted and incubated in 0.02% triton-X in PBS. 
Nuclei were counterstained with 4'-6-Diamidino-2-phenylindole (DAPI) and washed in 0.02% triton-
X/PBS. The last wash step was in PBS, upon which cells were dehydrated: 1 minute in 70% 
ethanol, 2x 1 minute in 100% ethanol and air-dried. Cells were mounted in Vectashield (Vector 
Laboratories, Inc. Burlingame, CA) and analyzed using a NIKON TE200 Eclipse fluorescence 
microscope and photographed using a NIKON DXM1200 digital camare in combination with NIS 
Elements 3.0 Imaging software. The following antibodied were used: anti γH2A.X Mab JBW301 
(Upstate), anti BrdU (BD biosciences) and anti H3K9me3 #07-442 (Upstate), anti H3K27me3 
Poab, #07-449 (Upstate). 
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Chromatin Immunoprecipitation 
ChIPs were performed and analyzed essentially as described previously 51. 
Briefly, U373 and HCT116 cells were fixed in 1% formaldehyde. Cross-linking was allowed to 
proceed for 10 min at room temperature and stopped by addition of glycine at a final concentration 
of 0.125 M, followed by an additional incubation for 5 min. Fixed cells were washed twice with PBS 
and harvested in SDS Buffer (50 mM Tris at pH 8.1, 0.5% SDS, 100 mM NaCl, 5 mM EDTA), 
supplemented with protease inhibitors (Aprotinin, Antipain and Leupeptin all at 5µg/mL and 1mM 
PMSF). Cells were pelleted by centrifugation, and suspended in IP Buffer (100 mM Tris at pH 
8.6, 100 mM NaCl , 0.3% SDS, 1.7% Triton X-100, and 5 mM EDTA), containing protease 
inhibitors. Cells were disrupted by sonication, yielding genomic DNA fragments with a bulk size of 
200-500 bp. For each immunoprecipitation, 1 mL of lysate was precleared by addition of 35 µL of 
blocked protein A beads (50% slurry protein A-Sepharose, Amersham; 0.5 mg/mL fatty acid-free 
BSA, Sigma; and 0.2 mg/mL herring sperm DNA in TE), followed by clarification by centrifugation. 
10µl aliquots of precleared suspension were reserved as input DNA and kept at 4°C. Samples 
were immunoprecipitated overnight at 4°C with antibodies for either HA as a negative control (sc-
805; Santa Cruz), H3K27me3 (07-449; Upstate), anti H3K4me3 Poab (ab8580) (Abcam), anti Egr1 
Poab sc-110 (Santa Cruz Biotechnology). Immune complexes were recovered by adding 40 µL of 
blocked protein A beads and incubated for 4 h at 4°C. Beads were washed three times in 1 mL of 
Mixed Micelle Buffer (20 mM Tris at pH 8.1, 150 mM NaCl, 5 mM EDTA, 5% w/v sucrose, 1% 
Triton X-100, and 0.2% SDS), twice in 1mL of Buffer 500 (50 mM HEPES at pH 7.5, 0.1% w/v 
deoxycholic acid, 1% Triton X-100, and 1 mM EDTA), twice in 1mL of LiCl Detergent Wash Buffer  
(10 mM Tris at pH 8.0, 0.5% deoxycholic acid, 0.5% NP-40, 250 mM LiCl, and 1 mM EDTA), and 
once in 1mL of TE. Immuno-complexes were eluted from beads in 250µL elution buffer (1% SDS; 
and 0.1M NaHCO3) for 2 h at 65 oC with continuous shaking at 1000 rpm, and after centrifugation 
supernatants were collected. 250µL elution buffer was added to input DNA samples and these 
were processed in parallel with eluted samples. Crosslinks were reversed overnight at 65oC 
followed by a 2h digestion with RNAse A at 37oC and 2h proteinase K (0.2µg/µL) at 55oC. DNA 
fragments were recovered using QIAquick PCR purification columns, according to manufacturers’ 
instructions. Samples were eluted in 75 μL EB buffer and then further 1/5 diluted in TE buffer. The 
immunoprecipitated DNA was quantified by real-time qPCR. Primers used are listed in 
supplemental Table 1. 
 
Affymetrix gene arrays 
Affymetrix NuGO mouse arrays (~24k) were run on RNA from ATDC5 cultures sampled over time 
post induction of differentiation (pid). For each time point 3 samples were taken from both a 
wildtype (WT) and a Egr1 knock-down (KD) culture. After scanning, data preprocessing and 
analysis were done using R2.7.1 with the use of Bioconductor libraries 80,81. Data were 2log 
transformed and normalized using gcRMA 82. 
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Results 
Egr1 is rapidly induced in differentiation 
To identify early responses to differentiation stimuli, ATDC5 cells were stimulated to undergo 
chondrogenesis. An expression-array experiment was designed to assay immediate early, early 
and late changes in gene expression profiles, as a function of time (0, 2, 4, 8, 16, 24 and 72 hrs). 
Expression analysis revealed a rapid upregulation of a number of immediate early growth 
response genes (IEGs): expression of IEGs belonging to the FOS, JUN and EGR1 subfamilies is 
significantly enhanced within 2 hours upon induction of chondrogenesis in murine mesenchymal 
progenitor ATDC5 cultures (Suppl. Figure 1A). Also c-MYC is induced, albeit at more moderate 
levels (2x; FS, GvdA, JWV; unpublished data).  
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Figure 1. Egr1 is rapidly induced in chondrogenic differentiation and binds to chondrogenic promoters.  
(A) qRT rtPCR analysis of Egr1 expression up to 4 hours pid with 20 or 30 minute intervals. (B) qRT rtPCR analysis of 
Sox9 expression up to 4 hours pid with 20 or 30 minute intervals. (C, E, G) ChIP using anti-Egr1 antibodies and n; 0, 2 
and 8 hours pid immunoprecipitated DNA was analyzed by qRT rtPCR for the respective promoters. (D,F,H) ChIP using 
anti-H3K27me3 and anti-H3K4me3 antibodies and n; 0, 2 and 8 hours pid immunoprecipitated DNA was analyzed by 
qRT rtPCR for the respective promoters.  
 
Expression of most IEGs rapidly declines over the next 2 hours. To investigate a role for IEGs in 
chondrogenesis we focused on EGRs; EGR1 and EGR3 are both massively induced upon adding 
ITS: EGR1 expression is induced up to 200x at the mRNA and returns to baseline levels within 4 
hours pid (post-induction of differentiation). An independent real time expression analysis using a 
time resolution of 20 minute intervals essentially confirmed the microarray findings: EGR1 mRNA 
increases within 20 minutes into differentiation, peaks at 1-2 hours and falls off to pre-induction 
levels within 2-3 hours (Figure 1A). EGR1 expression increases again later during chondrogenesis 
around 6 days (Suppl Figure 1B). Protein expression parallels the observed changes in EGR1 
mRNA levels nicely: whereas absent at t=0, Egr1 protein is first detected at 1 hour pid, peaks at 2 
hours and rapidly declines thereafter (Figure 2A).  
 
Egr1 initiates chondrogenesis through SOX9 and RUNX2 expression 
This early IEG-induction profile suggested a role for EGR1 in activating downstream differentiation 
programs. To chart potential target genes for Egr1 and to build a chondrogenic gene-interaction 
network, we combined published data, with a mouse genome-wide screen for Egr1 binding sites 
and software tools to predict promoter binding sites for numerous transcription factors. Multiple 
consensus binding sequences for Egr familiy members exist 27-29 we confined our genomic scan to 
GCGG/TGGGCG motifs and its reverse complementary sequence, both in sense and antisense 
orientation. Genes containing predicted binding sites were mapped using pathway analysis tools 
(Pathvisio with Wikipathways content; Suppl Figure 2).  Several known key-regulators of 
chondrogenesis, such as SOX9 and RUNX2 30-33, contain predicted Egr1 binding sites. At the 
mRNA level, SOX9 shows a transient, approximately 1 hour out-of-phase induction in response to 
differentiation medium as compared to EGR1 (Figure 1B). In silico SOX9 promoter analysis using 
GENOMATIX software revealed several putative binding sites for Egr family members a number of 
which correspond to potential Egr1 consensus binding sites (Suppl Figure 3). To confirm the in 
silico mapping, we performed chromatin immunoprecipitation (ChIP) with anti-Egr1 antibodies on 
ATDC5 cells differentiated for 0, 2 and 8 hours. Two independent primer sets were designed to 
detect co-precipitated SOX9 promoter sequences using real time PCR. In good agreement with the 
expression kinetics of EGR1 upon induction of differentiation, both SOX9 primer sets show 
substantial enrichment of Egr1 within the vicinity of the Egr1 binding sites at 2 hours pid (10-15 
fold; Figure 1C; Suppl Figure 4A). Likewise, the RUNX2 promoter is enriched 67-fold for Egr1 at 2 
hrs (Figure 1E). Both promoters carry histone H3K4me3, an epigenetic status permissive for 
transcriptional activity (Figure 1D, F; Suppl Figure 4B). Consistent with a sharp drop in protein 
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levels (Figure 2A), 8 hours into differentiation, Egr1 occupation at these promoters was restored to 
levels found in undifferentiated cells. Conversely, the Aggrecan (ACAN) promoter, appears not 
enriched for Egr1 at 2 hours pid, and, in contrast to the SOX9 and RUNX2 promoters, ACAN is 
marked for repression with H3K27me3 (Figure 1G, H). Both findings are consistent with a 
significantly later transcriptional activation of ACAN in chondrogenesis as opposed to SOX9 and 
RUNX2 at approximately 10 days (Suppl Figure 4C-H). To firmly establish a role for Egr1 in 
chondrogenesis, we studied chondrogenic marker gene expression in the context of RNA-
interference mediated knock-down (KD) of EGR1. A shRNA vector targeting murine EGR1 mRNA 
(shEGR1) was designed based on criteria published before 34. Expression analysis at both mRNA 
level and protein level shows that the retroviral shEGR1 vector efficiently targets EGR1 expression 
(Figure 2A,B). Both SOX9 and RUNX2 display a multi-phasic expression profile throughout 
differentiation (Suppl Figure 4C-F). Relevantly, loss of EGR1 function (EGR1-LOF) blunts early 
SOX9 and RUNX2 expression (Figure 2C; Suppl Figure 4D). Egr1 enrichment in the SOX6 
promoter is only marginally changed and EGR1-LOF appears to have very little effect on mRNA 
expression (Suppl Figure 5A,D). 
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Figure 2. Egr1 is required for induction of chondrogenic differentiation.  
(A) Western blot analysis of Egr1 expression in ATDC5 cells stably expressing shControl or shEgr1 at 0, 1, 2 and 4 
hours pid. GAPDH is used as loading control (B) qRT rtPCR analysis of Egr1 expression in ATDC5 cells stably 
expressing shControl or shEgr1 up to 4 hours pid. (C) qRT rtPCR analysis of Sox9 expression in ATDC5 cells stably 
expressing shControl or shEgr1 up to 12 hours pid. (D,F) qRT rtPCR analysis of collagen 2a1 and agrrecan expression 
in ATDC5 cells stably expressing shControl or shEgr1 up to 15 days pid. (E) Western blot analysis of chondrogenic 
marker expression in ATDC5 cells stably expressing shControl or shEgr1 up to 15 days pid. 
 
 
This suggests that SOX6 and SOX4 loci may not be prime Egr1 targets for transcriptional 
activation early in chondrogenesis; indeed both SOX6 and SOX4 are not expressed until later in 
chondrogenesis (Suppl Figure 5C). Expression of genes encoding the ECM proteins Collagen type 
II (Col2A1) and Acan is activated 7-10 days pid in reference cultures; Egr1-KD significantly 
reduces COL2A1 and ACAN expression at the mRNA and protein level (Figure 2D,E; Suppl Figure 
4C). RUNX2-induced Collagen type X (COL10A1) expression coincides with hypertrophic 
differentiation 35; Col10A1 levels are severely reduced in Egr1-KD cultures (Figure 2E). Thus, 
activation of Egr1 early in chondrogenesis directly activates transcription of key regulators of 
downstream differentiation pathways.  
 
Loss of Egr1 elicits replication stress induced senescence-like cell cycle arrest. 
An important feature of early chondrogenesis is the capacity of chondrocytes to rapidly proliferate. 
We studied ATDC5 differentiation induced hyperproliferation as a function of EGR1 expression. 
Proliferation rate of control cells is approximately 3 fold increased from 1 day pid onward as 
compared to cells under normal, non-differentiating culture conditions (Figure 3A). Differentiating 
cells typically overgrow each other and form nodules, i.e focal points of chondrogenesis (Suppl 
Figure 6). The proliferative burst coincides with a second period of EGR1 upregulation (Suppl 
Figure 1B), indicating a potential requirement for EGR1 during enhanced cell division. Remarkably, 
EGR1-LOF completely abrogates the ability of ATDC5 cells to hyperproliferate and cells cease 
proliferation when they reach confluency (Figure 3B; Suppl Figure 6). The proliferative block was 
independently confirmed using incorporation of BrdU as a read-out (Figure 3C). The 
hyperproliferative block is accompanied by dramatic morphological changes: EGR1-LOF cells 
display the ‘large flat cell’ phenotype typically associated with cellular senescence (Figure 3D). 
Consistent with this, ATDC5 EGR1-LOF cultures show polyploidy and reveal transcriptional 
induction of numerous genes implicated in cellular senescence, DNA damage and stress signaling 
(Suppl Figure 7). 
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Figure 3. Loss of Egr1 elicits replication stress induced senescence-like cell cycle arrest.  
(A) ATDC5 cells hyperproliferate upon induction of chondrogenic differentiation. Proliferation determined by Crystal violet 
incorporation with subsequent extraction and spectrophotometric analysis. (B) ATDC5 cells stably expressing shEgr1 fail 
to undergo differentiation induced hyperproliferation, measured by Crystal violet incorporation. (C) ATDC5 cells stably 
expressing shEgr1 or shControl were differentiated for 2 days, then BrdU was administered to the cells for 45 minutes. 
BrdU was visualized with anti-BrdU antibodies. (D) Morphological analysis of ATDC5 cells stably expressing shEgr1 or 
shControl at 4 days pid. 
 
Activation of a DNA damage response (DDR) was confirmed by immunoblotting of phosphorylated 
H2A.X (H2A.X) and Chk2 in chondrogenic cultures (Figure 4A-B). In control cells Chk2 is 
phosphorylated at a basal level and slightly reduced during hyperproliferation, differentiation in the 
absence of Egr1 induces a substantial increase in pChk2 at day 3 (Figure 4A). Upregulation of 
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several cell stress markers suggests that the Atm/Atr DDR (pChk2, H2A.X; Chk1) pathway and 
cell cycle arrest (Trp53, Gmnn) are activated. Consistent with this, immunohistochemical staining 
for H2A.X confirms DNA damage in Egr1-KD cells under differentiating conditions (Figure 4C).  To 
map processes regulated by Egr1, the genes identified in a genome-wide blast for Egr1 binding 
sites were analyzed using GenMAPP; this yielded a number of overrepresented processes known 
to be involved in chondrogenesis and differentiation in general (table 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Egr1-LOF elicits DNA damage in transit amplifying chondrocytes 
A, B) Western blot analysis of proteins related to DNA damage responses in ATDC5 cells stably expressing shControl or 
shEgr1. bActin is used as loading control. (C) Protein expression of γH2Ax in ATDC5 shControl and shEgr1, at 2 days 
pid. Counterstaining by DAPI. 
 
In addition, we identified cytokine signalling pathways as potential targets of Egr1. Relevantly, 
interleukins, like IL6, are known to play an important role in establishment of senescence 36, 37. In 
good agreement with this, IL6 is significantly induced upon differentiation in the absence of Egr1 
(Suppl Figure 7).  Taken together, this data clearly identifies Egr1 as an essential regulator protein 
for hyperproliferation in the context of chondrogenesis and shows loss of Egr1 results in cellular 
senescence-like response. 
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Egr1 controls epigenomic remodeling 
As Egr1 controls both transcriptional reprogramming and hyperproliferation, we studied global 
epigenomic changes throughout chondrogenesis as a function of Egr1. Histone acetylation 
(H3K9/K14ac and H4K12ac), trimethylation at lysine 27 (H3K27me3), lysine 4 (H3K4me3) and 
lysine 9 (H3K9me3) all undergo dynamic changes throughout chondrogenesis: all trimethyl marks 
peak during hyperproliferation and gradually increase toward hypertrophy (Figure 5A). In contrast, 
histone acetylation is high in shcon chromatin at the initial stages of chondrogenesis, and gradually 
declines over time (Figure 5A). Remarkably, all epigenomic changes were substantially perturbed 
in Egr1-KD cultures. Consistent with a role in recruiting HAT (histone acetyl transferase) activity, 
EGR1-LOF cells display a striking inability to induce and/or maintain acetylation levels throughout 
hyperproliferation (Figure 5B). In contrast, trimethylation levels at histone H3K4, H3K9 and H3K27 
appear initially low and substantial elevate at later time points in the absence of Egr1 (Figure 5B, 
C). We next investigated the effect of Egr1-KD on a number of H3K27me3 and K9me3-associated 
proteins. Polycomb Group proteins are known to affect skeletogenesis in vivo. The Polycomb 
PRC2 and PRC1 complex are both functionally connected to the H3K27me3 mark. Egr1-KD 
cultures fail to properly induce BMI1 both at the mRNA and protein level, suggesting a direct effect 
of EGR1 on BMI1 expression (Figure 5D; Suppl Figure 8A). Also Ezh2 expression is deregulated 
in Egr1-KD cultures: under normal conditions Ezh2 protein levels slightly increases in response to 
early signaling in chondrogenesis; this induction fails in Egr1-KD cultures (Figure 5E; Suppl Figure 
8A). Conversely, Ezh2 is substantially induced in Egr1-KD cells at late time points in differentiation 
(Figure 5E). The enhanced Ezh2 expression correlates well with the increase in H3K27me3 
(Figure 5C,G).  
The presence of multiple predicted EGR-family member consensus binding sites in the Bmi1 
promoter, and a more than 50 fold increased Egr1 presence at the Bmi1 promoter (Suppl. Figure 
8C, D) are consistent with direct control of Bmi1 expression by Egr1. The Ezh2 promoter is 
substantially less enriched for Egr1 (± 4 fold) and Ezh2 mRNA levels are not consistently 
suppressed in the absence of Egr1 arguing for a possibly secondary effect of EGR1-LOF on 
expression of Ezh2. (Suppl Figure 8B,E). A substantial increase of KAP1/TIF1B expression, a 
factor associated with HP1/H3K9me3, correlated well with the observed increase in H3K9me3 
levels at late time points in Egr1 LOF cultures (Figure 4C,F,G). In summary, the above data 
demonstrate that Egr1 is crucial for initiation of an epigenome wide reprogramming during 
chondrogenesis and that differentiation in the absence of Egr1 results in abnormal epigenetic 
responses.  
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Figure 5. Loss of Egr1 affects histone modifications and histone modifiers.  
(A,B,C) Westernblot analysis of histone modifications in ATDC5 shControl and shEgr1 throughout chondrogenesis. 
(D,E,F) Westernblot analysis of PcG proteins and Kap1, a novel PcG interacting protein, in ATDC5 cells stably 
expressing shControl or shEgr1. (G) Immunocytochemical analysis histone modifications in ATDC5 cells stably 
expressing shControl or shEgr1. 
 
 
Egr1-promoter binding is not sufficient for transcriptional activation  
The genome-wide abundance of Egr1-family consensus binding sites and of Egr1 in particular, 
combined with the dramatic effects of Egr1-LOF on global epigenomic reprogramming during 
chondrogenesis suggested that Egr1 may not enhance transcriptional activity by itself upon DNA 
binding. The SOX9 promoter is predicted to be in a relatively ‘open’ chromatin configuration at t=0, 
based on the presence of transcriptional activity-associated H3K4me3 marks and the absence of 
repressive H3K27me3 marks. This chromatin state is maintained early in chondrogenesis (Figure 
1D). The same holds true for RUNX2, which, as SOX9, is free of repressive H3K27me3 marks 
(Figure 1F), and for PRC gene promoters of BMI1 and EZH2 (Suppl Figure 8F, G). All ‘open’ 
chromatin promoters, i.e. only marked H3K4me3, appear enriched for Egr1 at 2 hrs of induction of 
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differentiation. Yet, not all these “open” genes neither follow the induction profile typical of e.g. 
SOX9, nor lose induction of gene activity in the absence of Egr1 as SOX9 does. In contrast, gene 
promoters of ACAN and SOX6, appear initially silenced by PRC1 (Figure 1H, Suppl Figure 5B): the 
ACAN promoter carries H3K27me3 marks, consistent with ACAN being a PRC1 target in cells of 
mesenchymal origin 11. Indeed, a comparison of chondrogenic promoters with putative Egr1-
binding sites and reported Polycomb-associated gene promoters yielded a number of potential 
common target genes for both Egr1 and Polycomb (Suppl Figure 2). SOX6, a presumed Sox9 
target, gradually loses its PRC-associated repressive mark over the initial 8 hrs in differentiation. 
Regardless of these initial epigenetic conversions, however, neither ACAN nor SOX6 are 
transcriptionally activated until late in chondrogenesis. Neither gene is substantially enriched for 
Egr1, despite the presence of predicted Egr1 binding sites in their promoters (Suppl Figure 3) 
suggesting that a repressive chromatin confirmation prevents Egr1 access.  
To independently test the hypothesis that Egr1 binding does not induce gene activity per se, we 
analyzed HOX cluster gene expression in the context of Egr1 presence. HOX genes are key 
developmental regulators of anterio-posterior (AP) patterning and skeletal development 38,39. HOX 
genes are functionally grouped in 4 multi-gene clusters in mammals; expression within these 
clusters is subject to co-linear regulation, hence expression boundaries within a cluster are sharply 
defined in a cell-context specific manner 40, 41. HOX clusters carry predicted Egr1 binding sites 
(Suppl Figure 9B).  
To examine induction of HOX gene activity in relation to Egr1 enrichment, HOXA cluster genes  
(A1, A4, A6, A7, A9 and A11) were subjected to ChIP analysis for Egr1, H3K27me3 and H3K4me3 
during early chondrogenic differentiation. Relevantly, a gradient of epigenetic marking over the 
HoxA cluster is readily visible: HOXA1 and HOXA4 promoters are up to 400-fold enriched for 
H3K4me3, whereas HOXA6 shows a lower, approximately 20-fold enrichment compared to the 
HA-control (Figure 6A). None of these HOXA genes are enriched for H3K27me3. The HOXA7 
promoter appears only moderately enriched for both epigenetic modifications, whereas HOXA9 
and HOXA11 lack H3K4me3, they display enrichment for the repressive H3K27me3 mark (Figure 
6A). These findings predict an expression boundary within the HOXA cluster at HOXA6/A7 in non-
differentiated ATDC5 cells. Strikingly, Egr1 is only enriched at epigenetically accessible HOXA 
promoters, as defined by H3K4me3-marking; none of the H3K27me3 promoters are enriched 
(Figure 6B). Despite the increased Egr1 occupation at 2 hours pid, Egr1-binding does not induce 
transcriptional regulation of any gene within the HOXA cluster, irrespective of epigenetic status 
(Figure 6C). Consistent with this, none of the Hox gene clusters respond to EGR1-LOF (Suppl 
Figure 9). Taken together the above data shows that Egr1 binding of consensus sequence motifs 
is not sufficient for activation of transcription. 
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Figure 6. Egr1-promoter binding is not sufficient for transcriptional activation. (A,B) ChIP analysis for enrichment of 
H3K27me3, H3K4me3 and Egr1 on promoters of the HoxA cluster. (C) Relative mRNA expression of the HoxA cluster in 
ATDC5 cells differentiated for up to 24 hours. 
 
Discussion 
We here report for the first time that many IEGs are rapidly induced in the context of 
chondrogenesis: Egr1 is highly induced and controls relevant chondrogenic pathways: RNA 
interference-mediated knock-down of Egr1 affects early global chromatin acetylation and severely 
impedes chondrogenesis: both expression of key regulator genes of chondrogenesis, like SOX9 
and RUNX2, as well as transit amplification are blocked. The block in rapid progenitor expansion 
correlates with DNA-damage induced signaling and display characteristics of a senescence-like 
response. Our analysis also shows that Egr1 promoter binding does not activate transcription per 
se, and suggests a more general role for Egr1 in epigenomic reprogramming during differentiation.  
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The observation that Egr1-KD specifically blocks rapid differentiation-induced progenitor expansion 
strongly suggests that replication stress is involved in the proliferative block. The conditions at 
onset of differentiation show remarkable resemblance to oncogenic stress and several lines of 
evidence suggest parallels with oncogene induced senescence (OIS). Firstly, ATDC5 cells 
undergo a transit proliferative amplification, a situation identical to the early increase in proliferation 
induced by oncogenes 42-44. Secondly Egr1-KD cells accumulate DNA damage and activate a 
DDR, as evidenced by phosphorylation of H2AX, Chk2 and Kap1, and upregulation of multiple 
DDR genes. Thirdly, in the context OIS, cell cycle exit and irreversible senescence are dependent 
on activation of a DDR 43. We show here that DDR in Egr1-KD cells coincides with a strong 
replicative block and a senescence-like phenotype: cells display distinctive features associated 
with senescence: large flat cell morphology, polyploidy, expression of numerous senescence-
associated marker genes. Combined this data strongly argues that Egr1 facilitates proliferative 
expansion in transit amplifying chondrogenic progenitors.  
The early abnormal global acetylation in the absence of Egr1 is in good agreement with Egr1‘s 
ability to recruit HAT activity 45. C-Myc, one of the first IEGs identified, was recently found to 
augment global acetylation through both transcriptional regulation and recruitment of GCN5 46. 
Early acetylation may be required for making rapid proliferation possible. It is conceivable that 
global acetylation in response to DNA binding of IEG-encoded proteins may help define regions 
within a network of increased DNA-templated activity, and support differentiation-specific changes 
in transcription and proliferation.  
It is currently only possible to speculate about the biological relevance of the co-regulation of 
seemingly conflicting trimethyl levels on H3K4, H3K9 and H3K27 under normal and stressed 
conditions. It seems unlikely, given their stability across cell generations, that these changes in 
global trimethylation reflect a cell cycle dependent enrichment. Besides with transcriptional activity, 
each mark is associated with distinctive other processes. H3K9me3 is a hallmark of 
heterochromatin. H3K9me3 and HP1 accumulation at distinct nuclear foci has been associated 
with replication stress induced senescence 47 . Increased accumulation of H3K9me3 at these 
senescence-associated heterochromatin foci (SAHF) is the consequence of subnuclear 
redistribution rather than increased global H3K9me3 levels 48. We identified several indicators of a 
senescence-like response in Erg1-KD cultures pid. In addition, however, a global H3K9me3 
increase at later time points (9, 15 days) is observed. The elevated H3K9me3 is preceded by 
increased KAP1 expression, which was reported to increase heterochromatin formation through 
recruitment of SETDB1 49. KAP1 is specifically required to resolve DNA damage in 
heterochromatin, down stream of ATM signaling 50. As Kap1 and HP1 physically interact 51, the 
elevated global H3K9me3 levels may point to increased heterochromatin formation. DNA damage 
in senescent cells was reported to persist for weeks on end 52. As such H3K9me3 and Kap1 may 
provide a means to protect damaged DNA from replication. 
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Ezh2 levels were found to decrease in the context of replicative senescence 53. Consistent with 
this, Ezh2 levels decrease during replicative stress in Egr1-KD cultures at 6 days pid. At late time 
points, elevated H3K27me3 correlates with increased Ezh2 expression. It is conceivable, that the 
formation of trimethylated chromatin represents a protective response against abnormal 
differentiation, cell death or transformation. Of note: all three trimethyl marks on histone 3 increase 
during transit amplification, suggesting a role under conditions of increased chromatin stress. In 
line with this notion, increased H3K4me3 and H3K27me3 have both been associated with other 
cellular stress responses: we and others have observed increased histone 3 K4me3 and K27me3 
in response to hypoxia or conditions that evoke replication stress (54,FS, PP and JWV; unpublished 
data). In addition, H3K4me3 was identified as a crucial determinant of Rag2-mediated V(D)J 
recombination in B and T cells, and is linked to DDR-induced cellular responses via ING family 
proteins 55, 56. These combined observations suggest roles for global trimethyl marking in 
processes in addition to local regulation of transcription.  
Interestingly we observe potential mechanistic interactions of Egr1 with PRC function at several 
levels. Firstly, loss of Egr1 affects, directly or indirectly, expression of two important PRC 
members, Ezh2 and Bmi1. Both proteins have been associated with cell cycle regulation: Ezh2 is a 
direct target of E2F1 57, and Bmi1 controls expression of P16/INK4A and P14ARF, both encoded by 
the CDKN2/INK4A locus 58, 59. Secondly, comparative analysis of published PRC targets and a 
genome wide scan for Egr1 consensus binding sites yielded potential common targets and 
suggests coordinated regulation. Indeed we observe a close correlation between the presence of 
PRC-repressive H3K27me3 marks and lack of Egr1 enrichment 2 hours pid, suggesting that PRCs 
prevent Egr1 access to promoters. Interestingly, likewise, H3K27me3 prevents Myc from 
interacting with its genomic targets 60. Importantly, we recently found that PRC1-LOF has 
comparable effects on chondrogenesis as Egr1-LOF, suggesting that at least part of the Egr1-LOF 
phenotype can be explained by PRC-LOF (FS, JWV: in preparation). 
Finally, Egr1 was reported  to be sumoylated in a P14ARF mediated process 61. The responsible E3 
ligase, UBC9, also interacts with PRC1 & 2 62, 63. Egr1-sumoylation is required for transcriptional 
activation of the Egr1-target PTEN. The protein phosphatase PTEN deactivates PI3K, which in turn 
will no longer activate AKT. In our experimental setting, however, we observe no induction of 
PTEN mRNA and Egr1-KD only marginally affects PTEN expression. This would suggest, that 
either most regulation occurs at the level of post-translational modification or that the EGR1-PTEN-
AKT-INK4AARF axis may not be a prime regulatory module early in chondrogenesis. In line with 
cell context dependent responses, several studies report cell type-dependent responses an Egr1-
targeted reporter gene was activated in neural cells, whereas in cartilage and heart it was 
suppressed 64, 65. 
Epigenomic reprogramming by Egr1 may serve to define concerted transcriptional or replication 
activity of gene-networks to guide cells through chondrogenesis. In agreement with such a 
coordinating role, Egr1 is known to transactivate and recruit CBP/P300, the consequence of which 
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is increased local HAT activity 66. In contrast, Egr1 interaction with NAB1/2 and recruitment of the 
NuRD complex would repress transcription by bringing HDAC activity to target genes 67-69. The 
global distribution of Egr1 binding sites may point to a more general task in epigenomic 
reprogramming, not exclusively linked to transcription. By analogy, recent studies on genomic 
distribution of transcription factor (TF) binding sites (PPARy, ERa) identified up to half of such 
binding sites either in intragenic regions (introns) or at distant locations (>25 kb away from the 
nearest gene), suggest additional epigenomic roles besides TF binding in gene promoters 70-72. It is 
tempting to hypothesize a role for IEGs in early epigenomic pre-programming, such that ensuing 
processes (concurrent transcription and replication) are facilitated in the context of development. 
Several observations support a close relationship between epigenetic marking and changed DNA 
replication during differentiation. Replication of lineage-relevant and non-relevant genes appears 
functionally separated in time: relevant genes (‘open’ chromatin 73, 74) is replicated earlier in S-
phase than non-lineage related genes. Dynamic change of replication timing throughout 
differentiation is crucial, and regulation of these processes is provided by the micro-environment of 
a stem cell or progenitor. Although still far from completely understood, translation of this 
epigenomic ‘landscape’ 75 provides the ‘traffic signs and road maps’ to terminally differentiated cell 
fates. It will be of considerable interest to map global and local acetylation in respect to Egr1 
binding and replication activity. Likewise, correlation of K4, K9 and K27 trimethyl marks, and likely 
numerous additional epigenetic marks, in the ATDC5 Egr1-KD system to DNA-templated activity 
will help advance insight into epigenetic regulation of the genome. These experiments are currently 
underway.  
Although epigenetic mechanisms in differentiation begin to emerge, exact knowledge of how cells 
communicate environmental changes to chromatin and how global epigenomic remodeling 
accompanies differentiation is lacking. At the onset of the study reported here, knowledge on IEGs 
in the context of chondrogenesis was limited. A general loss of Egr1 expression was reported in 
degenerating human cartilage 76. Although EGR family members may regulate each others 
expression 77 several studies provide evidence for distinctive functions for individual Egr1 family 
members. In adipogenesis, Egr1 and Egr2 have different roles 78. In keeping with this, the here 
reported strong phenotypic response to Egr1-LOF, despite induction of other closely related Egr-
familiy IEGs, point to absence of functional compensation and argue for a unique role for EGR1 in 
early chondrogenesis: the acute nature of an RNAi mediated knock-down approach used in this 
study, may prevent activation of redundant mechanisms often observed in null-mutant models 79. 
Here, we report a dual function for the transcription factor Egr1 in activating a lineage-specific 
transcriptional re-programming, as well as transit progenitor expansion. The inappropriate 
chromatin reprogramming in the absence of Egr1 strongly support an important task for Egr1 in 
early epigenomic remodeling during chondrogenesis and pave the way for further studies in gene-
environment interactions. 
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Table 1: Genmapp overrepresentation table (database used: Mm_Derby_20090509.pgdb; 
processes with a Z score > 1.96 are presented).  
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Figure S1. Expression profiles Inmediate Early Genes throughout chondrogenesis.  
(A,B) Microarray analysis of Immediate Early Genes mRNA expression in ATDC5 chondrogenic differentation presented 
as fold induction compared to T=0 (A), or arbitrary units (B).  
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Figure S2. Enchondral ossification pathway analysis for predicted Egr1 targets and published PcG targets (Bracken et 
al.) 
A genome-wide blast search was performed for Egr1 consensus binding sequences. The search was confined to 
GCGG/TGGGCG motifs and its reverse complementary sequence, both in sense and antisense orientation. Genes 
containing predicted binding sites were mapped using pathway analysis tools (Pathvisio with Wikipathways content).   
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Figure S3. Genes involved in chondrogenesis contain multiple Egr1 consensus binding sites. 
Using GENOMATIX promoter analysis software, promoters were analyzed for Egr1 binding sites. Arrows indicate 
primers designed for qRT rtPCR to quantify immunoprecipitated chromatin.  
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Figure S4. Egr1 directly binds and regulates the Sox9 promoter. 
(A,B) Chromatin immunoprecipitation using anti-Egr1, anti-H3K27me3 and anti-H3K4me3 antibodies. Precipitated DNA 
was analyzed by gRT rtPCR for enrichment on the Sox9 promoter using primer set 2 (see figure S3). (C-H) Microarray 
mRNA expression analysis of chondrogenic genes in ATDC5 cells stably expressing shControl or shEgr1 throughout 
chondrogenesis. 
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Figure S5. Egr1 directly binds and regulates the Sox6 promoter 
(A,B) Chromatin immunoprecipitation using anti-Egr1, anti-H3K27me3 and anti-H3K4me3 antibodies. Precipitated DNA 
was analyzed by gRT rtPCR for enrichment on the Sox6 promoter. (C-F) Microarray mRNA expression analysis of Sox6 
and Sox4 in ATDC5 cells stably expressing shControl or shEgr1 throughout chondrogenesis. 
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Figure S6. Loss of Egr1 affects differentiation induced hyperproliferation 
Morphology analysis of ATDC5 stably expressing shControl or shEgr1 during the first 6 days of chondrogenesis. 
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Figure S7. Loss of Egr1 induces numerous genes implicated in cellular senescence, DNA damage and stress signaling. 
Microarray mRNA expression analysis of genes involved in cellular senescence, DNA damage and stress signalling in 
ATDC5 cells stably expressing shControl or shEgr1 throughout chondrogenesis. 
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Figure S8. Egr1 directly binds PcG promoters and regulates PcG expression. 
(A,B) Relative mRNA expression of Bmi1 and Ezh2 in ATDC5 stably expressing shControl and shEgr1 up to 4 days pid. 
(C) using GENOMATIX promoter analysis software, Bmi1 and Ezh2 promoters were analyzed for Egr1 binding sites. 
Arrows indicate primers designed for qRT rtPCR to quantify immunoprecipitated chromatin. (D-G) Chromatin 
immunoprecipitation using anti-Egr1, anti-H3K27me3 and anti-H3K4me3 antibodies. Precipitated DNA was analyzed by 
gRT rtPCR for enrichment on the indicated promoter. 
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Figure S9. Egr1 promoter binding is not sufficient for transcriptional activation. 
(A) Microarray mRNA expression analysis of all Hox clusters in ATDC5 cells stably expressing shControl or shEgr1 
throughout chondrogenesis. (B) The number of predicted Egr1 binding sites (GENOMATIX) in the promoters of 
the respective Hox genes. 
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Supplemental Table 1:
Primers used for qRT rtPCR
Ezh2 Forward GAAAAAAGATGAGACGTCCAGCTC
Reverse GAGGTTCAATATTTGGCTTCATCTTTAT
Aggrecan Forward CATGAGAGAGGCGAATGGAA
Reverse TGATCTCGTAGCGATCTTTCTTCT
Sox9 Forward AGTACCCGCACCTGCACAAC
Reverse TACTTGTAGTCCGGGTGGTCTTTC
Bmi1 Forward TGGAGAAGAATGGCCCACT
Reverse GCAAGTTGGCCGAACTCTGT
Collagen 2a1Forward CAAGAACCCTGCTCGCACTT
Reverse CCGCTCTTCCACTCGGG
Egr1 Forward AGCCGAGCGAACAACCCTAT
Reverse TGTCAGAAAAGGACTCTGTGGTCA
Primers used for Chromatin Immunoprecipitation
Sox9-1 Forward GTTCCAAAACTGTGACATTCCG
Reverse TCCGCGTGTGTAAGTTTGCTCTCT
Sox9-2 Forward TCTCCTGGACCCCTTCATGA
Reverse GCCAGACAGGCCCTTCT
Sox6 Forward AAGCCAATTGTCCTTTGCAGTT 
Reverse ATCTTTGAAACAGAGAAATTGACAGTG 
Hoxa1 Forward TCACTGAGTGATTGGATCCTGC
Reverse GGAGGAAGTGAGAAAGTTGGCAC
Hoxa2 Forward GACAAGGTTGAAATTGGACCG
Reverse CAAATTGTCATTGGGCAGAAGC
Hoxa4 Forward CTCTGGAATAAAACGAAGGAGGC
Reverse GGACAAAGAATCAAAGGGCGAG
Hoxa6 Forward CTTTCCTTTTTTGCCTTCATGG
Reverse TTGTCAGGTTTCCTGTTTGGG
Hoxa7 Forward AACCCTTCCCCTAAACGCCTC
Reverse AAAAGGTCGCCAGTCTTCCAG
Hoxa9 Forward ATCTGTATGCCTAGTCCCGCTCC
Reverse TTGATGTTGACTGGCGATTTTC
Hoxa11 Forward GGAAGCAACAGATCGTCACTCG
Reverse TGAGTTACACCGGCGATTACG
Ezh2 Forward GAGGCGCTTGATAGTGCTGG
Reverse ACCCAATCGCCATCGCT
Bmi1 Forward CATTTTGGAGCCGGTGTCA       
Reverse AAAAAATGCACGGCTGAAGG         
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Abstract 
Segmentation phenotypes in Polycomb loss-of-function mutants correlate with defective 
maintenance of HOX gene expression boundaries along the antero-posterior axis, yet little is 
known about the possible direct involvement of Polycomb Repressive Complex 1 proteins (PRC1) 
in enchondral ossification. We here investigate chondrogenesis in relation to loss of Polycomb 
function. We provide evidence that normal chondrogenic hypertrophy in vitro and in vivo shares 
characteristics with replicative senescence. We find that acute shRNA-mediated reduction of 
PRC1-function compromises transit amplification during differentiation: rapid accumulation of 
massive DNA damage and activation of an intra-S-phase checkpoint result in a senescence-
associated secretory phenotype and a senescence-like replicative arrest. Using global nuclear 
analysis of active transcription and replication, we show that coordinated regulation of active 
transcription and replication is lost in Bmi1-deficient cells and that DNA damage occurs at sites of 
DNA synthesis. Hence, acute loss of PRC1-function during early replication in chondrogenesis 
renders cells unable to deal with increased chromatin stress. This is the first report revealing an 
important function for PRC1 in orchestrating simultaneous chromatin-associated processes, i.e. 
DNA replication and transcription damage repair, in differentiating transit amplifying cells.  
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. 
Polycomb Group proteins act in transcriptionally repressive complexes (Polycomb Repressive 
Complexes; PRC), which vary in protein composition between cell types 1. These multi-component 
PRCs maintain gene expression profiles in the context of differentiation and development. PRC-
mediated silencing is controlled at the chromatin level by epigenomic indexing: PRC complexes 
install and bind post-translational modifications on N-terminal histone tails, often in conjunction with 
associated epigenetic activity 2,3. Well-known PRC-associated epigenetic marks are H3K27me3 
and H2AK119ub1, both are required for PRC-mediated transcriptional repression 2-5. As such PRC 
are believed to constitute a molecular epigenetic memory and fulfill an important task in 
maintaining cell identity.  
Analogous to PRC mutations in Drosophila Melanogaster, which cause abnormal segment identity 
development along the antero-posterior (AP) axis, the effect of PRC1 loss-of-function (LOF) on 
murine skeletal development correlates with defective maintenance of expression boundaries in 
HOX gene clusters 6-9. The exact role of PRC1 in bone and cartilage formation however, is not 
clear. Moreover, the relatively mild skeletal phenotypes of numerous single PRC1-null mutants as 
opposed to compound PRC1 mutants 9-13, suggest that redundant mechanisms may mask acute 
effects of loss-of-PRC1 function during skeletogenesis. The mature ossified mammalian skeleton 
develops from a cartilaginous scaffold (endochondral bone formation); we therefore studied 
chondrogenesis in vitro in the context of PRC1 loss-of-function (LOF). The murine ATDC5 
embryonal mesenchymal stem cell line reiterates the multi-step chondrogenic differentiation 
program observed during endochondral bone formation and is an excellent, widely used in vitro 
model system to study chondrogenesis 10: a growth factor-induced differentiation program is 
initiated which is readily monitored by chondrogenic marker gene expression (e.g. SOX9, RUNX2, 
Collagen type II and X (COL2A1, COL10A1), Aggrecan (ACAN); 11. We focused on PRC1 complex 
genes with known null-mutant skeletal phenotypes 7,12-14. Several PRC1 complex genes are highly 
expressed, among which BMI1 (PCGF4), PHC1 and 2 (EDR1/MPH1/RAE28 and EDR2/MPH2) 
and RNF2 (RING1B), and regulated throughout chondrogenesis (figure S1A): Bmi1 protein 
expression is elevated at 6 days (figure 1A, B) post induction of differentiation (pid), pointing to an 
increased reliance on Bmi1 function. Retroviral short hairpin RNAs (shRNA) were designed to 
target both human and mouse (shBMIhm) or exclusively human (shBMIh) BMI1 mRNA for RNAi-
mediated degradation ((figure 1B,C; S1B). RNAi-mediated Bmi1 knock-down (KD) delays 
chondrogenesis as evidenced by reduced ACAN and COL2A1 expression (figure 1D); conversely 
shBMIh has no effect on differentiation, in line with its selective targeting of human BMI1 mRNA 
(figure S1C). In keeping with published gene dosage effects on skeletal phenotypes in PRC1 
genetically modified mice 6,8,12,13, re-expression of mBMI1 cDNA in ATDC5-shBMIhm cells restores 
Bmi1 expression and induces the exact opposite effect of shBMIhm on chondrogenic marker gene 
expression (figure 1E, 1SD), Thus this data demonstrates the significance of the ATDC5 model for 
probing PRC1-function, and is consistent with a specific function for PRC1 in chondrogenesis. 
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Figure 1. Bmi1 expression is required for chondrogenic differentiation.  
(A) qRT rtPCR analysis of Bmi1 expression during ATDC5 chondrogenesis. (B) Western blot analysis of Bmi1 protein 
expression in ATDC5 cells stably expressing shControl or shBmi1 (control versus differentiation medium) at t=0 and 6 
days. (C)  Immunofluorescence analysis of Bmi1 expression in ATDC5 shControl and shBmi1 and DAPI nuclear staining. 
(D) qRT rtPCR analysis of chondrogenic markers in ATDC5 shControl and shBmi1 up to 15 days pid. (E) qRT rtPCR 
analysis of ACAN in Bmi1 overexpressing ATDC5 and control cells up to 15 days pid. 
 
 
Numerous published data support a role for PRC1 proteins, including Bmi1, in cell cycle regulation 
under normal and oncogenic conditions 17-20. The exact mechanism(s) by which PRC control cell 
cycle in different settings, however, are insufficiently clear. Differentiating ATDC5 monolayer 
cultures typically become multi-layered and develop distinctive three-dimensional nodules that 
produce cartilage matrix proteins 10. In line with a reduced chondrogenic potential, nodule-
formation is delayed and reduced in numbers in Bmi1-KD cultures (see below: figure 4C). As multi-
layering and nodule formation are, at least in part, dependent on sustained proliferation, we 
examined cell proliferation in relation to PRC1-LOF. Under non-differentiating conditions, Bmi1-KD 
marginally affects cell proliferation (figure 2A,B). Upon induction of differentiation, proliferation rate 
in control cultures increases substantially from 1 day pid (fig 2A) and is sustained until 5-6 days 
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pid; this early, rapid, transient increase in cell division, is observed in various cell systems and 
resembles transit amplification (TA) of progenitor cells 15,16. Relevantly, transient rapid progenitor 
proliferation is part of normal endochondral ossification in vivo, and is apparent in the proliferative 
zone of growing long bones (fig S2A). Remarkably, Bmi1-KD cells fail to undergo transit 
amplification pid: cell proliferation does not exceed that of cells (Bmi1-KD or control) under 
continuous culture conditions (figure 2B). Of note: the proliferative burst of differentiating ATDC5 
cells corresponds in time with elevated Bmi1 expression (figure 1A,B), suggesting transit 
amplification is either controlled by or controlling Bmi1 levels. Transit amplification responds 
positively to Bmi1 dosage: overexpression of Bmi1 increases proliferation slightly yet significantly 
(figure S2A). Under non-differentiating conditions, DNA profiling and BrdU incorporation assays 
reveal neither significant differences in cell cycle phase distribution nor in BrdU incorporation 
(figure 2C, S2B) between Bmi1-KD and control cells. In sharp contrast, differentiating Bmi1-KD 
cells show a substantially increased S-phase population at 6 days pid (figure S2B). Similarly Phc2-
KD reduces cell proliferation pid and increases S-phase accumulation, pointing to a general 
involvement of PRC1 in transit amplification (figure S2C). Transient BrdU exposure at 6 days pid 
reveals active incorporation of BrdU by rapidly dividing control cells and confirmed a block in de 
novo DNA synthesis in Bmi1-KD cultures (figure 2C). Consistent with this, differentiating ATDC5 
Bmi1-KD cultures display significantly less G2/M related H3S10 phosphorylation (figure 2D). 
Importantly, normal healthy human cartilage-derived chondrogenic precursors respond similarly to 
BMI1-LOF: proliferative and chondrogenic capacity are severely reduced (figure 2E). Combined, 
the above data support the notion that cells lacking PRC1 cannot replicate their DNA as efficiently 
as control cells during the hyperproliferative phase.  An intra-S-phase arrest is indicative of stalled 
replication forks; these are known to coincide with double strand DNA breaks (DSB) and locally 
induce Ser139 phosphorylation on histone H2AX (H2A.X). Under normal (non-differentiation) 
culturing conditions, ATDC5 cultures (independent of genotype) typically include some cells 
carrying H2A.X foci, presumably due to local replication-associated DSB (figure S3A,B). Normally 
such DNA damage is rapidly repaired to ensure cell cycle completion 17. At 6 days pid, however, 
H2A.X detection in Bmi1-KD cultures is dramatically increased compared to control cells (figure 
3A). Differences in DSB are first detectable at 1-2 days pid (figure 3B); at 10 days pid DNA 
damage is substantially reduced (figure 3C); control cultures do not accumulate as much damage, 
yet show detectable H2A.X throughout the proliferative phase (figure 3C). Differentiating Bmi1-
deficient primary human h929 cells also show elevated H2A.X (figure 3D). High-density culturing 
of chondrogenic models triggers differentiation even in the absence of ITS. Consistent with 
differentiation-induced DSB, high-density Bmi1-KD cultures show S-phase accumulation and 
increased DNA damage as opposed to control cultures (Figure S3C). Whereas Phc2-LOF has 
comparable effects on progenitor expansion under these conditions (figure S3D), interestingly, the 
effect of PRC1-LOF on chondrogenic potential differs between PRC1 members (figure S3E). 
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Figure 2. Loss of Bmi1 elicits replication stress induced S-phase arrest.  
(A) ATDC5 cells hyperproliferate upon induction of chondrogenic differentiation, as compared to continuous culture 
conditions (cc). Proliferation determined by Crystal violet incorporation with subsequent extraction and 
spectrophotometric analysis. (B) ATDC5 cells stably expressing shBmi1 fail to undergo differentiation induced 
hyperproliferation, measured by Crystal violet incorporation. (C) ATDC5 cells stably expressing shEgr1 or shControl were 
differentiated for 6 days, then BrdU was administered to the cells for 45 minutes. BrdU was visualized with anti-BrdU 
antibodies and subsequently analyzed by flowcytometry. DNA content is determined by propidium iodide staining. (D) 
ATDC5 shBmi1 or shControl were differentiated for 3 days, then BrdU was administered to the cells for 45 minutes. BrdU 
was visualized by immunofluorescence with anti-BrdU antibodies. (E) Human primary chondrogenic precursors stably 
expressing shBmi1 or shControl were differentiated for 2 days, then BrdU was administered to the cells for 45 minutes. 
BrdU was visualized by immunofluorescence with anti-BrdU antibodies. 
 
This phenotypic variation may reflect divergent effects of PRC1-LOF on skeletal morphogenesis in 
full genetic knock-outs in vivo 6,14. In line with a proliferative block, detection of nuclear H2A.X and 
H3S10ph inversely correlate between control and KD cells at 3 days pid (figure S4A). Expression 
array analysis at 6 days pid confirms massive upregulation of DNA damage repair pathways in 
Bmi1-KD cultures (Table S1); consistent with activation of a DNA damage response (DDR) Bmi1-
KD nuclei show ATM-induced Kap1S824 and Chk2-phosphorylation besides enhanced Rad51 and 
RPA70 chromatin-association (Figure S4B-D; and data not shown).  
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Figure 3. Replicating shBmi1 expression ATDC5 cells accumulate DNA damage during differentiation
induced transit amplification.
(A) Immunofluorescence analysis of DNA damage in ATDC5 shControl and shBmi1 visualized with anti-
?H2A.X antibodies at 6 days pid. DAPI used as nuclear staining. (B) Immunofluorescence analysis of DNA
damage and replication in ATDC5 shControl and shBmi1 visualized with anti-?H2A.X and anti-BrdU
antibodies, respectively, at 1 day pid. DAPI used as nuclear staining. (C) Western blot analysis of ?H2A.X in
ATDC5 shControl and shBmi1 throughout differentiation. B-actin and Gapdh as loading controls. (D)
Immunofluorescence analysis of DNA damage in human primary chondrogenic progenitors expressing
shControl and shBmi1 visualized with anti-?H2A.X antibodies at 2 days pid. DAPI used as nuclear staining.
Loss of PRC1-function causes premature replicative senescence in mouse embryo-fibroblasts
cultures and other cell types 18-20. Analogously, Bmi1-deficiency induces a cell senescence-like
morphology as does LOF of other PRC1-proteins (figure 4A). The presence of gH2A.X in enlarged
cells at 6 days pid suggests that these cells probably accrued DSB and activated a DDR and an
associated senescence-like response (SLR) overtime (figure 3A), in agreement with the causal
relationship between DNA damage and senescence 21,22. In line with this notion, also sporadic
large flat cells in non-differentiating cultures carry DNA damage and are polyploid irrespective of
genotype; large flat Bmi1-KD cells again show substantially more DSB (figure S5A). The relative
resistance of ATDC5 under normal growth conditions to Bmi1-LOF was unexpected given its
otherwise significant anti-proliferative effect in cell cultures 26,27,23. This prompted us to investigate
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senescence-related signaling in the context of differentiation. Of note: important checkpoints (i.a. 
contact inhibition, IR induced arrest/senescence; data not shown) are intact in non-differentiating 
ATDC5. Senescent fibroblasts typically express senescence-associated ß-Galactosidase 
(SAbGal/Glb1) 20. Surprisingly, GLB1 mRNA is induced approximately 2 fold and SAbGal is 
activated during chondrogenesis in vitro (figure 4C, S5B). Importantly, we observe SAbGal-
activation in all primary human and rabbit chondrogenic cultures examined (figure S5C). Rapidly 
expanding murine ATDC5 and primary human h929 cells display focal H3K9me3, a feature 
reminiscent of senescence associated heterochromatin foci (SAHF; 29) and Bmi1-LOF further 
augments H3K9me3 levels (figure 4B,D, S5C). Besides a global increase of H3K9me3, H3K27me3 
increases during hyperproliferative stress in Bmi1-KD cultures (figure 4C,E). Ezh2 protein is slightly 
more expressed in Bmi1-KD cells at 6 days pid and may contribute to enhanced H3K27me3 levels 
(figure S5E). However, the H3K27me3 demethylase Jmjd3, which is normally induced 4.2 fold 
during hyperproliferation, fails to do so in Bmi1-KD 6 days pid (figure S5F). Lack of JMJD3 was 
recently associated with replicative senescence 24; hence it is likely that absence of Jmjd3 is 
responsible for the senescence-associated increase in H3K27me3. In good agreement with 
activation of SLR, numerous additional markers associated with cell cycle exit and/or a 
senescence-associated secretory phenotype (SASP;25) are subject to dynamic regulation in the 
context of normal differentiation and show an exaggerated response (i.a. IL6, CCL5, CXCL10) in 
Bmi1-LOF cultures during hyperproliferation (figure S5G). Bmi1-LOF does not appear to change 
the onset of SAbGal activation (figure 4C). Remarkably, although overexpression of oncogenic 
RasV12 in chondrogenic control cultures enhances onset and intensity of SAbGal activation and, it 
does not induce replicative arrest and leaves chondrogenic potential fully intact (figure 4C, S5H).  
We next explored involvement of known senescence-related checkpoints. PRC1-dependent 
transcriptional regulation of the CDKN2A/Ink4A locus 26 links Bmi1 directly to cell cycle regulation, 
stem cell self-renewal and oncogenesis 27-33. We could not detect significant differences in 
expression of CDKN2A/INK4A, TRP53 and P21CIP1/WAF1 between control and Bmi1-KD cells during 
chondrogenesis (figure S5C). In addition, preliminary analyses indicate that inactivation of 
INK4A/ARF or TRP53 does not bypass cell cycle arrest in ATDC5 Bmi1-KD pid cells, but in stead 
reveals a dependency of chondrogenesis on these cell cycle regulators (FS, JWV unpublished 
observations). These findings are in agreement with published reports showing that the intra-S-
checkpoint, although pRb and/or Trp53-dependent, is not induced by p16INK4A or P21CIP1/WAF 3834. In 
support of this, a differentiation and S-phase arrest by CHAF1A/CAF1b-LOF in zebrafish was not 
rescued by Trp53-LOF 35.  Our observation in ATDC5 contrasts with a recently uncovered lineage-
specific role of p21CIP1/WAF1 in NSC self-renewal 36, and suggests lineage specific PRC-independent 
checkpoint mechanisms are operative during self-renewal and/or transit amplification in 
chondrogenic. Taken together, above observations suggest that the chondrogenic lineage is 
inherently refractory to signaling known to induce irreversible replicative arrest in other systems. 
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Figure 4. PRC1-LOF results in replicative senescence; terminal chondrogenic differentiation resembles senescence.  
(A) Morphological analysis ATDC5 shControl, shBmi1, shRnf2 at t=2d pid. (B) Western blot analysis of senescence 
associated histone modifications in ATDC5 shControl and shBmi1 throughout chondrogenesis. (C) Senescence-
associated bGalactosidase staining on ATDC5 expressing shControl, shBmi1, vector or Rasv12 cultures under control 
conditions or differentiation conditions (ITS) for the indicated time points. (D,E) Immunofluorescence analysis of 
senescence associated histone modifications in ATDC5 shControl and shBmi1 at indicated time points. DAPI used as 
nuclear staining. (F) Senescence-associated bGalactosidase staining only or in combination with alizarin red on ribcages 
of WT mice. Brackets highlight the hypertrophic zone. 
 
Chondrogenic differentiation during endochondral ossification terminates in hypertrophy and 
subsequent tissue replacement (mineralization/ossification) by invading osteoclasts and 
osteoblasts 11. Importantly, RUNX2, an oncogene known to activate SLR, is implicated in 
hypertrophic differentiation 37,11. Based on our findings thusfar, we hypothesized that endochondral 
differentiation may naturally terminate in a senescence-like phenotype, and thus SAbGal-positive 
cells should be detectable adjacent to growth plates in elongating bones of newborn mice. In line 
with activation of SAbGal during chondrogenic hyperproliferation in vitro, histological analysis of 
pp1 (day 1 post-partum) skeletal elements revealed prominent SAbGAl activity precisely at the 
prehypertrophic zone in long bones and intercalated disks (figure 4F, S6A,B). SAbGal positive 
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zones are positioned proximal to mineralization zones in rib bones (figure 4F). We reasoned that 
PRC1-LOF may result in increased hypertrophy during endochondral ossification which should be 
reflected in the width of the HZ. In good agreement with this, RING1A-KO pp1 mice, which display 
a comparatively prominent PRC1-LOF related skeletal phenotype 14, revealed an increased HZ 
(Figure S6C). Thus, our collective findings corroborate a hitherto unrecognized role for PRC1 in 
chondrogenic transit proliferative amplification.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Fold change increases during transit amplification. 
(A) Pie charts of all reporters fulfilling p < 0.05, FC > 1.1 up or down, expression > 2log(100) in either group for time 
points 0, 1 day and 6 days pid respectively (for all time points c.f. Figure S7A). For each time point two percentages are 
indicated: the first indicates the amount of reporters fulfilling all criteria as compared to the number of reporters above 
expression limit; the second indicates the amount of reporters fulfilling all criteria as compared to the total number of 
reporters. (B) Boxplots of WT vs. Bmi1-KD logratios for all reporters (regardless of expression level, fold change or 
significance) for each time point in the experiment. (C) Scatterplot for each timepoint versus each other timepoint of the 
2log expression values in WT (left) and Bmi1-KD (right) cells, based on the reporters fulfilling p < 0.05, absolute FC > 2, 
expression > 2log(100) in either group, at 1 or 6 days pid. 
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We next investigated the origin of DNA damage. As differentiation requires coordinated regulation 
of several DNA-templated processes, among which transcription and replication, we analyzed the 
effect of Bmi1-LOF on global transcriptional responses in the context of differentiation. Contrary to 
expectation, loss of repressive function produced comparable percentages up or down regulated 
genes (figure 5A, S7A). Transcriptional re-profiling (i.e. number of genes involved and fold 
changes) intensifies when transit amplification is initiated both in control and Bmi1-LOF cultures; 
however, differences in log expression prior to and following transit amplification are substantially 
smaller in control cultures that in Bmi1-LOF cultures, indicating much tighter controlled 
transcriptome reprogramming in the presence of Bmi1 (figure 5C). Differences in gene expression 
between control and Bmi-LOF cultures become more prominent between 1 and 6 days pid: 
expression of over one third of genes is more than 1.2 fold enhanced (figure 5B, S7B). 
Transcriptomic deregulation revealed distinctive clustering (figure 5C, S7C). Profile analysis of the 
most extreme deregulated genes (i.e.  2 fold changed) reveals a number of different profile 
clusters: genes that are consistently a) higher or b) lower expressed in Bmi1-KD versus control 
throughout differentiation, c) genes of which transcription is low and not regulated during 
chondrogenesis in control cells, but that dramatically respond to PRC1-LOF at the time when 
control cells enter the hyperproliferative state, and vice versa d) genes that are expressed and 
induced at hyperproliferation in control but fail to do so in Bmi1 KD cells (figure S7D). Numerous of 
the abnormally highly induced genes in KD cultures, map to differentiation programs and pathways 
irrelevant to chondrogenesis (figure S7E). A number of genes in category c is related to SLR/SASP 
(figure S7F; see also figure S5C). In addition, induction of some genes appears inconsistent with 
chondrogenic differentiation. Per example, SCrystalline (CryGS), a major functional component of 
the lens, is normally exclusively expressed by cell of ectodermal origin (ATDC5 cells are 
mesodermal derivatives). In line with an aberrant induction of CryGS during chondrogenesis, the 
crystalline gene cluster was recently identified as PcG target in cells of mesenchymal origin 38. The 
diversity of aberrant response profiles combined with the observation that many genes are down-
regulated upon PRC1-LOF suggests that besides a function in (direct) target gene repression, 
PRC1 fulfills additional tasks that impinge on transcription. We therefore focused on the potential 
role of transcription and replication in the origin of DDR and consequential S-phase arrest. 
Typically, BrdU-positive cells co-stain for the DNA polymerase processivity factor PCNA 
(Proliferating Cell Nuclear Antigen) in control cultures (figure S8B); PCNA-dim cells are either in 
G1 or G2. Consistent with an intra-S-phase arrest, we find a large percentage of cells PCNA 
positive, yet BrdU negative (figure S8B). Importantly, all BrdU-positive cells are also positive for 
H2A.X in Bmi1-KD cultures (figure 6A); cells that exclusively show H2A.X signals arrested prior 
to BrdU incubation and, moreover, DNA damage in Bmi1-KD cells perfectly co-localizes with BrdU 
signals (figure 6A). This strongly supports the idea that damage occurs at sites of active de novo 
DNA synthesis and that lack of PRC1 is causally related to replication induced DNA damage. The 
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more intense staining for Rpa70 (figure S4A), a protein which prevents single stranded DNA from 
back-folding during DNA-replication, is in good agreement with replication-induced damage. 
Indeed, Bmi1-KD cultures are significantly more sensitive to the replication poisons etoposide than 
control cells under normal culturing conditions (figure S8A) (camptothecin similar results; data not 
shown).  
To study transcriptional status, cells were stained for active Ser5-phosphorylated RNA polymerase 
2 (pRpol2). Control cells reveal a cell cycle dependent non-uniform nuclear distribution of active 
pRpol2: pRpol2-bright cells are generally PCNA-dim (G1/early S), whereas late in S-phase 
pRpol2–negative nuclei are strongly positive for PCNA; likewise, these cells are DAPI-bright (figure 
S8C); pRpol2-dim nuclear regions in control cells show BrdU incorporation (figure 6B). This 
nuclear partitioning of DNA-templated activities indicates coordinated regulation of replication and 
transcription under normal chondrogenic conditions and is in good agreement with earlier reports 
on dynamic segregation of mRNA and DNA synthesis throughout S-phase 39. Remarkably, the 
non-uniform distribution of pRpol2 is lost in PCNA-bright PRC1 LOF cells, and, moreover, Bmi1-KD 
nuclei arrested in S-phase show uniform nuclear staining for both pRpol2 and BrdU (figure 6B; 
S8C), suggesting that concerted regulation of replication and transcription is lost in the absence of 
intact PRC1 (figure 6B). In addition, damaged Bmi1-KD cells have reduced pRpol2 levels, 
suggesting reduced transcription as a functional consequence of global DNA damage (figure 6C). 
DNA damage as a result of failure to tune replication to transcription, and vice versa, is expected to 
not be restricted to abnormally derepressed transcriptional activity, but instead occurs throughout 
the genome. The finding that many genes show consistent deregulated transcription, regardless of 
chondrogenic induction (figure 5C) most likely directly relates to defective 
transcriptional/replicational coordination and enhanced chromatin stress in PRC1-KD cultures.  
Bmi1 and Rnf2, were recently identified as a ubiquitin E3 ligase for Geminin (Gmnn/Gem), a factor 
important for termination of replication at late S-phase 40,41. PRC1-LOF stabilizes Gmnn and 
interferes with haematopoietic stem cell (HSC) self renewal 41. In good agreement with this, we find 
that Bmi1-KD cells stain positive for Gmnn (Figure 7A), whereas proliferating control cells generally 
do not. In line with the observed DDR and SLR, all Gmnn positive Bmi1-KD cells co-stain for 
yH2A.X, and the Cdt1/Gmnn ratio <1 is indicative for re-replication and polyploidy in Bmi1-KD cells 
(figure 7B). The enhanced Gmnn chromatin-association shows an inverse correlation with global 
loss of Bmi1 (figure 1C). We recently observed a positive correlation between PRC-
phosphorylation, PRC1/chromatin dissociation and Gmnn stabilization (VvL JWV unpublished 
observations). In the context of stress signaling, redistribution of Phc1 (Rae28), through which 
Gmnn is associated with PRC1, may provide a docking point for Gmnn stabilization; stress 
signaling induces chromatin dissociation of other PRC1 members (Bmi1, Ring and CBX proteins; 
JBC & YT, JWV; unpublished data). 
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Figure 6. ATDC5 shBmi1 accumulate DNA damage at sites of deregulated transcription and replication.  
(A,B,C) Immunofluorescence analysis of replication (BrdU), active transcription (pRNA polymerase II) and DNA damage 
(γH2A.X) in ATDC5 stably expressing shControl or shBmi1 at 3 days pid. 
 
Combining these observations, we propose a molecular switching mechanism that controls local 
transcription versus replication: local presence of Rnf2/Bmi1 represses transcription 
(H2AK119ub1), targets GMNN for proteolysis, relieving a potential replication block. Conversely, 
loss of BMI1/RNF2 stabilizes GMNN and blocks replication and is permissive for transcription 
(figure 7C).  
The most direct interpretation of our data is that PRC1 generates a chromatin state which tunes 
transcription to DNA replication and prevents DNA-damage during a differentiation-coupled 
proliferative burst. Polycomb proteins are found at promoters also when genes are not silenced 42.  
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Figure 7. Accumulation of DNA damage correlates with stabilization of the replication inhibitor geminin.  
(A) Immunofluorescence analysis of Bmi1, Phc1 and Geminin in ATDC5 shControl and shBmi1. (B) Immunofluorescence 
analysis of γH2A.X and Geminin in ATDC5 shControl and shBmi1. Cdt1/Geminin ratio <1 is indicative for re-replication 
and polyploidy. 
(C) Proposed model: PRC1 regulates a switching mechanism that controls local transcription versus replication: local 
presence of Rnf2/Bmi1 represses transcription (H2AK199ub1), targets geminin for degradation, relieving a potential 
replication block. Conversely, loss of Rnf2/Bmi1 stabilizes geminin and blocks replication and is permissive for 
transcription. 
 
A substantial amount of H3K27me3 marked genes is expressed in ES cells; in addition, numerous 
gene promoters are bivalently marked (i.e. with both activation-associated H3K4me3 and 
repression-associated H3K27me3; 43). Many of these promoters map to important developmental 
control genes, and bivalency often resolves into monovalency, dictated by their involved in specific 
lineage commitment programs. Gene expression and replication timing are strongly correlated: 
actively transcribed genes often replicate early. Both replication timing and transcription change 
substantially in the context of differentiation in mid S-phase, when replication origins are spatially 
redefined and replication timing and transcription are re-tuned 44. Although a single study into 
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effects of PRC2-LOF on replication timing within the context of neurogenic differentiation revealed 
no obvious differences, a potential role for PRC1 in replication timing requires analysis in the 
context mesenchymal lineage commitment 45. In addition to a direct involvement in transcriptional 
repression, it is conceivable that H3K27me3 and H3K4me3 (respectively PcG and trxG-associated 
epigenetic marks) functionally partition the genome and help coordinate DNA-templated processes 
like transcription and replication in the context of development. Indeed, PRC proteins interact with 
basal factors of the transcription machinery as well as replication factors (reviewed in Chapter 2). A 
link between PRC-function and DNA replication has been suggested before: Polycomb LOF in 
D.melanogaster, results in replication defect 46. Hyperproliferation-associated replication damage 
and senescence are important features of oncogene induced senescence (OIS) and suggest a 
functional analogy. Chondrocytes appear to have a remarkable ability to hyper-replicate under 
conditions unfavorable for cell division (e.g. cartilage is extremely hypoxic). In addition, 
(pre)hypertrophic chondrocytes excrete vast amounts of ECM proteins that build and support the 
cartilaginous matrix. These conditions are known to induce endoplasmic reticulum (ER) stress 
signaling (ERSS) and the unfolded protein response (UPR); both ER stress and UPR are known 
inducers of OIS in the context of tumorigenesis 47. ERSS/UPR and hypertrophic zone expansion 
are also at the basis for chondrodysplasia in mice and men 47,48. The proposed biological analogy 
between hypertrophy and SLR is also consistent with a shared role for RUNX proteins in OIS and 
chondrocyte hypertophy 11,37. These combined observations suggest that chondrogenic cells 
tolerate replication stress better than other cells. In agreement, we find that oncogenic RasV12 
does not induce a replication arrest; in stead chondrogenic differentiation seems more robust. 
Indeed robust MAPK signaling is important in chondrogenesis 49. PRC-LOF induces an 
exaggerated SASP/SMS response and blocks proliferation as a result of massive replication 
damage. Conversely, Bmi1 and RasV12 cooperate in oncogenesis 50. Hence, transit amplification 
during chondrogenesis shares important characteristics of cellular responses to oncogenic 
activation and emphasizes a pivotal role for PRC1. 
The findings reported here may point to a novel aspect of Polycomb biology during skeletogenesis: 
it is conceivable that proliferation and hence tissue expansion, co-determines positioning along the 
A-P axis and that premature termination of differentiation contributes to the PcG-phenotypes 
observed in null-mutants. Presence of SAbGAL in intervertebral disk cartilage possibly implicates a 
proliferative component in axial positioning. It is possible that abnormal HOX gene expression 
patterns contribute to the PRC1-phenotypes observed in null-mutants, both through direct effects 
on proliferation and differentiation. Indeed, recognition of a potential role for proliferation in axial 
patterning is long standing 51. Combined our data suggest that PRC1 plays an important role in 
DNA damage avoidance in transit amplifying progenitor cells and that differentiation and 
senescence programs may be linked through DNA-damage responses. This then raises the 
interesting possibility that replication-mediated DNA-damage may also contribute to stem cell self-
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renewal defects, a possibility which appears to hold true for mesenchymal osteogenic progenitors 
in Bmi1-null mice 52. 
The findings presented herein consolidate a function for PRC1 at the cross road of transcription 
and replication. Our observations findings provide important connecting points for further research 
and have important implications for our mechanistic understanding of PRC1 proteins in 
embryogenesis and oncogenesis. 
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Supplemental Materials and methods 
 
Cell culture 
ATDC5 cells were cultured at 37 °C, 5% CO2, 100% humidity in DMEM/ F-12 supplemented with 
5% fetal calf serum (FCS), antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin), 200 mM 
L-glutamine on tissue culture plates (Greiner Bio-One). For differentiation experiments cells were 
seeded at 6400 cells/cm2 and were allowed to attach overnight. Growth medium was changed for 
differentiation medium, which includes ITS (10 μg/ml insulin, 10 μg/ml transferrin and 3 x10-8M 
sodium selenite). Differentiation medium was replaced every two days. 
 
Retroviral infections 
Ecotropic retroviral supernatants were produced by transfection of phoenix cells with calcium-
phosphate precipitation; 24-48 hours post-transfection, the supernatant was harvested, filtered and 
used for infection of ATDC5 cells in presence of 4µg/ml polybrene. Cells were incubated for 12 
hours and then allowed to recover for 24 hours on fresh medium before selection pressure was 
applied. Infected cells were selected with puromycin (8 µg/ml) for 72 hours, before experiments 
were initiated. Short-hairpin (sh)RNA target sequence for shBMI1hm 5’- 
GTTCACAAGACCAGACCAC -3’, shBMI1h  5’- GAATGGTCCACTTCCATTG-3’, shRNF2  5’- 
GTATCTGGCTGTGAGGTTA-3’, shPHC2 5’- GTTCAAGCGTTCCAAGCGC-3’. Short hairpin 
sequence targeting shGFP was used as reference sh sequence 57. 
 
Chrystal violet  
ATDC5 cells were plated in 12-multiwell plates (Greiner Bio-one). At each time point cells were 
washed twice with phosphate-buffered saline, and fixed for 10 minutes with 3.7% formaldehyde at 
room temperature. Next, cells were rinsed 5 times with demiwater. Cells were stained with 0.1% X-
tal violet for 30 minutes or overnight, respectively, and washed 5 times with demiwater. X-tal was 
extracted with 10% acetic acid and absorbance was measured spectrophotometrically at 590 nm 
(Benchmark, Biorad).  
 
RNA isolation and cDNA synthesis 
Cells were suspended in Tri-reagent, and RNA was extracted according to the protocol of the 
manufacturer (Sigma). Quantity and purity of the RNA were determined by 260/280 nm 
absorbance measurements. cDNA was synthesized using iScriptTM cDNA synthesis kit (Biorad). 
Primers used are described in supplemental figure 2. 
 
Western analysis 
Cells were lysed in RIPA buffer containing 5 mM Benzamidine, 5 μg/ml Antipain, 5 μg/ml 
Leupeptin, 5 μg/ml Aprotinin, 1 mM Sodium Vanadate, 10 mM Sodium Fluoride, 10 mM 
Pyrophosphate, 10 mM β-glycerophosphate, 0.5 mM DTT and 1mM PMSF. Lysates were 
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subjected to 3 freeze-thaw cycles in liquid nitrogen, and to 3 cycles of sonication. After 
centrifugation for 10 minutes at 13.2k rpm, protein concentration was determined using a BCA 
protein assay kit (Pierce). Equal amounts of protein were boiled in Laemmli buffer and loaded on 9-
15% polyacrylamide gels. Proteins were transferred to polyvinylidene fluoride (PVDF) membranes. 
After blocking with 5% non-fat dry milk in PBS containing 0.1% Tween-20, membranes were 
incubated o/n at 4ºC with the following antibodies:  anti β-actin Mab (C4, 691001, MP 
Biomedicals), anti Gapdh, anti Ezh2 Mab (BD43; coutesy D. Pasin Copenhagen, Denmark), anti 
Bmi1 Mab (F6; Courtesy M. van Lohuizen; Amsterdam, The Netherlands), anti H2A.X (Ser139) 
Poab #2577 (Cell signaling), anti H3K27me3 Poab, #07-449 (Upstate) and anti H3K9me3 #07-442 
(Upstate). After extensive washing, membranes were incubated with corresponding horseradish 
peroxidase conjugated secondary antibodies for 1h at room temperature. Signals were detected 
using enhanced chemoluminescence. 
 
Immunofluorescence 
Briefly, cells were washed and fixed for 10-15 minutes in 100% methanol at -20°C and stored at 
4°C in 70% ethanol or used directly for immuno-histochemistry. Cells were permeabilized for 5-10 
minutes in 0.2& triton-X in PBS. To prevent epitope loss in combination with acid treatment for 
BrdU detection, primary antisera were incubated for 1.5 hours at 37°C, 4-5x washed in 0.02% 
triton-X/PBS and fixed in 2% formaldehyde/PBS for 10 minutes at room temperature. Cells were 
washed with PBS and incubated for 20 minutes in 2.0N HCl at 37°C, followed by two rinses of 0.1 
M sodium tetraborate solution, pH 8.5 for in total 2 minutes. Cells were than incubated with the 
primary antisera against BrdU, washed at indicated before and incubated with secondary 
fluorescently labeled antibodies. All Antisera were diluted and incubated in 0.02% triton-X in PBS. 
Nuclei were counterstained with 4'-6-Diamidino-2-phenylindole (DAPI) and washed in 0.02% triton-
X/PBS. The last wash step was in PBS, upon which cells were dehydrated: 1 minute in 70% 
ethanol, 2x 1 minute in 100% ethanol and air-dried. Cells were mounted in Vectashield (Vector 
Laboratories, Inc. Burlingame, CA) and analyzed using a NIKON TE200 Eclipse fluorescence 
microscope and photographed using a NIKON DXM1200 digital camare in combination with NIS 
Elements 3.0 Imaging software. The following antibodied were used: anti γH2A.X Mab JBW301 
(Upstate), anti BrdU (BD biosciences), anti H3K9me3 #07-442 (Upstate), anti H3K27me3 Poab, 
#07-449 (Upstate), anti Bmi1 Mab (F6; Courtesy M. van Lohuizen; Amsterdam, The Netherlands), 
anti H3S10Ph Poab #06-570 (Upstate), anti Pcna PC10 Poab (Chemicon International), anti Phc1 
(03041; Courtesy of H. Koseki), anti pRNA polymerase II Mab, ab24759 (Abcam), anti Rad51 Poab 
sc-8349 (Santa Cruz), anti pKap1 (S824) Poab      A300-767A (Bethyl Laboratories), anti RPA70 
Poab ab12320 (Abcam)an ant Geminin Poab (FL-209) sc-13015 (Santa Cruz).  
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Affymetrix espression arrays 
A total of 48 Affymetrix NuGO mouse arrays (~24k) were run on RNA from cell cultures sampled 
over time at 0, 2, 4, 8 hours and 1, 6, 10, 15 days post induction of differentiation (pid). For each 
time point 3 samples were taken from both a wildtype (WT) and a Bmi1 knock-down (KD) culture. 
After scanning, data preprocessing and analysis were done using R2.7.1 with the use of 
Bioconductor libraries 53,54. First, data were 2log transformed and normalized using gcRMA 55. 
Hereafter several statistics were computed for each reporter on the arrays: the average (2logged) 
expression for each group at each time point, the logratio (2log fold change, logFC) between the 
two groups at each time point, and the t- and p- value of a Student t-test at each time point. After 
computing statistics, subsets of reporters fulfilling specific criteria based on these statistics were 
selected for the several analyses, where generally cut-offs on p-value, logratio, and minimum 
expression were imposed and controls removed from the data set. Unless otherwise specified, the 
cut-off limits had to be met at either 1day pid or 6 days pid. Specific cut-off limits chosen are 
indicated where applicable in the paper. Overrepresentation of biological processes was 
determined using PathVisio, using the pathways available from WikiPathways 56,57. 
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Figure S1. Expression analysis of PRC1 complex genes.  
(A) mRNA expression of PRC1 complex genes during chondrogenesis by microarray analysis. (B) Western blots 
confirming functionality of short hairpins designed to target PcG mRNAs for RNAi mediated degradation (C) 
quantification of Bmi1 protein levels shown in figure 1b. (D) qRT rtPCR analysis of collagen 10A1 mRNA expression 
during differentiation in ATDC5 cells overexpressing Bmi1 and control cells. 
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Figure S2. PRC1-LOF cells accumulate in S-phase during transit amplification.  
(A) ATDC5 cells overexpressing Bmi1 show enhanced hyperproliferation upon induction of chondrogenic differentiation 
compared to control cells. Proliferation determined by Crystal violet incorporation with subsequent extraction and 
spectrophotometric analysis. (B) Representative cell cycle profiles of ATDC5 shControl and shBmi1 at t=0 and t=6d pid. 
Values are percentage of S-phase cells compared to total cell population, in addition quantification S-phase positive cells 
of total experiment. (C) Proliferation of ATDC5 cells expressing shControl, shBmi1 and shPhc2 upon induction of 
chondrogenic differentiation. Proliferation determined by Crystal violet incorporation with subsequent extraction and 
spectrophotometric analysis. (D) overview of growthplate. RZ= Resting Zone, PZ= Proliferation Zone, pre-HZ= pre-
Hypertrophic Zone, HZ= Hypertrophic Zone, the transition from cartilage to bone is located between HZ and 
mineralization. 
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Figure S3. Accumulation of DNA damage in shBmi1 cultures.  
(A, B, C) Immunofluorescence staining for γH2A.X in ATDC5 shControl and shBmi1 cultures at varying densities. DAPI 
used as nuclear staining. (D) Quantification of S-phase positive cells in ATDC5 shControl, shBmi1 and shPhc2 cultures 0 
and 6 days pid. (E) ACAN mRNA expression measured by qRT rtPCR in ATDC5 shControl, shBmi1 and shPhc2 
throughout differentiation. 
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Figure S4. Bmi1-LOF results in activation of DNA damage responses and correlates to proliferative arrest. (A-D) 
Immunofluorescence analysis for indicated proteins in ATDC5 shControl and shBmi1 at t=3 pid. DAPI is used as nuclear 
staining. 
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Table S1. Activation of DNA damage response in Bmi1-LOF cultures. 
Expression array analysis of DNA damage response genes presented as log fold change. Associated processes based 
on Genmapp.   
 
 
 
 
 
 
 
 
 
 
 
 
 
fold description Processesinvolved in
4,9 interferon activated gene 204 tracri /// tracri /// tracriPol II/// transport /// // DDR /// Diff
4,1 RIKEN cDNA E130016E03 gene Dre/// DDR
3,5 BRCA1 interacting protein C-terminal helicase 1 Nucmet/// Dre/// tracriPol II/// DDR
2,5 Fanconi anemia, complementation group B Dre/// DDR
2,4 RAD9 homolog (S. pombe) CC /// CC checkpoint /// DDC /// Dre/// DDR/// RadR/// apop
2,3 pituitary tumor-transforming 1 Dmet/// Dre/// DDR/// CC /// Cseg/// mit /// Cseg/// biog
2,2 RAD51 homolog homR/// Dmet/// REP/// Dre/// DDR /// mei /// meiR
2,2 heat shock protein 1B TELm/// Dre/// fold /// anti-apop /// UPR/// hs /// 
2,1 X-ray repair complementing defective repair Dmet/// Dre/// Drec/// DDR
2,1 RAD51 associated protein 1 homR/// Dre/// Drec/// DDR
2,0 damage specific DNA binding protein 2 Dre/// pyrimidine dimer repair /// DDR
1,9 exonuclease 1 Nucmet/// Dre/// NER/// MMR/// Drec/// DDR/// mei
1,9 Bloom syndrome homolog (human) REP/// Dre/// Drec/// 
1,8 essential meiotic endonuclease 1 homolog 1 Dre/// Drec/// DDR
1,8 chromatin assembly factor 1, subunit A (p150) REP/// Dre/// tracri /// tracri /// fold /// DDR/// CC
1,8 serum/glucocorticoid regulated kinase kin/// apop /// DDR
1,8 heat shock protein 1A TELm/// Dre/// fold /// UPR/// hs
1,8 breast cancer 2 homR/// Dre/// chrom/// DDR /// S-CC /// mitC/// tracri
1,8 breast cancer 2 homR/// Dre/// chrom/// DDR /// S-CC /// mitC/// tracri
1,8 RAD51-like 1 Dmet/// Dre/// Drec/// DDR
1,7 div cycle 2 homolog A kin/// anti-apop /// CC /// mit /// G2-C/// div
1,7 three prime repair exonuclease 1 REP/// Dre/// MMR/// Drec/// DDR
1,7 flap structure specific endonuclease 1 REP/// DNA repair
1,6 mutS homolog 3 Dmet/// Dre/// MMR/// DDR/// somH/// somR
1,6 general tracri factor II H, polypeptide 1 Dre/// tracri /// tracri /// DDR
1,6 claspin homolog DRC/// Dre/// DDR/// CC
1,5 RAD50 homolog Dmet/// Dre/// DDR/// CC /// mei
1,5 mitogen activated protein kinase 1 kin/// DDR /// CC /// ST/// morf/// kin /// kin /// cytosine met/// diff
1,4 topoisomerase I binding, arginine/serine-rich Ubc/// apop /// DDR /// met/// prol/// tracri /// trapo
1,4 ligase I, DNA, ATP-dependent REP/// Dre/// Drec/// DDR/// CC /// div
1,4 growth arrest and DNA-damage-inducible 45 alpha regulation of progression through CC /// Pase/// DDR /// CC /// CC arrest 
1,4 replication factor C (activator 1) 5 REP/// DNA repair
1,4 eukaryotic tral elongation factor 1 epsilon 1 CC /// Dre/// tral /// arr/// embr/// apop /// DDR
1,4 general tracri factor II H, polypeptide 2 Dre/// tracri /// tracri /// DDR/// tracri
1,3 XPA binding protein 2 blast /// Dre/// TCR/// tracri /// Rproc
1,3 UV radiation resistance associated gene Dre
1,3 Fanconi anemia, complementation group A Dre/// DDR/// male mei /// Mgon/// Fgon/// prol
1,3 brain and reproductive organ-expressed protein Ubc/// apop /// DDR /// anti-apop
1,3 polymerase (DNA directed), delta 1, catalytic subunit S-CC /// Dre/// REP/// BER/// REP
1,3 topoisomerase (DNA) II beta binding protein Dre/// DDR/// meiR
1,3 mutS homolog 5 Dmet/// MMR/// mei /// mei I /// syn /// Fgam
1,3 high mobility group box 2 REP/// REP/// Dre/// BER/// chrom/// nucl/// tracri /// tracriPol II
1,3 poly (ADP-ribose) polymerase family, member 2 Dre/// BER/// ribos
1,2 structural maintenace of chromosomes 3 Dmet/// Dre/// DDR/// CC /// spin/// Cseg/// SCC/// mit /// mei /// ST/// biog/// div
Geneacronym
Ifi204 
E130016E03Rik 
Brip1 
Fancb
Rad9 
Pttg1 
Rad51 
Hspa1b 
Xrcc2 
Rad51ap1 
Ddb2 
Exo1 
Blm
Eme1 
Chaf1a 
Sgk
Hspa1a 
Brca2 
Brca2 
Rad51l1 
Cdc2a 
Trex1 
Fen1 
Msh3 
Gtf2h1 
Clspn
Rad50 
Mapk1 
Topors
Lig1 
Gadd45a 
Rfc5 
Eef1e1 
Gtf2h2 
Xab2 
Uvrag
Fanca
Bre
Pold1 
Topbp1 
Msh5 
Hmgb2 
Parp2 
Smc3 
Smc5 1,2 structural maintenance of chromosomes 5 Dmet/// Dre/// Drec/// DDR
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Figure S5. DNA damage and senescence in chondrogenesis.  
(A+C) Immunofluorescence analysis in ATDC5 shControl and shBmi1 of γH2A.X and H3K9me3 at t=3d pid. DAPI is use 
as nuclear staining. (B,F) Expression array analysis of GLB1 and JMJD3 in ATDC5 shControl and shBmi1 during 
differentiation. (D) Senescence-associated bGalactosidase staining on chondrogenic cell lines. (E) Western blot analysis 
of H3K27me3 and Ezh2 in ATDC5 shControl and shBmi1 during differentiation. bActin is used as a loading control. (G) 
Expression array analysis of senescence associated genes in ATDC5 shControl and shBmi1 during differentiation. (H) 
qRT rtPCR analysis of mRNA expression of chondrogenic markers in ATDC5 expressing shControl, shBmi1, vector or 
Rasv12 throughout differentiation. 
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Figure S6. Growth plates of longitudinal bones are positive for SAbgal.
(A,B) Representative senescence-associated bGalactosidase staining on longitudinal bones and ribcage/spinal column
of wild-type mice. (C) Representative pictures of femur growth plates of Ring1a+/+ and Ring1a -/- mice. Brackets indicate
hypertrophic zone.
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Figure S7. Fold change increases during transit amplification 
(A) Pie charts of all reporters fulfilling p < 0.05, FC > 1.1 up or down, expression > 2log(100) in either group, for each time 
point in the experiment. (B) The table indicates for each time point: athe number of reporters reaching the expression limit 
of 2log(100) in either group; bthe number fulfilling significance (p < 0.05), FC > 1.1 (respectively 1.2) up or down, and 
expression above limit; cthe percentage of the latter versus the total number of expressed reporters. The figure is a 
graphical representation of the values in columns c.(C) Heatmap of the logratios of all reporters fulfilling p < 0.05, FC > 2 
(left) or FC < 0.5 (right), expression > 2log(100) in either group, at 1 or 6 days pid. Euclidean distance and complete 
linkage hierarchical clustering were used to cluster and reorder the reporters. (D) Profile analysis of the most extremely 
de-regulated genes identified in expression arrays (up or down). (E) Biological pathways that are overrepresented based 
on Pathvisio analysis using as criteria: p < 0.05 WT vs. Bmi1-KD, FC > 1.2 up or down WT vs. Bmi1-KD, and average 
group expression 2log(100) in either group, at 1 or 6 days pid, as compared to all reporters on the array for which the 
Affymetrix ID (or Unigene ID) could be mapped to a pathway (F) Biological pathways that are overrepresented based on 
Pathvisio analysis using as criteria: p < 0.05 WT vs. Bmi1-KD, FC > 1.2 up or down WT vs. Bmi1-KD, and average group 
expression 2log(100) in either group, at 1 or 6 days pid, as compared to all reporters on the array for which the Affymetrix 
ID (or Unigene ID) could be mapped to a pathway. 
 
 
 
 
pathways (r) (n) total % Z Score
Irinotecan Pathway 4 10 13 40,00% 10,28
Mm Selenium metabolism/Selenoproteins 5 43 49 11,63% 5,67
Endochondral Ossification 5 56 68 8,93% 4,77
Oxidative Stress 2 23 29 8,70% 2,94
Osteoblast 1 7 11 14,29% 2,86
GPCRs, Class B Secretin-like 1 10 13 10,00% 2,28
Osteoclast 1 13 18 7,69% 1,9
TGF-beta Receptor Signaling Pathway 4 115 149 3,48% 1,89
pathways (down) (r) (n) total % Z Score
Irinotecan Pathway 4 10 13 40 10,28
Selenium metabolism/Selenoproteins 5 43 49 11,6 5,67
Endochondral Ossification 5 56 68 8,9 4,77
Oxidative Stress 2 23 29 8,7 2,94
Osteoblast 1 7 11 14,3 2,86
GPCRs, Class B Secretin-like 1 10 13 10 2,28
pathways (r) (n) total % Z Score
Irinotecan Pathway 5 10 13 50 7,59
Endochondral Ossification 9 56 68 16,1 4,79
Oxidative Stress 5 23 29 21,7 4,47
Cytokines and Inflammatory Response 4 21 25 19,1 3,63
TGF Beta Signaling Pathway 6 41 52 14,6 3,61
Selenium metabolism/Selenoproteins 6 43 49 14 3,46
Osteoblast 2 7 11 28,6 3,4
Prostaglandin synthesis and regulation 4 24 31 16,7 3,27
Adipogenesis 10 108 132 9,3 2,97
Osteoclast 2 13 18 15,4 2,16
Complement activation, classical pathway 2 14 16 14,3 2,03
pathways (up) (r) (n) total % Z Score
Adipogenesis 10 108 132 9,3 4,48
Prostaglandin Synthesis and Regulation 4 24 31 16,7 4,38
TGF Beta Signaling Pathway 5 41 52 12,2 3,92
Cytokines and Inflammatory Response 3 21 25 14,3 3,4
Oxidative Stress 3 23 29 13 3,19
F
PRC1 Coordinates Replication and Transcription in Chondrogenic Progenitors 
 111
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S8. PRC1-LOF cultures are more sensitive to replication stress 
(A) ATDC5 cells stably expressing shControl, shBmi1, shPhc2, shRnf2, vector or overexpress mBmi1 are exposed to 0 
or 50 μg/ml etoposide for 1 hour, washed and allowed to recover for 9 days. Proliferation determined by Crystal violet 
incorporation with subsequent extraction and spectrophotometric analysis. (B,C) Co-staining for Pcna and BrdU or Pcna 
and pRNA polymerase II in ATDC5 shControl or shBmi1 at 2 days pid. 
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Supplemental Table 2
Primers use for qRT rtPCR
Cyclophillin Forward CAAATGCTGGACCAAACACAA
Reverse TTCACCTTCCCAAAGACCACAT
Bmi1 Forward TGGAGAAGAATGGCCCACT
Reverse GCAAGTTGGCCGAACTCTGT
Collagen 2a1 Forward CAAGAACCCTGCTCGCACTT
Reverse CCGCTCTTCCACTCGGG
Aggrecan Forward CATGAGAGAGGCGAATGGAA
Reverse TGATCTCGTAGCGATCTTTCTTCT
Collagen 10a1 Forward CATGCCTGATGGCTTCATAAA
Reverse AAGCAGACACGGGCATACCT
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Abstract 
Valproic acid (VPA) is a drug used to treat epilepsy, schizophrenia and other neurological 
conditions. VPA administration during pregnancy can have severe adverse effects on the unborn 
child, including neural tube defects and skeletal malformations. During development stem cells 
undergo lineage commitment and ultimately adopt terminally differentiated states. Epigenetic 
regulation, i.e. chromatin remodeling, controls gene-environment interactions during development. 
Although recently VPA was identified as an epigenetic drug, the mechanism(s) of action for VPA 
remain unclear. VPA has been studied in the context of chondrogenesis, yet published studies 
report conflicting results. In this study we use the widely used ATDC5 model to study gene-
environment interactions in the context of chondrogenesis and to elucidate effects of VPA 
treatment on chondrogenic differentiation. We find that VPA treatment severely affects 
chondrogenesis: ATDC5 fail to induce the transcriptional reprogramming required for 
chondrogenesis. Further, VPA affects differentiation induced hyperproliferation in a TP53 
dependent manner. Relevantly, VPA treatment in ATDC5 cells causes replication stress, DNA 
damage response and results in a senescence-like response. We show that epigenomic 
remodeling is essential for proper induction of differentiation programs. Our findings support the 
notion that VPA treatment can be useful to sensitize rapidly proliferating cells to replication stress, 
providing therapeutic applications for cancer treatment. 
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Introduction 
Valproic acid (VPA) is a pharmacological compound widely used to effectively treat convulsive 
disorders, migraine, bipolar disorders and schizophrenia. VPA use during pregnancy, however, 
causes severe developmental abnormalities, both in humans and various laboratory animals: 
teratogenic effects in mice include neural tube defects, as anencephaly and spina bifida, and 
skeletal malformations, predominantly along the anteroposterior (AP) axis 1-6. The outcome of VPA 
treatment is cell type dependent: rat embryonic neural progenitor cultures (cerebral cortex or 
hippocampus), show enhanced neurogenesis, and reduced proliferation, accompanied by 
increased promoter acetylation and expression of neural transcription factors 7,8. VPA enhances 
hepatic and osteogenic differentiation in bone marrow derived and adipose tissue derived stromal 
stem cell cultures, respectively 9,10. Conversely, in various cancer cell types VPA is toxic and leads 
to senescence and cell death by apoptosis or other mechanisms 11-14. VPA toxicity in embryonic 
stem cells is manifested in reduced cell viability and a potent inhibition of mesodermal and 
endodermal development 15. Also, at non-cytotoxic concentrations VPA causes abnormal cartilage 
matrix gene expression in the lumbar spine in chick embryos 1. Although the molecular bases for 
its effects are poorly understood, experimental studies demonstrated that VPA treatment affects 
multiple regulatory pathways: Akt activation and consequent glycogen synthase kinase 3β 
inhibition have been reported 16, besides stimulatory effect on the GABA and NMDA 
neurotransmitter receptors 17.  
Recently, VPA was shown to directly inhibit histone deacetylases (HDACs) 18. HDACs play an 
important role in DNA templated processes, such as transcription and replication, through 
epigenetic remodeling of chromatin. Epigenetic regulation of chromatin structure is widely studied 
in the context of cancer and development. In pluripotent embryonic stem cells (ESCs) key 
developmental regulator genes, including Hox genes, display large stretches of repression–
associated H3K27me3 and activating H3K4me3 at their promoters. This seemingly conflicting 
combination of modifications was termed ‘bivalency’ 19. Differentiation of ESCs is accompanied by 
remodeling of the epigenome, to facilitate activation of appropriate lineage specific gene 
expression, and epigenetic silencing of non-lineage specific genes 19. Not surprisingly, many 
mutant epigenetic regulator genes display developmental defects. Polycomb group (PcG) and 
Trithorax group (trxG) mutant mice, associated with H3K27me3 and H3K4me3 marks, 
respectively, are responsible for malformations along the antero-posterior (AP) axis. Skeletal 
phenotypes correlate with deregulation of expression boundaries within HOX gene clusters, well-
known PcG and trxG target genes 20-22. Combined, this demonstrates how proper epigenetic 
regulation is pivotal to proper cellular differentiation.  
Surprisingly little is known about the molecular mechanisms by which VPA affects endochondral 
ossification (formation of an ossified skeleton from a cartilage scaffold). VPA treatment in utero 
was reported to affect expression of Hox genes and PcG genes in whole mouse embryos 3,4,23. The 
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mature ossified skeleton of mammals arises from a cartilage scaffold. However, direct effects of 
VPA on chondrogenesis remain poorly understood. The present study therefore aimed to further 
elucidate effects of VPA in development, with a focus on epigenetic deregulation during 
chondrogenesis. ATDC5 cells are a widely used model to study chondrogenesis. A remarkable 
feature of ATDC5 cell differentiation is an early, transient hyperproliferative burst upon induction of 
differentiation. This phase reflects the transit amplification that mesenchymal progenitor cells 
undergo during development. We assessed the effects of VPA on ATDC5 chondrogenic 
differentiation and proliferation. Briefly, we find that VPA specifically impedes proliferation of transit 
amplifying cells in a Trp53(P53)-dependent manner. In addition, VPA completely abolishes 
chondrogenic marker gene expression, demonstrating a direct and dramatic effect on 
chondrogenesis. We here discuss these effects in the context of altered epigenetic control. 
 
Materials & Methods 
 
Cell culture and VPA treatment 
ATDC5 cells were cultured at 37 °C, 5% CO2, 100% humidity in DMEM/ F-12 supplemented with 
5% fetal calf serum (FCS), antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin), 200 mM 
L-glutamine on tissue culture plates (Greiner Bio-One). For differentiation experiments cells were 
seeded at 6400 cells/cm2 and were allowed to attach overnight. Growth medium was changed for 
differentiation medium, which includes ITS (10 μg/ml insulin, 10 μg/ml transferrin and 3 x10-8M 
sodium selenite). Differentiation medium was replaced every two days. VPA (Sigma, P4543) was 
prepared freshly and supplemented to differentiation medium to pharmacologically relevant end 
concentrations of 0.3, 1 and 3 mM (FDA). 
 
Retroviral infections 
Ecotropic retroviral supernatants were produced by transfection of phoenix cells with calcium-
phosphate precipitation; 24-48 hours post-transfection, the supernatant was harvested, filtered and 
used for infection of ATDC5 cells in presence of 4µg/ml polybrene. Cells were incubated for 12 
hours and then allowed to recover for 24 hours on fresh medium before selection pressure was 
applied. Infected cells were selected with puromycin (8 µg/ml) for 72 hours, before experiments 
were initiated. Short-hairpin (sh)RNA vector used for RNA interference-mediated knock-down of 
murine Trp53 was described elsewhere 24. Short hairpin sequence targeting shGFP was used as 
reference sh sequence 25. 
 
Chrystal violet and Alcian blue stainings 
ATDC5 cells were plated in 12-multiwell plates (Greiner Bio-one). At each time point cells were 
washed twice with phosphate-buffered saline, and fixed for 10 minutes with 3.7% formaldehyde at 
room temperature. Next, cells were rinsed 5 times with demiwater. Cells were stained with 0.1% X-
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tal violet or 0.1% Alcian blue for 30 minutes or overnight, respectively, and washed 5 times with 
demiwater. X-tal was extracted with 10% acetic acid and Alcian blue with guanidine/HCL (6M) and 
absorbance was measured spectrophotometrically at 590 nm or 645 nm, respectively (Benchmark, 
Biorad).  
 
Senescence-associated β-galactosidase (SA-bGal) assay 
Staining was performed according to protocol described by Dimri et al. [26]. Shortly, cells were 
washed in PBS, fixed for 3-5 min (room temperature) in 2% Formaldehyde /0.2% 
glutaraldehyde, washed, and incubated at 37°C (ambient C02) with fresh senescence 
associated (3-Gal (SA-,3-Gal) stain solution: 1 mg of 5-bromo-4-chloro-3-indolyl P3-D-
galactoside (X-Gal) per ml (stock = 20mg of dimethylformamide per ml)/40 mM citric 
acid/sodium phosphate, pH 6.0/5 mM potassium ferrocyanide/5 mM potassium 
ferricyanide/150 mM NaCl/2 mM MgCl2. SA-bGal activity was measured after 12-16 hours. 
Staining at pH 4.0 was used as negative control; this detects lysosomal galactosidase activity. 
 
RNA isolation and cDNA synthesis 
Cells were suspended in Tri-reagent, and RNA was extracted according to the protocol of the 
manufacturer (Sigma). Quantity and purity of the RNA were determined by 260/280 nm 
absorbance measurements. cDNA was synthesized using iScriptTM cDNA synthesis kit (Biorad). 
Primers used are listed in supplemental Table 1.  
 
Western analysis 
Cells were lysed in RIPA buffer containing 5 mM Benzamidine, 5 μg/ml Antipain, 5 μg/ml 
Leupeptin, 5 μg/ml Aprotinin, 1 mM Sodium Vanadate, 10 mM Sodium Fluoride, 10 mM 
Pyrophosphate, 10 mM β-glycerophosphate, 0.5 mM DTT and 1mM PMSF. Lysates were 
subjected to 3 freeze-thaw cycles in liquid nitrogen, and to 3 cycles of sonication. After 
centrifugation for 10 minutes at 13.2 krpm, protein concentration was determined using a BCA 
protein assay kit (Pierce). Equal amounts of protein were boiled in Laemmli buffer and loaded on 
9-15% polyacrylamide gels. Proteins were transferred to polyvinylidene fluoride (PVDF) 
membranes. After blocking with 5% non-fat dry milk in PBS containing 0.1% Tween-20, 
membranes were incubated o/n at 4ºC with the following antibodies:  anti β-actin Mab (C4, 
691001, MP Biomedicals), anti Ezh2 Mab (BD43; coutesy D. Pasin Copenhagen, Denmark), anti 
Bmi1 Mab (F6; Courtesy M. van Lohuizen; Amsterdam, The Netherlands), anti H3K9Ac Poab (#06-
599, Upstate Biotechnology) and anti H4K12Ac Poab (ab1761, Abcam). After extensive washing, 
membranes were incubated with corresponding horseradish peroxidase conjugated secondary 
antibodies for 1h at room temperature. Signals were detected using enhanced 
chemoluminescence.  
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Immunofluorescence 
Briefly, cells were washed and fixed for 10-15 minutes in 100% methanol at -20°C and stored at 
4°C in 70% ethanol or used directly for immuno-histochemistry. Cells were permeabilized for 5-10 
minutes in 0.2& triton-X in PBS. Primary antisera were incubated for 1.5 hours at 37°C, 4-5x 
washed in 0.02% triton-X/PBS and fixed in 2% formaldehyde/PBS for 10 minutes at room 
temperature. Cells were washed with PBS and were than incubated with the primary antisera for 
1.5 hours at 37°C, 4-5x washed in 0.02% triton-X/PBS, and incubated with secondary fluorescently 
labeled antibodies. All antisera were diluted and incubated in 0.02% triton-X in PBS. Nuclei were 
counterstained with 4'-6-Diamidino-2-phenylindole (DAPI) and washed in 0.02% triton-X 
/PBS. The last wash step was in PBS, upon which cells were dehydrated: 1 minute in 70% ethanol, 
2x 1 minute in 100% ethanol and air-dried. Cells were mounted in Vectashield (Vector 
Laboratories, Inc. Burlingame, CA) and analyzed using a NIKON TE200 Eclipse fluorescence 
microscope and photographed using a NIKON DXM1200 digital camare in combination with NIS 
Elements 3.0 Imaging software. The following antibodied were used: anti γH2A.X Mab JBW301 
(Upstate), anti p-Kap1S824 Poab (A300-767A, Bethyl laboratories) and anti H3K9me3 #07-442 
(Upstate). 
 
Cell cycle profiles 
Cells were fixed in cold methanol overnight at -20ºC, washed and resuspended in PBS containing 
100 μg/ml RNAse and 20 μg/ml PI for 2-3 hours at RT in dark environment, immediately prior to 
FACS analysis. Analysis was performed using a Becton Dickinson FACS machine with CellQuest 
software. 
 
 
Results 
 
VPA inhibits chondrogenic differentiation  
To examine how VPA affects chondrogenesis ATDC5 cells were differentiated in the presence of 
neuropharmacologically relevant concentrations of VPA (range: 0.3, 1, 3.0 mM; therapeutic plasma 
concentrations: 0.3mM – 1mM (FDA)). Starting cultures with low cell density were exposed to a 
combination of chondrogenic factors (Insulin, Transferrin, Selenite; ITS) and followed for 2 to 3 
weeks. Chondrogenic differentiation was assessed by multiple parameters: chondrogenic marker 
gene expression, progenitor cell proliferation and alterations in morphological appearance. Under 
the experimental conditions applied in this study, VPA robustly inhibits differentiation even at the 
lowest concentration, as measured by realtime rtPCR of chondrogenic markers aggrecan (AGC), 
collagen type II (COL2A1) and collagen type X (COL10A1) after 10 and 15 days of differentiation 
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(Figure 1A-C). Alcian blue staining for cartilage glycosaminoglycans confirmed the differential 
effects of VPA on low and high density ATDC5 differentiation (see below; Figure 3B).  
Differentiating ATDC5 monolayers undergo a phase of hyperproliferation, and form three-
dimensional cartilage nodules [27]. VPA inhibits hyperproliferation during ATDC5 chondrogenesis 
in a dose dependent manner (Figure 1D) Consistent with altered cell  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. VPA blocks ATDC5 differentiation and proliferation. (A, B, C) qRT rtPCR analysis of chondrogenic markers of 
VPA treated ATDC5 cells. (D) VPA inhibits proliferation during ATDC5 differentiation. (E) Cell cycle profiles of VPA 
treated ATDC5 cells at 2 and 6 days of differentiation. (F) Quantification of figure 1E. 
 
 
cycle kinetics, DNA profiling showed an accumulation of tetraploid cells upon treatment with VPA: 
at 3.0 mM VPA ATDC5 show an approximately 10-15% increase in the G2/M peak (Figure 1E,F), 
mainly at the expense of diploid cells. In parallel with a dramatic decline in cell proliferation, 
Combined these results demonstrate that VPA blocks chondrogenic transcriptional reprogramming 
as well as differentiation induced hyperproliferation. 
 
 
VPA induces senescence in differentiating chondrocytes. 
VPA treatment was previously shown to induce cellular senescence 13, a cellular phenotype which 
is associated with irreversible replicative arrest 28. Senescent cultures often display a large-flat cell 
morphology accompanied by senescence related marker gene expression profiles. To determine 
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the adverse effect of VPA on cell cycling, we studied cell morphology. Both ATDC5 and primary 
human chondrocytes display the typical ‘large flat cell’ morphology upon exposure to VPA (Figure 
2A). Indeed, in good agreement with these morphological changes, staining for senescence-
associated-β-galactosidase (SA-βGal/Glb1) activity, a marker closely associated with replicative 
senescence, confirms a dose-dependent induction of senescence by VPA (see below; Figure 3C)). 
Expression profiling of senescence-associated marker genes further corroborated the senescence 
phenotype: GLB1 expression is upregulated in response to VPA throughout differentiation 
compared to control cells (Figure 2B). Chop (Ddit3/Gadd153), a protein involved in the unfolded 
protein response (UPR) and DNA damage responses, both of which are associated with 
senescence [29-33], is dramatically upregulated upon treatment with VPA (Figure 2C). Recently, 
elevated interleukin 6 (IL6) expression was established as a robust marker for senescence-
associated secretory phenotype (SASP; 34,35). In keeping with this, we find that expression of IL6 
was dose-dependently increased in differentiating ATDC5 cells upon treatment with VPA (Figure 
2D). Finally, also the cell cycle inhibitor p19arf was dose-dependently upregulated in VPA 
stimulated ATDC5 cells (Figure 2E), whereas p16ink4a, expressed from the same locus and 
associated with senescence, did not respond to VPA treatment (FS, JWV; unpublished data). 
Immunofluorescent analysis of VPA exposed cultures reveals phosphorylated histone H2A.X 
(γH2A.X) and phosphorylated Kap1, both markers of early DNA damage responses (Figure 2F,G). 
Taken together, our findings convincingly show that VPA induces morphological changes, 
transcriptional reprogramming and DNA damage signaling associated with a senescence-like 
response during chondrogenesis. 
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Figure 2. VPA induces senescence in differentiating chondrocytes.  
(A) VPA induces a proliferative block and large flat cell phenotype. (B-E) qRT rtPCR analysis of genes associated with 
senescence in VPA treated chondrocytes. (F,G) Chondrocytes treated with VPA (3mM) accumulate DNA damage, 
measure by γH2Ax (F) and p-Kap1 (G). 
 
VPA induced inhibition proliferation, but not differentiation, is dependent on TP53 
We next investigated the pathways involved in VPA-induced senescence. In the context of 
oncogene-induced senescence, activation of a DNA damage responses (DDR) is sufficient to 
induce senescence, however, inactivation of the DDR, e.g. by ablation of Trp53 or ATM, bypasses 
proliferative arrest 32,33. The cell cycle regulators Trp53 and p19ARF are both causally involved in 
replicative senescence; P19ARF blocks MDM2-induced proteolytic degradation of Trp53 36,37. To 
determine whether the effects of VPA on chondrogenic differentiation are dependent on Trp53, we 
stably expressed a short hairpin (sh)RNA which targets Trp53 mRNA for degradation 24,38. 
Remarkably, ablation of Trp53 reproducibly enhances proliferation in control cultures (Figure 3A – 
top panel; FS, JWV unpublished data) and induction of chondrogenesis allows for higher 
production of glycosaminoglycans in absensce of P53 (Figure 3B). Loss of Trp53 function (LOF) 
rescues proliferation in differentiating ATDC5 cells at low VPA concentration range to a 
proliferative rate observed in normal chondrocytes (0.3 and 1.0 mM VPA; Figure 3A). VPA was 
reported to induce abnormal nuclear morphology in cancer cells 39. We find that VPA also 
dramatically changes nuclear morphology in chondrogenic cultures at high concentration: nuclei 
acquire extremely irregular multi-lobed shapes irrespective of Trp53 (Figure 3C; lower panels). We 
recently discovered that SAbGal is induced as part of normal chondrogenesis (FS, JWV in 
preparation); as such the effect of VPA on SAbGal induction can only be studied under conditions 
in which VPA induces an acute proliferative arrest (preceding hyperproliferation). 3 mM VPA 
activates the typical bGal staining observed in senescent cells 26. Remarkably, when stained for 
SAbGal, we find that Trp53-LOF prevents SAbGal activation at the higher VPA concentrations (1.0 
and 3.0 mM; Figure 3D), suggesting that transcriptional activation of or signaling to SAbGal is 
dependent on Trp53. 
Surprisingly, Trp53-LOF does not rescue the defective differentiation of VPA treated ATDC5 cells, 
as measured by Alcian Blue staining for cartilage matrix glycosaminoglycans (Figure 3B) and 
quantitative RT/rtPCR of chondrogenic markers (Figure 3E): expression of key chondrogenic 
regulator genes SOX9 and RUNX2 is differentiatally affected by Trp53 or p19ARF-LOF: RUNX2 
mRNA is clearly suppressed at 7-10 days pid, whereas SOX9 expression appears largely 
unaffected. Conversely, although Trp53 or p19ARF-LOF leads to an exaggerated SOX9 and RUNX2 
induction at 10 days pid (Figure 3E), which correlates with the increased alcian blue staining at this 
timepont (Figure 3B). Overall, however, Trp53 or p19ARF-LOF do not rescue terminal chondrogenic 
capacity as judged by ACAN, COL2A and COL10A1 expression and glycosaminoglycan staining 
(Figure 3F,B). We conclude from this combined data that Trp53-dependent proliferative control is 
an important component of chondrogenic differentiation, but that chondrogenic transcriptome 
reprofiling is not controlled by Trp53.  
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VPA affects epigenetic modifiers and histone modifications
To study possible effects of VPA on epigenetic regulation during chondrogenesis we examined
expression on epigenetic regulators belonging to the Polycomb Group proteins in VPA exposed
cultures. A recent study implicated reduced Polycomb Group gene expression in abnormal
skeletogenesis of VPA-exposed fetuses in utero 23. We therefore investigated the effect of VPA on
expression of a number of relevant Polycomb genes. Polycomb repressive protein complexes
(PRCs) harbor enzymes with intrinsic epigenetic activities, among which histone H3 lysine 27
methyl transferase activity
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Figure 3.  VPA induced inhibition proliferation, but not differentiation, is dependent on TP53. 
(A) Expression of shTP53 rescues part of VPA induced proliferation block. (B) Quantification of alcian blue staining from 
ATDC5 cells stably expressing shControl and shTP53, in VPA treated (3mM) and non-treated differentiating 
chondrocytes. (C) Nuclear morphology (DAPI staining) of ATDC5 cells stably expressing shControl and shTP53 treated 
with VPA (0, 0.3, 1 and 3mM) at day 6 of differentiation. (D) SAbGAL staining on shControl and shTP53 expressing 
ATDC5 cells treated with VPA (0, 0.3, 1 and 3mM) at day 6 of differentiation. (E,F) qRT rtPCR analysis of chondrogenic 
markers of VPA treated (0, 0.3 and 1mM) ATDC5 cells expressing shControl, shTP53 or shP19ARF. 
 
(EZH2), histone H2A lysine 119 ubiquityl E3 ligase activity (RNF2, BMI1, RING1). Expression 
analysis of these factors revealed apparent regulation of PRC gene expression through out 
chondrogenesis (Figure 4A, white bars), however, transcriptional deregulation in the context of 
VPA exposure failed to show significant reproducible changes in expression or consensus trends 
among PRC genes (Figure 4A, shaded bars). Of PRC genes examined, VPA only reduces BMI1 
expression at 6 days pid, both at the mRNA and protein level (Figure 4A,B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. VPA affects epigenetic modifiers and histone modifications.  
(A) qRT rtPCR analysis of epigenetic modifiers in ATDC5 treated with VPA (0, 0.3, 1 and 3mM) at T=0, 2h, 3d, and 6d. 
(B) ATDC5 cells were differentiated for 0, 1, 3, 5 and 7 days, treated with VPA (0, 0.3 and 1mM) and analyzed for protein 
expression of epigenetic modifiers. (C) ATDC5 cells were differentiated for 0, 1, 3, 5 and 7 days, treated with VPA (0, 0.3 
and 1mM) and analyzed for expression of histone modifications. (D) qRT rtPCR analysis of Egr1 in ATDC5 with VPA (0, 
0.3, 1 and 3mM) at T=0, 2h, 3d, and 6d. (E) VPA dose-dependent increase in H3K9me3 levels in ATDC5 and DAPI 
nuclear staining 
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To determine global changes in epigenetic marking as a result of VPA exposure, we analyzed 
covalent histone modifications throughout chondrogenesis in control cultures (t=0) and compared 
these to cultures exposed to VPA. Covalent histone modifications were analyzed using specific 
antisera against acetylated lysine 9 and 14 on histone 3 (H3K9/14ac) or H4K12ac. We find a dose 
dependent hyperacetylation of histone H3 and 4 in response to VPA (Figure 4C). This global 
hyperaceylation correlates well with substantially increased early chondrogenic expression of the 
immediate-early response gene EGR1, which was reported to recruit histone acetyl transferases 
(HAT; Figure 4D). Finally, H3K9 trimethylation, which is associated with cellular senescence 
(Lowe), is induced in a dose dependent manner by VPA (Figure 4E). Relevantly, nuclei with 
altered morphology display very high H3K9me3 levels (Figure 4E inset). Combined these data 
substantiate the importance of epigenetic modulation early in chondrogenesis and confirm a 
prominent role for VPA during the early stages of chondrogenic differentiation. 
 
 
Discussion 
 
The widely used anticonvulsant and mood-stabilizing drug VPA is known to cause brain damage 
and birth defects in the fetus. As the molecular mechanisms underlying VPA-induced AP-axis 
abnormalities remained incompletely understood, we investigated VPA in the context of 
chondrogenic differentiation. We report here that VPA treatment strongly inhibits chondrogenic 
differentiation and blocks progenitor proliferation during the hyper-proliferative phase in 
chondrogenic differentiation. Furthermore, we show that VPA induces a stress response that 
activates TRP53-dependent proliferative block during differentiation induced hyperreplication.  
Chondrogenic differentiation is a multi-phasic process, which is controlled by a variety of 
transcription factors, growth and differentiation factors. During the earliest phase of chondrogenic 
differentiation the cells proliferate rapidly, which is critical for formation and extension of the 
cartilage scaffolds that ultimate will form bony elements of the skeleton. The Sox-family of 
transcription factors are key regulators of these early phases of differentiation. Eventually, the 
differentiating chondrocytes withdraw from the cell cycle and become hypertrophic. Toward 
terminal differentiation chondrocytes excrete a variety of extracellular matrix proteins (i.a. Col2A1; 
Col10A1; Acan) that will constitute the cartilage matrix. Hypertrophic chondrocytes excrete factors 
which initiate vascularization and attract osteoblasts. Eventually hypertrophic chondrocytes 
undergo apoptosis, are replaced by invading osteoblasts, which signals ossification of the cartilage 
matrix 40. 
Previous reports established axial skeletal transformations in mice exposed to VPA in utero 4,23. 
Also in lumbar spines from chick embryos cultured ex vivo VPA was found to affect mRNA 
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expression of collagen IX and Aggrecan, and VPA induced cytotoxicity in mesenchymal cells 
isolated from the chick spine in a dose-dependent manner 1. Our studies which show a dramatic 
effect of VPA on chondrogenesis in ATDC5 are in good agreement with these findings. A recent 
study reported no effects of VPA on ATDC5 chondrogenic differentiation when differentiation was 
initiated in a high density culture 41. These differences may be explained by differences in 
experimental procedure: protocols applied in the current study 27, induce differentiation in ATDC5 
cultures at low density, whereas the reported protocol involved pre-plating of cells and proliferation 
to confluency, and subsequent induction of ITS-mediated differentiation. The original ATDC5 
differentiation protocols revealed a hyperproliferative burst and the subsequent formation of 
multilayered cartilage nodules 27, thus allowing detailed analysis of both proliferation dynamics as 
well as transcriptome reprogramming. Preliminary comparative analysis of these two differentiation 
protocols shows that initiation of differentiation at high confluency does not lead to induction of 
hyperproliferation and formation of cartilage nodules (FS,TW,JWV unpublished data), most likely 
since cells have already ceased cycling at the start of differentiation. Together with our finding 
reported here, that chondrogenic hyperproliferation is controlled by Trp53, this further supports the 
notion that hyperproliferation is an essential element during chondrogenesis. Remarkably, Trp53-
LOF does not rescue the ability of VPA-exposed cells to differentiate. This points to a distinctive 
role for Trp53 in cell proliferation, rather than differentiation. Indeed, similar observations were 
made in zebrafish studies recently 42. These collective observations underscore the notion that 
transcriptional reprogramming and proliferation are integrated, yet distinctively regulated processes 
during chondrogenesis.  
In addition to apoptosis, senescence is increasingly recognized as a mechanism to protect cells 
from oncogenic transformation 43. Ectopic expression of oncogenes, such as RAS and BRAF in 
normal diploid fibroblasts evokes oncogene induced senescence (OIS) 32,44. Upon oncogenic 
activation these cells first undergo a short phase of hyperproliferation, after which replication is 
markedly reduced and senescence sets in. The origin of replicative senescence is viewed as an 
inability of cells to keep up with hyperproliferation, which results in DNA damage, stalled replication 
forks and,  importantly, a replication stress-induced DNA damage response (DDR) which triggers 
DDR dependent OIS; indeed, ablation of DDR (ATM, ATR, Trp53) bypasses aspects of OIS 29-33. 
Analogous to oncogenic activation of fibroblasts, ATDC5 differentiation includes a phase of rapid 
DNA replication. In keeping with activation of a senescence-like response by VPA, we find a 
number of senescence markers upregulated in VPA exposed cultures: the tumor suppressor 
p19ARF is progressively upregulated in VPA exposed chondrogenic cultures. Consistent with this, 
ATDC5 cells respond to VPA induced stress by undergoing Trp53-dependent proliferative arrest 
and senescence. P19ARF is known to stabilize Trp53 and early senescent-associated responses 
are known to involve both factors. In addition, elevation of Chop, also known as DNA damage 
inducible transcript-3 (Ddit3)/Gadd153, supports a role for DDR in VPA-induced senescence. Our 
findings are consistent with recent reports that VPA induces a senescent-like phenotype in 
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medulloblastomas 11. In addition, several reports show that VPA induces a proliferative arrest in 
cancer cells of haematologic origin 12,45, which may be associated with activation of 
autophagocytosis, a phenomenon known to be related to ERS and UPR 30,44. The molecular basis 
of the VPA-induced DDR is not fully clear. VPA was shown to induce a variety of stresses, e.g. ER 
stress and production of reactive oxygen species (ROS) 46,47. However, the mechanisms by which 
VPA treatment leads to ER stress or ROS production remain elusive. Consistent with the herein 
reported compromising effect of VPA on the ability of ATDC5 cells to hyper-replicate DNA, others 
have shown an enhanced sensitivity to the topoisomerase poisons 48. Finally, we show that 
H3K9me3 is strongly induced upon VPA exposure, providing an additional link to senescence. 
Senescent tumor cells show accumulation of H3K9me3 49. Although the exact role of H3K9me3 in 
OIS is still not clear 50, a global increase of H3K9me3 may be part of a cellular stress response 
(FS, PP, JWV unpublished data). 
Despite lack of experimental evidence for a generally reduced Polycomb function, the effect of 
VPA on chondrogenesis unlikely affects Polycomb gene expression directly, it is possible that 
abnormal associated epigenetic activity, like blocked HDAC function, contributes to the skeletal 
phenotype 1,4,51. The reduction of the PRC1 protein BMI1 upon VPA exposure is interesting, in that 
it is consistent with our recent observation that Bmi1 is a prime regulator of chondrogenesis (FS, 
JWV; in preparation). In addition to possible direct effects on chondrogenesis, Bmi1-LOF was 
reported to induce senescence 52,53; as such the VPA-induced response could be in part explained 
by defective Bmi1 function. 
We here report a concentration dependent hyperacetylation of histones H3 and H4 during the early 
phases of chondrogenesis in VPA-exposed cells. These observations are consistent with 
published reports on the effect of VPA on epigenome-wide histone acetylation in various cells 18. It 
has been speculated that the HDAC inhibiting activity of VPA promotes hyperacetylation leaving 
chromatin in an open configuration and more susceptible to DNA damage during replication 48. 
Interestingly, VPA induces a strongly amplified expression of EGR1, an immediate early gene we 
recently identified as a crucial factor for early epigenomic reprogramming in chondrogenesis (FS, 
JWV; in preparation). Egr1 recruits CPB/p300 HAT activity to promoters. It is conceivable that this 
exaggerated EGR1 activation is instrumental in the observed abnormal epigenomic responses. 
Relevantly, hyperacetylation has been connected to polyploidy, a phenomenon which is strongly 
associated with senescence 8,11,54; Egr1, depending on the cellular context, stimulates or reduces 
proliferation. The data presented here suggest a molecular connection between Egr1 and VPA in 
the context of early epigenomic remodeling and between VPA and Bmi1 in the regulation of 
hyperproliferation during chondrogenesis. The dose dependent effects of VPA on chondrogenesis 
we report are consistent with epigenetic (de)regulation, as epigenetic modulation most often 
produces hypomorphic (e.g. variegation or gene-dosage effects) rather than all-or-none effects. In 
light of findings reported by us and others, it is likely that chondrogenesis (and consequently 
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skeletogenesis) are specifically sensitive to VPA, because of characteristic biological features 
associated with endochondral ossification, among which rapid proliferation and hypertrophy.  
In conclusion, VPA causes an enhanced susceptibility to replication stress and induces a Trp53-
dependent replicative block and senescence-like response in hyperproliferating chondrocytes. Our 
findings have potentially important repercussion for the clinical use of VPA: the success of 
combination therapy of e.g. both solid and hematological cancers with VPA and topoisomerase 
inhibitors 48,55 may directly relate to enhanced sensitization of rapidly dividing cancer cells for 
replication stress, in analogy to the effects on chondrogenic progenitors we report here. These 
combined observations should provide important leads for detailed analysis of the molecular basis 
of the role of VPA on replication and provide relevant possibilities for therapeutic applications in 
cancer.  
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Cyclophillin Forward caaatgctggaccaaacacaa
Reverse ttcaccttcccaaagaccacat
Collagen 2a1 Forward caagaaccctgctcgcactt
Reverse ccgctcttccactcggg
Aggrecan Forward catgagagaggcgaatggaa
Reverse tgatctcgtagcgatctttcttct
Collagen 10a1Forward catgcctgatggcttcataaa
Reverse aagcagacacgggcatacct
Glb1 Forward gagaaagttcaagacagtggctg
Reverse ccattgggacacaggataccc
Il-6 Forward gctaccaaactggatataatcaggaaa
Reverse cttgttatcttttaagttgttcttcatgtactc
Chop Forward gggccaacagaggtcacac
Reverse cttcatgcgttgcttccca
P19ARF Forward aagacggccttgcaggtcat
Reverse ctagtaccggaggcatcttgga
Sox9 Forward agtacccgcacctgcacaac
Reverse tacttgtagtccgggtggtctttc
Runx2 Forward gacgaggcaagagtttcacc
Reverse ggaccgtccactgtcacttt
Ezh2 Forward gaaaaaagatgagacgtccagctc
Reverse gaggttcaatatttggcttcatctttat
Bmi1 Forward tggagaagaatggcccact
Reverse gcaagttggccgaactctgt
Rnf2 Forward tcaggccccatccaactct
Reverse ggcattgcctgaagtctttatgt
Ring1 Forward gccacagtggatcatctctcc
Reverse tgctgctgcctcctctcc
Egr1 Forward agccgagcgaacaaccctat
Reverse tgtcagaaaaggactctgtggtca
Supplemental Table 1 Primers used for qRT rtPCR 
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PcG proteins are epigenetic regulators, first identified in Drosophila melanogaster as regulators of 
segmental identity. PcG mutant Drosophila and mice show homeotic transformations along the 
antero-posterior axis, in mice resulting in vertebral transformations 1-4. The skeletal phenotype of 
PcG mutant mice has been ascribed to deregulation of HOX genes, classical PcG target genes, 
but the precise mechanism behind the development of segment identity shifts is currently 
unknown. Chondrogenesis is a multistep process that forms the cartilage matrix that will eventually 
ossify to form skeletal elements 1. We speculated that PcG proteins play a critical role in mediating 
the epigenomic responses to a changing microenvironment (here inducing chondrogenic 
differentiation), and thus in cell fate decisions. In this thesis various techniques were used to study 
chondrogenic differentiation and in particular the role of PcG proteins herein.  
We find that a hypoxic response during chondrogenesis is an important part of cellular responses 
to changing environmental conditions during chondrogenic differentiation (chapter 3). In addition, 
we find that interference with epigenomic remodelling during chondrogenesis severely affects 
chondrogenic capacity. This aspect was studied by exposure to Valproic acid (VPA), a reported 
HDAC inhibitor and by functional loss of important epigenetic regulators of the Polycomb Group 
(PcG) of proteins. Finally we find that induction of the immediate early response gene EGR1 is 
required for epigenomic remodelling during the early phases of differentiation. 
 
Gene-environment interactions in chondrogenic differentiation 
In a novel in vivo model we show that placing activated mesenchymal stem cells, derived from a 
periosteal callus (PC), into an induced lesion, repairs the osteochondral defect (Chapter 3). 
Without supplemental addition of growth factors, relevant pathways are activated and this model 
recapitulates the different stages of enchondral ossification. Lack of vascularization makes 
cartilage a very hypoxic tissue environment 2. In line with this notion we observed increased mRNA 
expression of HIF-1α and its transcriptional targets VEGF and GAPDH (Chapter 3). Under 
normoxic conditions HIF-1α is hydroxylated by prolyl hydroxylases and consequently ubiquitytlated 
by the von Hippel Lindau gene product VHL, and targeted for proteasomal degradation3. Under 
hypoxic conditions HIF-1α cannot be prolyl hydroxylated, resulting in stabilization of HIF-1α. HIF-1α 
helps cells adapt to a hypoxic environment, by activating downstream targets, involved in e.g. 
cellular survival, anaerobic metabolism and vascularization. We observed stabilization of the HIF-
1α at the protein level in non-hypertrophic chondrocytes. The absence of HIF-1α protein in 
hypertrophic chondrocytes is in good agreement with the onset of vascularization, and consequent 
oxygenation in the hypertrophic region of the growth plate.  
In this study, we observed a down regulation of BMP-2, -4, and -7, while increased levels were 
found at the protein level, throughout callus formation and osteochondral differentiation (Chapter 
3). Studies on BMP proteins in callus formation and osteochondral differentiation are not in 
agreement; while Yaoita et al. reports that levels BMPs remain unaffected in response to inducing 
a fracture, Kloen et al. reports a positive staining for BMPs in human callus. Others show an up-
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regulation of BMP-2 24 hours after surgical release of the periosteum 4. The results in the study 
presented here, show regulation of BMPs at both the transcriptional as well as post-transcriptional 
level. Recently, select mRNAs were found to be preferentially translated under hypoxic conditions 
through increased association of mRNAs with polysomes 5. Whether BMPs are subject to 
preferential translation under hypoxia remains to be determined. Combined, these results strongly 
suggest that the microenvironment, in which the PC is placed, results in activation of pathways 
relevant to chondrogenic differentiation and to adaptation to the hypoxic surroundings. 
 
Dual role for Egr1 during chondrogenic differentiation 
Murine ATDC5 mesenchymal stem cells activated to undergo chondrogenesis reiterate the well-
described multi-stage differentiation program, and are widely used to study chondrogenic 
differentiation. We report for the first time that in response to a changing the microenvironment (i.e. 
Growth factors in differentiation medium) rapidly and transiently induces EGR1 and other 
immediate early genes (IEGs). Knockdown of EGR1 in ATDC5 cells severely impedes two different 
characteristics of ATDC5 chondrogenesis.  
Firstly, the ability of Egr1-LOF (loss-of-function) cells to undergo chondrogenic differentiation is 
severely affected. In line with this, promoters of RUNX2 and SOX9, transcription factors critical for 
different aspects of chondrogenesis were identified as direct targets of Egr1 (Chapter 4); in the 
absence of Egr1, activation of these targets is blunted upon induction of differentiation. Egr1 was 
shown to recruit HAT activity 6, which is in good agreement with early abnormal global histone 
acetylation, observed in Egr1-LOF cells. Currently, we do not know whether Egr1 directly activates 
transcription of these targets, or whether recruitment of HAT activity to relevant promoters creates 
an epigenomic state permissive of transcriptional activation. 
Secondly, ATDC5 cells induced to differentiate undergo a transient phase of rapid progenitor 
proliferation; Egr1-LOF cells fail to undergo this differentiation induced expansion phase and 
undergo premature senescence, specifically during the hyperproliferative phase of chondrogenic 
differentiation (Chapter 5). Senescence is a protective mechanism to prevent oncogenic 
transformation of cells that accumulate excessive damage. Indeed, loss of Egr1 function results in 
accumulation of DNA damage and expression of numerous senescence-associated marker genes 
(Chapter 4). Intriguingly, this proliferative block resembles features of oncogene-induced 
senescence 9-11. Expression of oncogenes results in hyperproliferation, and thus hyperreplication, 
to such an extent that the cells cannot maintain proper regulation of replication 7-9. Consequently, 
replication forks stall, and DNA damage accumulates. Next, activated DNA damage responses 
(DDR) induce a cell cycle arrest in S-phase and irreversible senescence, which are dependent on 
the DDR 7.  
Our findings position Egr1 at the onset of a proliferative burst. Hence Egr1 fulfils a regulatory role 
in lineage-specific transcriptional re-programming, as well as in transit progenitor expansion. 
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Loss of Egr1-function affects epigenomic remodeling 
Apart from lack of global acetylation, examination of other histone modifications revealed a 
significantly increased trimethylation of H3K4, H3K9 and H3K27, both in control and Egr1-LOF 
cultures. In control cells trimethyl levels increase during the phase of transit amplification. In 
addition, an exaggerated increase in expression of these modifications is observed in Egr1-LOF 
cultures. These epigenetic trimethylation marks are seemingly in conflict with each other, as for 
instance H3K9 and H3K27me3 are associated with transcriptionally repressed/silent DNA, 
whereas H3K4me3 is often found at loci which are actively expressed. The observed increase in 
global trimethylation correlates with a period of enhanced cell stress and suggest that besides  in 
transcriptional regulation, these modifications are implicated in other, as of yet unkown regulatory 
processes. It has been reported that the heterochromatin markers HP1 and H3K9me3 both 
accumulate in distinct nuclear foci during or in response to cellular senescence 10. These 
senescence-associated heterochromatin foci (SAHF) appear during replication stress induced 
senescence. We find that expression of KAP1 precedes the accumulation of H3K9me3 in Egr1-
LOF cells (Chapter 4). Kap1, a factor known to directly bind HP1, was reported to be required to 
help resolve DNA damage specifically in heterochromatin 11. Together, H3K9me3 and Kap1 may 
be involved in protection against replication induced DNA damage. Also increased levels of 
H3K4me3 and H3K27me3 have been associated with cellular stress responses, i.e. hypoxia or 
induction of replication stress (Johnson et al. +FS, PP, JWV; unpublished data). H3K4me3 was 
reported to be essential for Rag2-mediated V(D)J recombination in B and T cells, and is linked to 
DDR-induced cellular responses via ING family proteins. In line with this notion, we also find that 
VPA, a reported HDAC inhibitor, severely affects chondrogenic differentiation. Like loss of Egr1 
and PcG function (chapter 5 + see below) VPA treatment leaves the ATDC5 cells unable to 
hyperproliferate and activates senescence response. The observed cellular stress responses again 
correlate with globally enhanced histone trimethylation. Interestingly, VPA treatment affects 
proliferation, but not on differentiation, in a TP53-dependent manner (Chapter 6). These findings 
are in agreement with similar observations in zebrafish 12. Combined these observations suggest 
that several important processes, including a proliferative response and transcriptomic 
reprogramming, are part of a coordinated response during chondrogenesis. Our findings support 
the importance of epigenomic remodelling for chondrogenesis. In addition, they suggest that global 
trimethylation may be part of a more generalized stress response. 
 
Egr1 initiates early epigenomic reprogramming via activation of PcG proteins 
In silico analysis of Egr1 binding sites predicted PcG proteins as potential target genes. 
Interestingly, we observed that Egr1-LOF affects expression of Ezh2 and Bmi1, and in line with 
these findings we were able to immunoprecipitate PcG promoter sequences with specific anti-Egr1 
antibodies (Chapter 4). Both Ezh2 and Bmi1 have been associated with cell-cycle regulation, as 
Ezh2 is a transcriptional target of E2F 13, and Bmi1 transcriptionally regulates the CDKN2/INK4A 
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locus, which encodes the cell-cycle regulators P16ARF and P14INK4a 14. This suggests that Egr1 is 
involved in transcriptional activation of PcG genes and that Egr1 thereby recruits epigenetic 
modulators essential for chondrogenic differentiation. Furthermore, a comparison between 
published PcG targets and predicted Egr1 consensus binding sites revealed potential common 
targets. Relevantly, two hours post induction of differentiation (pid) we observe a strong correlation 
between H3K27me3 marks at loci and the absence of Egr1 binding, and inversely, between the 
presence of H3K4me3 marks and local enrichment of Egr1, suggesting that PRCs regulate 
accessibility of Egr1 to promoters. Combined, this data reveal a number of potential mechanistic 
interactions between Egr1 and PRCs.  
 
The PRC1 complex regulates transit amplification and transcriptional reprogramming of 
chondrogenic progenitors 
Analogously to Egr1-LOF cells, loss of PRC1 function results in failure to properly differentiate. In 
addition we observe a significant intra-S-phase arrest and induction of senescence. In agreement 
with the intra-S-phase arrest, BrdU incorporation revealed an inability to properly replicate DNA in 
Bmi1-kd cells. Under differentiation conditions, PRC1-LOF cells accumulate massive amounts of 
DNA damage, as measured by phosphorylated H2A.X, Chk2 and Kap1 (Chapter 5). Again, as for 
loss of Egr1 function, these results show strong similarity to OIS, suggesting that hyperproliferation 
induced replication stress is the underlying cause of the phenotype observed in PRC-LOF.  
All chondrogenic cell lines available showed strong staining for senescence-associated 
bGalactosidase (SAbGAL). Furthermore, intercalated discs and in growth plates of elongating 
bones of WT mice show presence of SAbGAL. In good agreement with in vitro findings, RING1A-
KO mice show an increased hypertrophic zone (HZ) (Chapter 5). Importantly, Runx, an oncogene, 
reported to induce senescence, is implicated in hypertrophic differentiation. Together, our findings 
suggest that endochondral ossification may naturally terminate in a senescence-like phenotype. To 
the best of our knowledge, this is the first report describing an important role for hyperproliferation 
checkpoints in a naturally occurring differentiation process during development. Thusfar these 
cellular stress responses (DDR, intra-S arrest and senescence) have mainly been associated with 
oncogene-induced hyperproliferation and consequential checkpoint activation and cell cycle exit. 
We performed extensive microarray analysis on Bmi1-kd and control cells, and we found that 
transcriptional re-profiling in control cells intensifies during transit amplification. Transcriptomicl 
differences between Bmi1-kd and control cells increase dramatically at this time. Unexpectedly, we 
observed that equal amounts of genes are up- or down-regulated at 6 days pid  in Bmi1-kd cells 
compared to control cells (Chapter 5). Expression profiling of genes most extremely deregulated 
revealed a number of different response clusters, suggesting global deregulation of transcriptional 
responses rather than deregulation of specific relevant processes. Combined these finding 
illustrate that at the time of proliferative amplification, the transcriptome is heavily reorganized to 
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facilitate chondrogenic differentiation, and that PRC1 is critical for regulating these transcriptional 
changes.   
Cells undergoing differentiation require coordinated regulation of DNA-templated processes, 
among which transcription and replication. Using Immunofluorescence, we studied transcription, 
replication and the presence of DNA damage in respect to each other. Intriguingly, transcription 
and replication activity appear to be separated in space and time inside the nucleus, suggesting 
that the genome is partitioned into regions that are either actively transcribing or actively replicating 
DNA under normal conditions (Chapter 5). This unexpected finding is in good agreement with an 
earlier report on dynamic segregation of mRNA and DNA production throughout S-phase 15. 
Remarkably, this spatial segregation of transcription and replication is lost in PRC1-kd cultures, 
suggesting that concerted regulation of the two DNA-templated processes is regulated by PRC1. 
Moreover, in PRC1-LOF cells, DNA damage occurs at sites of de novo DNA synthesis. The 
majority of DNA damage in replicating cells, even under normal conditions, probably comes from 
highly frequent collisions between replication forks and transcription machineries, as both 
processes move along the same template 16-18. Our findings suggest that damage in PRC1-LOF 
cells accumulates as a result of failure to tune replication to transcription and vice versa. 
Bmi1-deficient cells are positive for geminin expression and control cells are not (Chapter 5). This 
inverse correlation between Gmnn and Bmi1/Rnf2 chromatin association during mid-S is in perfect 
agreement with the recently identified ubiquitin-mediated induction of Gmnn degradation by 
Bmi1/Rnf2 19. Chromatin dissociation of Bmi1/Rnf2 is likely controlled by post-translational 
modification (PTM). In line with this idea, we recently observed a positive correlation between 
PRC-phosphorylation, PRC1/chromatin dissociation and Gmnn stabilization under various 
conditions of cell stress (JWV, YT unpublished observations). Stress signaling induces chromatin 
dissociation of PRC1 members (Bmi1, Ring and CBX proteins; 22). In contrast, Phc1/Rae28 22, 
through which Gmnn is associated with chromatin, undergoes a nuclear redistribution under these 
conditions. Taken together, these observations point to Gmnn as a likely candidate for coordinated 
control of transcription and replication in the context of PRC1 function.  
Based on these findings, we propose a model in which the PRC/geminin interactions maintain a 
dynamic switch to spatially and temporally segregate transcription and replication: H3K27me3-
mediated recruitment of the core complex CBX/Rnf2/Bmi1 installs repressive H2AK119ub1 marks, 
which interfere with transcription initiation, possibly through recruitment of additional PRC 
(associated) proteins20. Local presence of Rnf2/Bmi1 E3 ligase activity would target Gmnn for 
degradation, relieving a potential replication block. Conversely, loss of Bmi1/Rnf2 stabilizes 
GMNN, hence blocking replication, yet permitting transcription (see figure 1, chapter 2).  
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Conclusions and future perspectives 
The research in this thesis provides novel insights to mechanisms mediating gene-environment 
interactions. Changing the environment to induce chondrogenic differentiation rapidly induces a 
wide array of responses (Chapters 3, 4 and 5). Egr1, while expressed only shortly, activates 
chondrogenic programs and initiates epigenomic remodeling. Initiating epigenomic remodeling by 
Egr1 is critical for subsequent transit amplification of chondrogenic progenitors, at least in part via 
regulation of PRCs (Chapter 4). The importance of epigenomic remodeling during transit 
amplification is stressed by the findings that the histone deacetylase inhibitor valproic acid results 
in replicative senescence and a failure to differentiate (Chapter 6). Detailed analysis of PRC 
function during chondrogenesis revealed novel insights in coordinated regulation of transcription 
and replication and proposes a role for PRCs therein (Chapter 5). Loss of PRC function results in 
replication stress, in accumulation of DNA damage and induction of replicative senescence 
(Chapter 5). Although our studies have increased our fundamental understanding of gene-
environment interactions and uncovered a novel role for PcG proteins in coordinating transcription 
and replication, many questions remain. May Egr1 binding to DNA define genomic regions with 
active transcription or replication? Is Egr1 binding restricted to promoter regions? How does Egr1 
binding to DNA relate to specific histone modifications, and to PRC occupation? Which genes are 
regulated by Egr1 or PRCs? Does PRC function in replication timing, and is Egr1 involved? Is 
enrichment of specific histone modifications and PRC occupation dynamic during S-phase, when 
transcription and replication are co-ordinately regulated? Are potential targets dynamically 
regulated in replication timing the genes that accumulate DNA damage in PRC- or Egr1-LOF?  
How, exactly does geminin contribute to Polycomb biology? Genome wide chromatin 
immunoprecipitation (ChIP-seq) of Egr1, specific histone modifications and PcG proteins during 
different stages of differentiation, will be important to map common targets. In combination with 
microarrays of Egr1-LOF versus control cells and the available Bmi1-LOF microarray data, these 
data sets will shed light on the importance of regulating these targets, in the context of 
transcription. Replication timing involves coordinated regulation of transcription and replication 
(discussed in Chapter 2). This process provides a relevant starting point to study the coordinate 
regulation of transcription and replication by PRCs. Genome wide ChIPs for active RNA 
polymerase II, BrdU, geminin and specific histone modifications in different stages of S-phase, as a 
function of PRC expression will help studying the proposed model (Chapters 2 and 7). Our findings 
suggest a novel aspect of Polycomb biology during skeletogenesis, and to the importance of 
proliferation and tissue expansion in positioning along the A-P axis. Further, premature termination 
of differentiation may account for the phenotype observed in PcG null-mutants. 
Overall, our observations provide important connecting points for further research, and contribute 
to mechanistic understanding concerning the role of PcG proteins in embryogenesis and 
oncogenesis. Finding answers to the above questions will be of significant importance to enhance 
our as of yet incomplete understanding of epigenomic regulation in development and disease. 
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Summary 
 
All genetic information that a cell needs to function is stored in its DNA. Genes are transcribed into 
mRNA, which is subsequently translated into proteins. When a cell prepares for cell division, the 
nuclear DNA is duplicated and divided between two daughter cells and all genetic information is 
maintained. During development, cells acquire specific functions, mediated by gene-environment 
interactions. Resting stem or progenitor cells are activated by molecules in their direct 
environment. These signals are transduced to the nucleus, where, depending on the nature of the 
signal(s), specific genes are activated, resulting in the production of RNA’s (mRNA, non-coding 
RNAs) and proteins which trigger a differentiation program, that ultimately leads to formation of 
specialized, fully functional cells. 
Although most somatic cells in a human body contain identical DNA sequences, the vast variety of 
cellular phenotypes implies that the information stored in the DNA sequence on its own is not 
sufficient to explain cell diversity and function. An additional layer of regulation, other then the DNA 
sequence itself, regulates accessibility of the DNA template. Nuclear DNA is not ‘naked’ but 
packed into a complex structure called chromatin. Chromatin predominantly consists of DNA 
wrapped around histone proteins. Histone proteins can be posttranslationally modified, and via 
these modifications many different protein complexes can bind and regulate chromatin. Chromatin 
structure is found in several ‘states’, ranging form tightly condensed inaccessible chromatin to 
open and accessible chromatin. Processes like DNA duplication (replication) and gene activation 
(transcription) are regulated by changes in chromatin structure, via increased or decreased 
accessibility of the DNA template. Collectively, these processes, that may involve concerted action 
of chemically modified DNA and proteins and non-coding RNAs, are referred to as epigenetic 
regulation. Polycomb group proteins (PcG) have been identified as epigenetic regulators of 
chromatin structure, and are best known as transcriptional regulators of Hox genes. An overview of 
our current understanding of regulation of replication and transcription by epigenetics in general 
and by PcG proteins in particular is presented in chapter 2.  
 
Although insight into Polycomb biology has improved a lot over recent years, mechanisms of action 
of PcG proteins are far from fully understood. Main questions are What is the mechanism behind 
PcG-mediated transcriptional repression? Is there perhaps a role of PcG in replication and DNA 
repair? How are PcG proteins involved in mediating gene-environment interactions? How are PcG 
proteins regulated themselves? How are PcG proteins targeted to lineage-type specific gene 
targets?   
As PcG proteins are involved in antero-posterior axis formation and many single PcG mutants 
cause skeletal abnormalities, this thesis aimed at elucidating the role of PcG proteins in one 
important aspect of enchondral ossification, namely chondrogenic differentiation.  
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The formation of bone (enchondral ossification) is a multistep process, in which an extracellular 
matrix is produced by chondrocytes that is ultimately calcified by osteocytes. Numerous locally 
produced soluble factors regulate different stages in this process, strongly suggesting that the 
microenvironment plays an important role in enchondral ossification. Many of these factors are 
activated in response to hypoxia, and downstream of HIF1α activation, which is consistent with the 
absence of blood vessels in cartilage. Most of these findings result from in vitro studies, and 
currently studies on enchondral ossification often are performed on whole embryos or growth 
plates. Chapter 3 describes the molecular analysis of pathways relevant to enchondral ossification 
in a novel in vivo model in rabbits. The model makes use of experimentally induced local damage 
of periosteum, which results in activation of mesenchymal stem cell (MSC)-like activity, and 
periosteal callus formation. Subsequently the callus is used to functionally restore an 
experimentally induced articular cartilage lesion. Analysis of mRNA and protein expression in the 
repaired lesion confirms that the model recapitulates the sequential steps of normal chondrogenic 
development. In addition, we provide in vivo evidence that during the chondrogenic phase Hif1α is 
activated, suggesting that the conditions of periosteal callus formation are, at least transiently, 
hypoxic. 
 
During cellular differentiation cells receive extracellular signals that lead to changes of the 
transcriptome (all cellular RNAs produced by transcription of DNA), resulting in production of RNAs 
and proteins needed for a specific cell type to adapt and function. At the onset of this project 
knowledge on Immediate Early Genes (IEGs) in chondrogenic differentiation was limited. The 
identification of IEGs as strong responders to a changing microenvironment (inducing 
chondrogenic differentiation), prompted us to study the role of the IEG Egr1 during ATDC5 
chondrogenesis (chapter 4). In a loss-of-function approach, using short hairpin RNAs targeting 
Egr1 mRNA, Egr1 was found to function in at least two, possibly interconnected, processes: Egr1 
is required for transcriptional activation of downstream chondrogenic differentiation pathways and 
Egr1 controls initiation of crucial epigenome wide reprogramming during chondrogenesis. 
Additionally, Egr1-LOF cells accumulate DNA damage, activate DNA damage responses, and 
induce a senescence-like response, which may be related to abnormal epigenetic responses.  
Relevantly, chapter 4 describes two ways in which Egr1 may connect to PcG biology. 
 
Polycomb repressive complex 1 (PRC1) mutant mice display abnormalities in skeletal development 
that correlate to defective maintenance of HOX gene expression boundaries, but our 
understanding of epigenetic mechanisms underlying chondrogenic differentiation is poor. To gain 
more insight in molecular mechanisms mediated by PRC1 during chondrogenesis, we studied 
Bmi1 in ATDC5 chondrogenic differentiation (chapter 5). Upon induction of differentiation ATDC5 
cells undergo a transient phase of hyperproliferation. Loss of Bmi1 leaves the cells incapable of 
undergoing this expansion phase. Bmi1-LOF cells accumulate massive amounts of DNA damage, 
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arrest in S-phase, and consequently display characteristics of replicative senescence. 
Accumulation of DNA damage and activation of intra-S-phase checkpoints is associated with 
replication stress, collisions of replication and transcription machineries. This led us to study global 
localization of transcription and replication. Interestingly, control cells showed spatially separated 
regulation of these two DNA-based processes, whereas this coordinated regulation is lost in Bmi1-
LOF cells during rapid proliferation. Furthermore, DNA damage in Bmi1-deficient cells accumulates 
at sites of de novo DNA synthesis, suggesting that loss of PRC1 function during hyperproliferation 
renders the cells unable to deal with increased chromatin stress. The data presented in chapter 5 
reveals an important function for PRC1 in orchestrating simultaneous chromatin-associated 
processes, i.e. DNA replication and transcription, extending PRC1 function as merely 
transcriptional repressors.  
 
Valproic acid (VPA) is a drug used to treat epilepsy and other neurological conditions. VPA 
administration during pregnancy can lead to neural tube defects, skeletal transformations and other 
adverse effects in the unborn child. VPA was designated as an epigenetic drug, but molecular 
mechanisms of actions are unclear. Treatment of differentiating ATDC5 cells with VPA in 
therapeutically relevant concentrations completely abrogates the ability of chondrogenic 
progenitors to differentiate, which is accompanied by severe alterations in global epigenetic 
modifications. Additionally, VPA affects the differentiation-induced hyperproliferation in a TP53-
dependent manner. Completely in line with the data presented in chapters 4 and 5, VPA treated 
cells accumulate replication stress, DNA damage, and induce senescence-like responses, further 
strengthening the conclusions that epigenomic remodeling is critical for proper differentiation to 
occur (chapter 6). 
 
Taken together, data in this thesis shows that in response to extracellular differentiation stimuli, 
epigenomic remodeling allows cells to and tune DNA-templated processes (transcription, 
replication), under conditions of increased proliferation and RNA and protein production. When 
epigenomic reprogramming fails, combined stress of uncoordinated transcription and replication 
stress leaves cells incapable of undergoing chondrogenic differentiation. The significance of the 
results in this thesis is discussed in chapter 7. 
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Samenvatting 
 
Alle genetische informatie die nodig is om een cel te laten functioneren ligt opgeslagen in ’n DNA. 
Genen kunnen afgeschreven worden in mRNA dat vervolgens kan worden vertaald naar eiwiten. 
Wanneer een cel zich voorbereidt voor celdeling, wordt het DNA in de celkern gedupliceerd en 
wordt het verdeeld tussen de twee dochtercellen, waardoor alle genetische informatie behouden 
blijft. Tijdens ontwikkeling, verkrijgen cellen een specifieke functie. Dit proces wordt gemedieerd 
door gen-omgevings interacties. Rustende stam of progenitor cellen worden geactiveerd door 
moleculen in hun directe omgeving. Deze signalen worden doorgegeven naar de celkern waar, 
afhankelijk van de aard van de signalen, specifieke genen worden geactiveerd, resulterend in de 
productie van RNA (mRNA, niet coderende RNA’s) en eiwitten, die een differentiatie programma 
kunnen activeren, wat uiteindelijk leidt tot het ontstaan van gespecialiseerde, volledig functionele 
cellen. Hoewel bijna alle lichaamscellen in een menselijk lichaam identieke DNA sequenties bevat, 
impliceert de grote variatie aan gespecialiseerde cellen, dat de informatie die in het DNA ligt 
opgeslagen niet voldoende is om celdiversiteit en functie te verklaren. Een andere vorm van 
regulatie, naast de DNA sequentie zelf, reguleert toegangelijkheid van DNA. DNA in de kern is 
ingepakt in een compleze structuur, dat chromatine genoemd wordt. Chromatine bestaat 
voornamelijk uit DNA dat om histon eiwitten gewikkeld is. Histon eiwitten kunnen posttranslationeel 
gemodificeerd worden, en via deze modificaties kunnen vele verschillende eiwitcomplexen het 
chromatine binden en het reguleren. De structuur van chromatine bevindt zich in verschillende 
staten, variërend van een hechte, gecondenseerde, ontoegangkelijke staat tot een open en 
toegankelijke staat. Cellulaire processen als DNA duplicatie (replicatie) en gen activatie 
(transcriptie) worden gereguleerd door veranderingen in chromatine structuur, via verhoogde of 
verlaagde toegankelijkheid van het DNA. Chromatine structuur wordt onder meer gereguleerd door 
chemische modificaties van DNA en eiwitten, en niet-coderende RNA. Samen wordt deze vorm 
van regulatie epigenetica genoemd. Polycomb groep eiwitten (PcG) zijn geindentificeerd als 
epigenetische regulatoren van chromatine structuur, en zijn vooral bekend als transcriptionele 
regulatoren van Hox genen. Een overzicht van ons huidige begrip van regulatie van transcriptie en 
replicatie door epigenetica in het algemeen en specifiek door PcG eiwitten wordt beschreven in 
Hoofstuk 2.  
 
Hoewel het inzicht in Polycomb biologie flink is toegenomen de afgelopen jaren, worden de 
mechanismen van PcG functioneren nog maar voor een klein deel begrepen. Er zijn in dit 
vakgebied verschillende kernvragen. Wat is het mechanisme van PCG gemedieerde 
transcriptionele repressie? Is er wellicht een rol voor PcG in replicatie en DNA reparatie? Hoe zijn 
PcG eiwitten betrokken bij het mediëren van gen-omgevings interacties? Hoe worden PcG eiwitten 
zelf gereguleerd? Hoe worden PcG eiwitten naar celspecifieke genen gestuurd? 
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Aangezien PcG eiwitten betrokken zijn bij antero-posterior as vorming en PcG mutante muizen 
skelet afwijkingen hebben, richt deze thesis zich op het verhelderen van de rol van PcG eiwitten in 
een belangrijk aspect van enchondrale ossificatie, namelijk chondrogene differentiatie. 
 
De vorming van bot (enchondrale ossificatie) is een meerstaps proces, waarin een extracellulaire 
matrix gevormd wordt door chondrocyten (kraakbeencellen), die uiteindelijk verkalkt wordt door 
osteocyten (botcellen). Talloze lokaal geproduceerde oplosbare factoren reguleren de 
verschillende stadia van deze processen, wat aangeeft dat de directe omgeving een sterke rol 
speelt in enchondrale ossificatie. Veel van deze factoren worden geactiveerd in reactie op een 
hypoxische omgeving, en activatie van de transcriptie factor HIF1α, wat consistent is met de 
afwezigheid van bloedvaten in kraakbeen. Het overgrote deel van deze bevindingen komen voort 
uit in vitro studies. Daarnaast worden vele studies naar enchondrale ossificatie uitgevoerd op totale 
embryos of groeiplaten. Hoofdstuk 3 beschrijft de moleculaire analyse van relevante 
signaleringspaden tijdens enchondrale ossificatie in een nieuw in vivo model in konijnen. Dit model 
maakt gebruik van een lokaal geinduceerde beschadiging van het periosteum, wat resulteert in de 
activatie van mesenchymale stem cell (MSC) gelijkende activiteit, en periosteale callusvorming. 
Vervolgens wordt de callus gebruikt voor een functioneel herstel van een experimenteel 
geinduceerde articulaire kraakbeen lesie. Analyse van mRNA en eiwit expressie bevestigt dat het 
model de opvolgende stappen van normale chrondrogene ontwikkeling recapituleert.  Daarnaast, 
bieden we in vivo bewijs voor activatie van HIF1α tijdens de chondrogene fase, wat suggereert  dat 
de omstandigheden van periosteale callusvorming, op zijn minst transient, hypoxisch zijn. 
Tijdens cellulaire differentiatie ontvangen cellen extracellulaire signaken die leiden tot 
veranderingen in het transcriptoom (alle RNA’s die tijdens transcriptie van DNA geproduceerd 
worden), resulterend in productie van specifieke RNA’s en eiwitten die een cel nodig heeft om zich 
aan te passen en een nieuwe functie aan te nemen. Aan het begin van dit project was er 
nauwelijks kennis van de rol van Immediate Early Genes (IEG’s) tijdens chondrogene differentiatie. 
De ontdekking dat IEG’s  zeer sterk reageren op een veranderende omgeving, leidde tot het 
bestuderen van de rol van de IEG Egr1 tijdens chondrogene differentiatie in ATDC5 cellen 
(hoofdstuk 4). In een verlies van functie aanpak, gebruik makend van geinduceerde afbraak van 
Egr1 mRNA, bleek Egr1 een tweeledige rol te spelen, die mogelijk verband met elkaar houden. 
Egr1 is vereist voor transcriptionele activatie van chondrogene differeniatie signaleringspaden,  en 
ook initieert Egr1 cruciale epigenoom wijde herprogrammering tijdens chondrogenese. Daarnaast 
lopen cellen zonder Egr1 tijdens chondrogenese DNA schade op, activeren ze DNA schade 
responsen, en induceren ze een verouderingsresponse (senescentie), die vermoedelijk 
gerelateerd is aan abnormale epigentische responsen. Hoofdstuk 4 beschrijft twee manieren 
waarin Egr1 vermoedelijk gelinkt aan PcG biologie is. 
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Polycomb repressive complex 1 (PRC1) mutante muizen vertonen abnormale skelet ontwikkeling, 
die correleert met defecte regulatie van Hox gene expressie, maar ons begrip van epigenetische 
mechanismen die hieraan ten grondslag liggen is beperkt. Om meer inzicht te krijgen in de 
moleculaire mechanismen die door PRC1 gemedieerd worden tijdens chondrogenese, 
bestudeerden we Bmi1 in ATDC5 chondrogene differentiatie (hoofdstuk 5). In response op inductie 
van differentiatie ondergaan ATDC5 cellen een transiente fase van hyperproliferatie. Verlies van 
Bmi1 functie leidt ertoe dat de cellen deze expansie fase niet kunnen ondergaan. Zonder Bmi1 
lopen de cellen enorme hoeveelheden DNA schade op, ondergaan ze een S-fase arrest, en laten 
ze vervolgens karakteristieken zien van replicatieve senescentie. Opstapeling van DNA schade en 
activatie van een S-fase arrest wordt geassocieerd met replicatie stress, collissies van  replicatie 
en transcriptie machineriën. Hierom bestudeerden we globale lokalisatie van transcriptie en 
replicatie. Controle cellen lieten een ruimtelijke scheiding zien van deze twee processen, terwijl 
deze gecoördineerde regulatie verloren is gegaan in cellen zonder Bmi1, die deze fase van 
hyperproleratie ondergaan. Daarnaast lopen de Bmi1 deficiënte cellen DNA schade op op posities 
waar replicatie plaatsvindt, wat suggereert dat cellen met verlies van PRC1 functie tijdens 
hyperproliferatie niet in staat zijn om met verhoogde chromatin stress om te gaan. De data in 
hoofdstuk 5 laat zien dat PRC1 een belangrijke rol speelt in het regisseren  van chromatine 
geassocieerde processen, zoals replicatie en transcriptie, wat betekent dat PRC1 niet enkel 
functioneert als transcriptionele repressor. 
Valproaat is (VPA) is een medicijn dat wordt gebruikt om epilepsie en andere neurologische 
aandoeningen te behandelen. VPA gebruik tijdens zwangerschap kan leiden tot neurale buis 
defecten,  malformaties van het skelet, en andere aandoeningen bij het ongeboren kind. VPA is 
beschreven als een epigenetisch medicijn, maar de moleculaire effecten zijn onbekend. 
Behandeling van differentierende ATDC5 cellen met therapeutisch relevante concentraties VPA 
leidt ertoe dat ATDC5 cellen het vermogen om te differentieren verliezen. Dit gaat gepaard met 
zeer sterke veranderingen in gobale epigenetische modificaties. Daarnaast, verliezen deze cellen 
de capaciteit om te hyperproliferen in een TP53 afhankelijke manier. Totaal in lijn met de 
experimenten beschreven in hoofdstukken 4 en 5, lopen de VPA behandelde cellen replicatie 
stress en DNA schade op. Eveneens activeren deze cellen senescentie responsen, wat verder 
bijdraagt aan de conclusies dat epigenomische herprogrammering essentieel is om volledige 
differentiatie plaats te laten vinden (hoofdstuk 6). 
De data in dit proefschrift laat zien dat in response op extracellulaire differentiatie stimuli, 
epigenomische herprogrammering de cellen in staat stelt om DNA gebaseerde processen (o.a. 
transcriptie en replicatie) op elkaar af te stemmen tijdens omstandigheden van versnelde 
proliferatie, en RNA en eiwit productie. Wanneer epigenomische herprogrammering niet goed 
plaats vindt, verliezen cellen het vermogen om chondrogeen te differentiëren, vanwege replicatie 
stress. De significatie van de resultaten beschreven in dit proefschrift worden bediscussieerd in 
hoofdstuk 7.  
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Dankwoord 
Eindelijk is het dan zover, ‘’het boekje’’ is af! Terugdenkend aan deze periode realiseer je je 
pas met hoeveel mensen je hebt samengewerkt. Jullie hebben er mede voor gezorgd dat dit 
proefschrift tot stand is gekomen, maar ook dat ik altijd met plezier in Maastricht heb 
gewerkt. Ook zijn er zoveel mensen geweest die interesse en enthousiasme getoond 
hebben, waardoor het op momenten dat het even tegen zit makkelijker is om toch nog even 
door te zetten. Daarom wil ik nu graag het woord tot jullie richten. 
 
Allereerst mijn co-promoter en promoter. 
Willem, toen ik een aantal jaren terug bij jou binnenstapte en een stortvloed aan informatie 
kreeg over PcG’s realiseerde ik me dat je als vers afgestudeerde eigenlijk pas begint met 
kennis opdoen. Wat dat betreft kan ik me geen betere leermeester voorstellen. Jouw 
enthousiasme voor wetenschap en het vermogen om dit op anderen over te brengen is een 
echte motivatie. Daarnaast heeft jouw brede parate kennis en inzicht in wetenschap ertoe 
geleid dat het woord serendipiteit (beeldend omschreven door de nederlandse Nobelprijs 
winnaar Pek van Andel als het zoeken naar een naald in een hooiberg, en eruit komen met 
een boerenmeid :) verschillende keren de revue passeerde, en we onverwachte data snel 
konden herkennen en in de juiste context konden plaatsen. De tijd van oogsten is gekomen, 
en met al de ideeën voor experimenten die we nog hebben, gaan we nog een spannende tijd 
tegemoet! Willem, ontzettend bedankt!! 
Professor Geraedts, beste Joep, uw rol heeft zich vooral achter de schermen afgespeeld, 
maar dat maakt die rol zeker niet minder belangrijk. Hartelijk bedankt voor uw inzet. 
 
Graag wil ik de beoordelings commissie onder leiding van Prof. Dr. F.C.S. Ramaekers 
danken voor de kostbare tijd en het beoordelen van dit proefschrift. Ik kijk er naar uit ‘’de 
degens te kruisen’’. 
 
Dan de WVO groep! Dankzij jullie zijn de afgelopen jaren omgevlogen! De saamhorigheid 
werkt motiverend, is bijzonder prettig en zeker ook gezellig. Hanneke (Hannniiieee!), je was 
een paar maanden eerder begonnen dan ik, waardoor ik veel van je heb kunnen leren in de 
begin periode. Al die uren op het lab zijn een stuk sneller gegaan door samen met de radio 
mee te zingen, al ligt onze muzikale interesse behoorlijk ver uit elkaar. Doordat je een paar 
maanden voor me uit liep, heb ik flink van je kunnen profiteren de laatste tijd, dus veel dank 
voor de duwtjes in de goede richting! Céline, you were such a pleasant colleague. You found 
your way back to France, and I wish you and your family all the best! Vivian, rustig en 
hardwerkend, ben je altijd bereid om vragen te beantwoorden en dingen uit te zoeken. Van 
Dankwoord 
 149
jouw vermogen om efficient en nauwkeurig een hoop tegelijk te doen, kunnen veel mensen 
wat leren! Peggy (oftewel Pegsywegsy, ofwel Babbelbox), wat een gezelligheid, altijd wel wat 
te vertellen. Je gaat inmiddels ook al weer bijna de afsluitende periodein, waar ik je veel 
succes bij wens. Gelukkig ben ik er nog om je hierbij te steunen. Guus, als student heb ik je 
alles kunnen vertellen wat ik weet over de ATDC’s. Je hebt dit allemaal snel opgepikt, wat er 
mede toe heeft geleid dat je mocht blijven :P en we samen de verbinding met Orthopedie 
vormen. Verder Claudia, Raymond (een van weinigen die mijn koffiegebruik kan 
evenaren…), Juliette, Nard, Iris en Elena bedankt voor jullie meer of mindere bijdrage aan dit 
proefschrift! Ook alle studenten (Yvette, Marjolein, Rene, Caroline, Martijn, Sjoerd, Joyce, 
Chantal, Frans, en vele anderen!) die voorbij zijn gekomen wil ik bedanken voor hun 
bijdrage, zowel voor hun werk op het lab, als het bijdragen aan gezelligheid en het 
groepsgevoel. 
 
Dan mijn orthopedische vrienden. Samen met Iris namen we de eerste stappen naar een 
inmiddels zeer hechte samenwerking. De groep is met de jaren flink toegenomen, maar het 
enthousiasme dat we van jullie kant mogen ontvangen is een constante factor. Tim, met jouw 
moleculair biologische achtergrond en drive, ben je inmiddels van grote waarde als 
verbindende factor tussen de twee groepen. Het samen begeleiden van enkele studenten 
heeft er toch mooi voor gezorgd dat ze goed terecht zijn gekomen (namelijk binnen onze 
samenwerking!). Don, als partner in crime van het eerste uur gaat er veel dank uit naar jou, 
uiteraard ook omdat je me na al die jaren aan het tennissen hebt gekregen! Andy, hartstikke 
bedankt voor bijdragen aan het VPA verhaal! Pieter, al zien we je niet veel vanwege jouw 
klinische verplichtingen, bedankt dat ik ook mocht bijdragen aan jouw onderzoek. Marjolein, 
als student ben je begonnen binnen deze samenwerking. Je hebt een hoop werk verricht aan 
het Egr1 hoofdstuk, en je bent inmiddels een eind op weg met je eigen promotietraject met 
veel mooie data, veel succes daarbij. 
 
De afgelopen jaren hebben we bij Moleculaire Genetica een hoop mensen zien komen en 
gaan. De grote variatie in onderzoek op de afdeling heeft ertoe geleid dat er niet veel is 
samengewerkt met de verschillende groepen. Een voordeel hiervan is wel dat er in de 
verschillende groepen een diversiteit aan labtechnische kennis is. Hierbij wil ik van de 
mogelijkheid gebruik maken om alle mensen die hebben bijgedragen te bedanken. Mijn 
(oud-)kamergenoten Sofia (also for the gezelligheid outside of work!), Debby (Koonen the 
Barbarian), Susan, Laura, Yeliz en Wino. Marten (voor de bijdragen tijdens de 
werkbesprekingen en mijn aio commissie bijeenkomsten), Ronit (for critically reviewing the 
Bmi1 paper and the review), Patrick (voor het 1000 en 1 keer helpen met van alles en nog 
wat!), Veerle B, Kristiaan en Ellen L, Jana, Menno, Monique, Marjon (zodat ik aan mijn 
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maatschappelijke verplichtingen kon voldoen, en er achter kwam dat ik toch niet in de wieg 
ben gelegd als voetbaltrainer), Danielle C (oa voor de begeleiding tijdens mijn afstuderen bij 
GRAT), Le (for liking my gehaktballen and the chitchat. See you in London!), Monique, Inge, 
Chantal, Stijn, Matthijs, Remco, Pieter, Lauran, Nadine, Veerle C, Guillaume, Sander en 
Petra, Jan, Joost (voor het delen van mijn interesse in AJAX, en altijd een, en dan bedoel ik 
1 en hetzelfde, onderwerp, aan te kaarten om te kletsen:), Robert (mijn gezellige nieuwe 
kamergenoot), Daphna,  Ellen D, Ine, Marjo, Nicole, Will, Mohammed, Danielle vd V, 
Maurice, Wilma, Brigitte, Roy, Olivier en Arjen. Allen bedankt! 
 
Dan zijn er nog een hoop mensen van andere afdelingen. Van Moleculaire Celbiologie, 
Andrea (for being a good friend, letting me win with squash, and for showing interest), Bert D 
(je hebt altijd je woordje klaar, of het nou gaat om bijhand te zijn, of om technische 
adviezen), Mieke en Bert S. voor techische adviezen en BrdU antilichamen. Verder, de 
mensen van Maastro en Pulmulogie voor hun bijdragen in de werkbesprekingen en 
journalclubs, waardoor we een breder blik op wetenschap kregen dan alleen PcG eiwitjes. 
Brad, Marianne, Jan, Roland, Kasper, Twan, Chantal, Ludwig, Michael, Maud, Sherry, 
Ashferd, Kim, Kim, Natasja en Younan van Maastro, en van Pulmunologie natuurlijk Jos (ook 
voor de nodige uurtjes zweten in de squashzaal en de wetenschappelijke praatjes tijdens het 
uitpuffen) en Ramon onder andere voor het deelnemen in de beoordelingscommissie. 
 
Vrienden en familie. De afgelopen jaren hebben veel mensen interesse getoond in mij en 
mijn onderzoeken. Aangezien dit teveel mensen zijn om iedereen persoonlijk te noemen: 
allen bedankt! Toch wil ik een aantal mensen persoonlijk noemen. Uiteraard mijn  
paranymfen, Joris en Eric. We gaan inmiddels een lange tijd terug. We hebben erg veel 
meegemaakt, en het is toch mooi om te zien dat we sinds de Einsteinstraat alle drie zo’n 
eind gekomen zijn. Ik ben er trots op dat jullie mij straks bij de verdediging als paranymf 
zullen bijstaan! Carmen, had je ooit kunnen denken dat er, toen je Eric leerde kennen, nog 
een verrassing in het pakket zat?? Je bent de afgelopen jaren een goeie vriendin geworden, 
en ik wil je ook bedanken dat Eric en ik de kans krijgen om onze vriendschap ten volle te 
benutten. Tom en Gemma, helaas kunnen jullie niet bij mijn promotie zijn, maar het goede 
werk dat jullie nu doen in Colombia is een inspiratie.  
En tenslotte, pap en mam. Tja, woorden zijn niet genoeg om mijn dankbaarheid te uiten. De 
stabiele thuisbasis heeft Tom en mij veel gebracht. Niet alleen een goede jeugd, maar ook 
de mogelijkheid om ons op allerlei terreinen te ontwikkelen, qua hobby’s en opleiding, maar 
zeker ook als mens. Hoewel de afstand af en toe wat groot is zijn we de afgelopen jaren nog 
meer naar elkaar toe gegroeid, en zonder jullie steun en vertrouwen had ik het nooit gered. 
Pap en mam, deze is voor jullie! 
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Frank Spaapen werd geboren op 7 februari 1978 te Haarlem en groeide op in Vogelenzang. In 
1990 rondde hij het VWO af op het Sancta Maria te Haarlem. In datzelfde jaar begon hij de studie 
Gezondheidswetenschappen aan de universiteit te Maastricht. Na gekozen te hebben voor het 
moleculair biologisch traject, voerde hij een korte stage uit op de afdeling Moleculaire Celbiologie 
onder supervisie van Bert Schutte. Tijdens deze stage werd klieving van cytokeratines tijdens 
inductie van apoptose bestudeerd. Tijdens zijn afstudeerstage aan de afdeling Gezondheidsrisico 
analyse en toxicologie werkte bij aan studies naar de genotoxische effecten van carcinogenen in 
humane longepitheelcellen. Deze stage was onder begeleiding van Prof. Dr. F.J. van Schooten en 
Danielle Curfs, en werd met succes afgerond waardoor hij in februari 2003 zijn diploma mocht 
ontvangen. Direct aansluitend op het afstuderen begon hij zijn werkzaamheden in de 
onderzoeksgroep van Dr. J.W. Voncken in de capaciteitsgroep Moleculaire Genetica aan de 
Universiteit Maastricht waar zijn interesse in moleculaire biologie zeer goed van pas kwam. Na een 
aantal maanden als analyst te hebben gewerkt, begon hij zijn promotieonderzoek naar de rol van 
PcG eiwitten tijdens chondrogene differentiatie. Na het afronden van het promotieonderzoek blijft 
hij werkzaam in de onderzoeksgroep van Dr. J.W. Voncken waar hij zich richt op de rol van PcG 
eiwitten tijdens replicatie timing. Door de toekenning van een EMBO fellowship wordt hij in staat 
gesteld om bekend te raken met  de technieken om replicatie timing te bestuderen onder 
begeleiding van Dr. V. Azuara op het Imperial College te Londen.   
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ACAN Aggrecan 
AP Antero-posterior 
ATM Ataxia telangiectasia mutated 
ATR Ataxia telangiectasia mutated- and Rad3-related 
BARR Barren 
BMI1 B-cell-specific Moloney murine leukemia virus integration site 1 
BMP Bone morphogenetic protein 
BrdU 5-bromo-2-deoxyuridine 
CBX  Chromobox protein 
ChIP  Chromatin immunoprecipitation 
Chk  Checkpoint kinase 
Col10a1 Collagen 10a1 
Col2a1 Collagen 2a1 
CRM Cramped 
CryGS γCrystalline 
DAPI 4',6-diamidino-2-phenylindole 
DDR DNA Damage Response 
DNMTs DNA methyltransferases 
DSB Double strand break 
DUB Deubiquitylase 
e.g.  Exempli gratia 
ECM Extracellular matrix 
EDR Early developmental regulator 
Egr Early growth response 
ERSS Endoplasmatic reticulum stress signaling 
ESCs Embryonal stem cells 
ETP Enhancer of Trithorax and Polycomb 
ETP Etoposide 
EZH2 Enhancer of Zeste homologue 
FC  Fold change 
FDA Food and Drug Administration 
GMNN Geminin 
GTF General transcription factor 
H2A Histone 2A 
H2AX Histone 2Ax 
H3K27me3 Histone 3 lysine 27 trimethylation 
H3K4 Histone 3 lysine 4 
H3K9me3 Histone 3 lysine 9 trimethylation 
H3S10 Histone 3 serine 10 
H3S28 Histone 3 serine 28 
HAT Histone acetyltransferase 
HDAC Histone deacetylase 
HIF1α Hypoxia inducible factor 1α 
HKMT Histone lysine methyltransferase 
HMT Histone methyltransferase 
HZ  Hypertrophic zone 
i.a. Inter alia 
i.e. id est 
IEG Immediate early gene 
Ihh Indian hedgehog 
Kap1 KRAB-associated protein1 
KD Knockdown 
LCR Locus control region 
LOF  Loss of function 
MAPK Mitogen activated protein kinase 
MCM Mini chromosome maintenance 
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MSC  Mesenchymal stem cell 
NSC Neuronal stem cell 
OIS  Oncogene induced senescence 
ORC Origin recognition complex 
PC Polycomb 
PC Perioseal callus 
PcG Polycomb Group 
PCNA Proliferating cell nuclear antigen 
PH Polyhomeotic 
PHC Polyhomeotic-like 
PIC  Pre-initiation complex 
PID Post induction of differentiation 
PO  Postoperative 
POSTN Periostin 
PRC Polycomb repressive complex 
PRE Polycomb responsive element 
pre-RC pre-Recognition complex 
PTHrP Parathyroid related protein 
PTM Posttranslational modification 
RING Really interesting new gene 
RNF2 Ring finger protein 
ROS  Reactive oxygen species 
RPOLII RNA polymerase II 
SAHF Senescence associated heterochromatin formation 
SASP Senescence associated secretory pheontype 
SAβGal Senescence associated β galactosidase 
SCMH Sexcombs on midleg homologue 
shRNA Short hairpin RNA 
siRNA Small interfering RNA 
SUZ12 Suppressor of Zeste 12 
TA transit amplification 
TBP  TATA-box binding protein 
TFIIA Transcription factor IIA 
TFIIB Transcription factor IIB 
TFIID Transcription factor IID 
TGFβ Transformation growth factor β 
Topo2 Topoisomerase 2 
TRX Trithorax 
UPR Unfolded protein response 
VEGF Vascular endothelial growth factor 
VPA Valproic acid 
WT Wildtype 
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Fig.3.2 Collagen Type II in periosteal reactive tissue (callus) 
 
 
          
 
Fig. 3.3 Periostin/POSTN expression in periosteum     Fig 3.4 BMP-4 expression in periosteal callus 
 
 
 
 
 
Fig 4.3 Egr1 is required for proper replication during chondrogenic replication 
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Fig 4.4c.  Egr1-LOF accumulate DNA damage Fig 4.5g.  Global histone modifications are 
affected in Egr1-LOF cells  
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Figure 5.3. ?H2Ax and BrdU staining in ATDC5 (A,B) and human primary chondrocytes (D). 
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Fig. 5.4 D,E Abnormal staining of histone modifications Fig. 5.4 C, F Senescence staining ATDC5 
cells and ribcage of wildtype mice 
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Figure 5.6. Accumulation of DNA damage at sites of deregulated replication and transcription.   
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Figure 5.7. IF analysis of Bmi1, Phc1, Geminin and ?H2Ax in ATDC5 shControl and shBmi1. 
 
 
 
 
Figure 5.S3. Accumulation of DNA damage in shBmi1 cells. 
 
 
 
 
Figure 5.S4. Bmi1-LOF results in DNA damage responses and a proliferative arrest 
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Figure 5.S4 continued. Bmi1-LOF results in DNA damage responses and a proliferative arrest 
 
 
 
 
 
 
 
 
 
Fig. 5.S5D. Senescence during     Fig. 5.S6 A,B Senescence staining on longitudinal bones 
chondrogenesis        ribcage/spinal column of wild type mice  
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  Fig 5.S8. IF staining for PCNA BrdU and pRPOL2 in ATDC5 shControl and shBmi1 at 2d pid. 
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